ESPE Abstracts

Contents

• Plenary Lectures
• • Oncofertility: From Bench to Bedside to Babies
  • • Oncofertility: From Bench to Bedside to Babies

      hrp0089pl1
  • Oxytocin and the healing power of love
  • • Oxytocin and the Healing Power of Love

      hrp0089pl2
  • Clinical and molecular genetics of corticothroph pituitary tumours (Cushings Disease)
  • • Abstract unavailable

      hrp0089pl3
  • Prediction, Identification, and Treatment of Early Stage Type 1 Diabetes
  • • Abstract unavailable

      hrp0089pl4
  • Dynamic control of tissue glucocorticoids - lessons for optimising replacement therapy
  • • Dynamic Control of Tissue Glucocorticoids - Lessons for Optimising Replacement Therapy

      hrp0089pl5
  • Personalized treatments using gut microbiome and clinical data
  • • Personalizing Treatments Using Microbiome and Clinical Data

      hrp0089pl6
  • New curative treatment strategies for Type 1 Diabetes
  • • Abstract unavailable

      hrp0089pl7
  • Turner syndrome: new insights from prenatal genomics and transcriptomics
  • • Turner Syndrome: New Insights from Prenatal Genomics and Transcriptomics

      hrp0089pl8
• Symposia
• • Recent developments in the understanding of Hypothalamo-pituitary disorders
  • • Molecular Basis of Pituitary Hormone Deficiency: From Mouse to Man and Back

      hrp0089s1.1
    • Stem Cells in the Pituitary: A Role for Regeneration?

      hrp0089s1.2
    • A Novel Role for Vasopressin in Parenting

      hrp0089s1.3
  • Gonads/DSD
  • • The Biology of Germ Cell Tumors in Disorders of Sex Development

      hrp0089s2.1
    • Disruption of Testicular Development and Function

      hrp0089s2.2
    • Abstract unavailable

      hrp0089s2.3
  • Recent consensus guidelines
  • • Diagnosis and Management of Silver-Russell Syndrome: First International Consensus Statement

      hrp0089s3.1
    • Abstract unavailable

      hrp0089s3.2
    • Pediatric Obesity—Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline

      hrp0089s3.3
    • Prevention and Management of Rickets

      hrp0089s3.4
  • Management of Late Effects of Cancer Therapy
  • • Abstract unavailable

      hrp0089s4.1
    • Hypogonadism in Girls after Cancer Therapy: Causes, Diagnosis, and Treatment

      hrp0089s4.2
    • Diagnosis and Treatment of Hypogonadism in Male Survivors of Childhood Cancer

      hrp0089s4.3
  • ISPAD - ESPE Preventing Late Complications in Children with T1D
  • • Abstract unavailable

      hrp0089s5.1
    • Re-defining Targets for Optimal T1D Control

      hrp0089s5.2
    • Abstract unavailable

      hrp0089s5.3
  • Molecular Mechanisms of Tissue Sensitivity to Glucocorticoids: Potential Clinical Implications
  • • Cardiomyocyte Glucocorticoid and Mineralocorticoid Receptors Antagonistically Regulate Heart Disease

      hrp0089s6.1
    • Immune Regulation by Glucocorticoids

      hrp0089s6.2
    • Chemical Modification of the Glucocorticoid Receptor as a Determinant of Tissue Glucocorticoid Sensitivity: Implications to Circadian Rhythms, Stress Response and Treatment of Pediatric Leukemia

      hrp0089s6.3
  • Bone
  • • X-linked Hypophosphataemic Rickets: Disease and Treatment

      hrp0089s7.1
    • Hypophosphatasia: Disease and Treatment

      hrp0089s7.2
    • Achondroplasia - New Hopes

      hrp0089s7.3
  • Thyroid disorders
  • • Thyroid Hormone Transporter Defects

      hrp0089s8.1
    • Central Hypothyroidism - an Update

      hrp0089s8.2
    • Paediatric Differentiated Thyroid Cancer: Outcome and Long Term Effects

      hrp0089s8.3
  • Novel advances in endocrine imaging
  • • Abstract unavailable

      hrp0089s9.1
    • Novel CNS Imaging Techniques

      hrp0089s9.2
    • Novel Techniques in Diagnostics of Bone Strength

      hrp0089s9.3
  • Paediatric obesity: Mechanisms and novel treatment
  • • Abstract unavailable

      hrp0089s10.1
    • Functional Leptin Deficiency Disorders and Treatment

      hrp0089s10.2
    • MC4R Agonists in the Treatment of Monogenic Disorders of Obesity

      hrp0089s10.3
  • Special Symposia: Nutrition and Growth
  • • It is not Just the Growth Hormone-IGF-I Axis

      hrp0089ss1.1
    • Fascinating Growth Phenomena: What Causes Individual Catch-up Growth and Population Secular Change?

      hrp0089ss1.2
    • Interaction between Nutrition, the Endocrine System and the Growth Plate

      hrp0089ss1.3
• Meet the Expert
• • The Role of Radiology in the Diagnosis of Skeletal Dysplasias
  • • The Role of Radiology in the Diagnosis of Skeletal Dysplasias

      hrp0089mte1.1
  • Endocrine Complications in Thalassaemia
  • • Endocrine Complications in Thalassaemia

      hrp0089mte2.1
  • (1) (1)
  • • Abstract unavailable

      hrp0089mte3.1
  • The Use of Modern Technologies to Optimize Diabetes Care
  • • The Use of Modern Technologies to Optimize Diabetes Care

      hrp0089mte4.1
  • Gonadal function in congenital adrenal hyperplasia (CAH)
  • • Gonadal Function in Congenital Adrenal Hyperplasia (CAH)

      hrp0089mte5.1
  • Management of Hypo and Hypercalcaemia
  • • Management of Hypo and Hypercalcaemia

      hrp0089mte6.1
  • (1)
  • • Abstract unavailable

      hrp0089mte7.1
  • Psychology of childhood diabetes: How to motivate children and families with T1DM
  • • Psychology of Childhood Diabetes: How to Motivate Children and Families with T1DM

      hrp0089mte8.1
• Novel Advances & Controversies in Paediatric Endocrinology
• • The clinical relevance of metabolomics; genomic engineering - CRISP-R/Cas9 and its many implications
  • • The Clinical Relevance of Metabolomics

      hrp0089na1.1
    • Abstract unavailable

      hrp0089na1.2
  • Cell engineering for treatment of diabetes
  • • Stem Cells as a Source of Beta Cells

      hrp0089na2.1
    • Induction of Pancreatic Beta-Cell Neogenesis

      hrp0089na2.2
  • Should growth hormone be used in ISS?
  • • PRO: Should GH Be Used in ISS?

      hrp0089con1.1
    • Abstract unavailable

      hrp0089con1.2
    • Abstract unavailable

      hrp0089con1.3
    • Abstract unavailable

      hrp0089con1.4
  • To prime or not to prime?
  • • PRO - To Prime or Not to Prime?

      hrp0089con2.1
    • Con-To Prime or Not to Prime

      hrp0089con2.2
• Henning Anderson Award
• • EAP1 mutations cause an impaired transcriptional activity on GnRH promoter that leads to self-limited delayed puberty
  • • EAP1 Mutations Cause an Impaired Transcriptional Activity on GnRH Promoter that Leads to Self-Limited Delayed Puberty

      hrp0089ha1
  • Generating a human gonadal cells model from terminal differentiated fibroblast-derived induced pluripotent stem cells
  • • Generating a Human Gonadal Cells Model from Terminal Differentiated Fibroblast-Derived Induced Pluripotent Stem Cells

      hrp0089ha2
• Working Groups
• • ESPE Disorders of Sex Development & Turner Syndrome Joint Session
  • • Long-Term Outcomes in Males with 45,X/46,XY Mosaicism: A Multicenter Study of 59 Males

      hrp0089wg1.1
    • Abstract unavailable

      hrp0089wg1.2
    • Cardiovascular Pathology in Males and Females with 45,X/46,XY Mosaicism

      hrp0089wg1.3
    • Abstract unavailable

      hrp0089wg1.4
    • Abstract unavailable

      hrp0089wg1.5
    • Abstract unavailable

      hrp0089wg1.6
  • ESPE Obesity Working Group (OWG)
  • • Abstract unavailable

      hrp0089wg2.1
    • Abstract unavailable

      hrp0089wg2.2
    • Abstract unavailable

      hrp0089wg2.3
    • Abstract unavailable

      hrp0089wg2.4
  • ESPE Bone and Growth Plate Working Group (BGP)
  • • Abstract unavailable

      hrp0089wg3.1
    • SHOX - From Gene to Growth Plate

      hrp0089wg3.2
    • Abstract unavailable

      hrp0089wg3.3
    • Abstract unavailable

      hrp0089wg3.4
    • Abstract unavailable

      hrp0089wg3.5
    • Abstract unavailable

      hrp0089wg3.6
  • ESPE Diabetes Technology and Therapeutics Working Group
  • • Abstract unavailable

      hrp0089wg4.1
    • Abstract unavailable

      hrp0089wg4.2
    • Use of Apps for Physical Activity in Type 1 Diabetes

      hrp0089wg4.3
    • The Future Role of Machine Learning and Computer Vision in Carbohydrate Estimation for Patients with Diabetes

      hrp0089wg4.4
    • Analyzing and Reporting of Sensor Glucose Levels

      hrp0089wg4.5
    • Updates on the Developments of Decision Support Systems for the Treatment of Diabetes

      hrp0089wg4.6
    • Use of Social Media for Improving Glucose Control in Patients with Type 1 Diabetes Use of Social Media for Improving Glucose Control in Patients with Type 1 Diabetes

      hrp0089wg4.7
  • ESPE Paediatric and Adolescent Gynaecology Working Group (PAG)
  • • Abstract unavailable

      hrp0089wg5.1
    • Abstract unavailable

      hrp0089wg5.2
    • Influence of Adiposity as a Determinant of the Age at Pubjeanertal Onset

      hrp0089wg5.3
    • Endocrine-Metabolic Outcome of Women with a History of Sexual Precocity

      hrp0089wg5.4
    • Abstract unavailable

      hrp0089wg5.5
  • ESPE Gender Dysphoria (GD)
  • • Abstract unavailable

      hrp0089wg6.1
    • Abstract unavailable

      hrp0089wg6.2
  • ESPE Paediatric Endocrine Nurse Specialists and Allied Health Professionals Working Group (PENS)
  • • Advanced Anthropometrics in Pediatric Endocrinology: Utility and Difficulty

      hrp0089wg7.1
    • Next Generation Nursing: Genomic Competencies for Pediatric Endocrine Nurses

      hrp0089wg7.2
    • Abstract unavailable

      hrp0089wg7.3
    • Abstract unavailable

      hrp0089wg7.4
    • Abstract unavailable

      hrp0089wg7.5
• Free Communications
• • Adrenals & HPA Axis
  • • A Novel Non-invasive Short Synacthen Test Validated in a Healthy Paediatric Population

      hrp0089fc1.1
    • Long-term Effects of Prenatal Dexamethasone Treatment and Postnatal Glucocorticoid Treatment on Brain Structure in the Context of CAH

      hrp0089fc1.2
    • Targetting the Binding of ACTH to the Melanocortin Receptor by Structure Modeling and Design of Peptide antagonists to Block Excess Androgens in 21-hydroxylase Deficiency

      hrp0089fc1.3
    • Whole Exome Sequencing in Patients with Primary Generalized Glucocorticoid Resistance Identifies a Novel TRIM28 Gene Mutation (p.R230X)

      hrp0089fc1.4
    • Untargeted Plasma Metabolomics in Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies a Novel metabolic Signature

      hrp0089fc1.5
    • A Novel Stem Cell Model for the Triple A Syndrome

      hrp0089fc1.6
  • Bone, Growth Plate & Mineral Metabolism 1
  • • Burosumab, a Fully Human anti-FGF23 Monoclonal Antibody, for X-linked Hypophosphatemia (XLH): Sustained Improvement in two Phase 2 Trials in Affected Children 1-12 years old

      hrp0089fc2.1
    • Whole Genome Sequencing Reveals Novel Intragenic Deletions of GNAS as Causes of Pseudohypoparathyroidism Type 1a

      hrp0089fc2.2
    • Clinical Course of Hypoparathyroidism in Patients with APECED (APS1)

      hrp0089fc2.3
    • Diagnostic Performance of Artificial Neural Network-based TW3 Skeletal Maturity Assessment

      hrp0089fc2.4
    • Radial ESWT Stimulates Longitudinal Bone Growth in Cultured Rat Fetal Metatarsal Bones

      hrp0089fc2.5
    • Final Height is Negatively Related to Disease Burden in Mitochondrial Disease

      hrp0089fc2.6
  • Diabetes and Insulin 1
  • • Neonatal Diabetes Owned to Potassium Channel Mutation: Response to Sulfonylureas According to the Genotype

      hrp0089fc3.1
    • Genome-Wide Meta-Analysis Identifies a Novel Low Frequency STK39 Variant of Large Effect on Risk of Type 1 Diabetes

      hrp0089fc3.2
    • Pediatric Patients with Type 1 Diabetes and Abnormal Nerve Conduction Studies Demonstrate Higher Neopterin Levels: Potential Role as a Biochemical Marker for Peripheral Neuropathy

      hrp0089fc3.3
    • Is the Glycaemic Response from Fat in Meals Dose Dependent in Children and Adolescents with T1DM on Intensive Insulin Therapy?

      hrp0089fc3.4
    • Genotype and Phenotype Correlation in Syndromic Forms of Hyperinsulinaemic Hypoglycaemia - a 10-year follow-up Study in a Tertiary Centre

      hrp0089fc3.5
    • Using CRISPR/Cas9 Gene Editing to Study the Molecular Genetics of Congenital Hyperinsulinism

      hrp0089fc3.6
  • GH & IGFs
  • • Monogenic and Digenic Gene Mutations are Present in Children with Idiopathic Short Stature (ISS)

      hrp0089fc4.1
    • Effects of IGF-1R Nuclear Localization in Glioblastoma Cells

      hrp0089fc4.2
    • The Reduction in Longitudinal Growth Induced By PAPP-A2 Deficiency is Associated with Reduced Body Weight, Increased Energy Expenditure and Behavior Modification

      hrp0089fc4.3
    • A Cross-Sectional Study of IGF-I Bioavailability Through Childhood and Associations with PAPP-A2, STC2 and Anthropometric Data

      hrp0089fc4.4
    • Prediction of Adult Height by Artificial Intelligence (AI) through Machine Learning (ML) from Early Height Data

      hrp0089fc4.5
    • Absorption and Excretion of Somapacitan, a Long-Acting Growth Hormone (GH) Derivative

      hrp0089fc4.6
  • Thyroid
  • • Beta1-Tubulin Gene (TUBB1) Mutations Cause Thyroid Dysgenesis Associated to Abnormal Platelet Morphology and Hyper-Aggregation

      hrp0089fc5.1
    • Enrichment of Inherited Rare Variants in Non-Syndromic Congenital Hypothyroidism from Thyroid Dysgenesis Identified By Exome Sequencing: the Contribution of IKBKE to Vasculogenesis and Thyroid Development

      hrp0089fc5.2
    • Computational Analysis of the Ligand Binding Domain of the Thyroid Hormone Receptor for the Rational Design of an Efficient Protein-Based Biosensor for the Detection of Thyroid Hormone Disrupting Chemicals

      hrp0089fc5.3
    • Thyroid Hormone Analog Therapy in Patients with MCT8 deficiency: the Triac Trial

      hrp0089fc5.4
    • Guidelines for the Management of Paediatric Differentiated Thyroid Carcinoma; a UK Endeavour

      hrp0089fc5.5
    • Alterations in DNA Methylation Status of Gene Promoters in Children and Adolescents with Autoimmune Thyroid Disease

      hrp0089fc5.6
  • Fat, Metabolism and obesity
  • • Correlations Between Measures of Adiposity Across Childhood and Adolescence and the Intestinal Microbiota in 15-17 year-old Children with a Family History of Obesity: Preliminary Findings from the QUALITY Cohort

      hrp0089fc6.1
    • Impaired Brain Satiety Responses to a Meal in Children with Obesity

      hrp0089fc6.2
    • Role of PTEN in the Proliferation and Differentiation of Preadipocytes

      hrp0089fc6.3
    • Identification of the First Obesity-Associated Mutations in Human Mesoderm-Specific Transcript (MEST) Result in Protein Overexpression, Adipocyte Hypertrophy and a Reduction in Adipocyte Mitochondrial Area

      hrp0089fc6.4
    • The Role of Adipocytes in Childhood Precursor Bcell Lymphoblastic Leukemia

      hrp0089fc6.5
    • MicroRNA-141 Directly Targets and Inhibits Sirtuins 1 Gene Expression and Its Elevation in Obese Subjects is Responsible for Reduced Levels of Sirtuin 1 and the Subsequent Hepatic Steatosis and Insulin Resistance

      hrp0089fc6.6
  • Fetal, Neonatal Endocrinology and Metabolism
  • • Expression and Localisation of Insulin, Glucagon, Amylin, Pancreatic Polypeptide and PDX-1 in Pancreatic Tissue of Children with Congenital Hyperinsulinism

      hrp0089fc7.1
    • Enteroinsular Hormone Responses During Fasting, Oral glucose Tolerance Test and Mixed Meal in Children with Hyperinsulinaemic Hypoglycaemia

      hrp0089fc7.2
    • Diazoxide-Induced Pulmonary Hypertension: UK Multicentre Retrospective Study on the Risk Factors, Monitoring Approach and Management Recommendations

      hrp0089fc7.3
    • Altered Substrate Specificities and Metabolite Production by Aromatase (CYP19A1) Due to the R192H Mutation

      hrp0089fc7.4
    • Thyroid Hormone Levels in Cord Blood are Associated with Fetal and Neonatal Growth

      hrp0089fc7.5
    • TSH-Resistance and Remaining Low-T4 in Former Low-Birthweight Infants - A Study in Monozygotic Twins with Intra-Twin Birth-Weight-Differences

      hrp0089fc7.6
  • Sex differentiation, Gonads and Gynaecology or Sex Endocrinology
  • • Estrogen Receptor 2 Variant as a Novel Cause for Dysgenetic Ovaries

      hrp0089fc8.1
    • Partial Restoration of Biological Effects of Estrogen in a Female with Estrogen Receptor [alpha] Variant

      hrp0089fc8.2
    • Exomic Sequencing Uncovers Novel Genetic Associations for Deciphering Developmental Disorders (DDD) Study Participants with Hypospadias, Cardiovascular and Neurodevelopmental Abnormalities

      hrp0089fc8.3
    • STARD8, a Novel Candidate Gene for 46,XY Disorders of Sex Development

      hrp0089fc8.4
    • DEAH-Box Helicase 37defects (DXH37) Deffects are a Novel Cause of 46,XY Gonadal Dysgenesis

      hrp0089fc8.5
    • The Roles of Steroids in Gonadal Development and Maintenance - Insights from a Zebrafish Model of Androgen and Cortisol Deficiency

      hrp0089fc8.6
  • Pituitary, neuroendocrinology and Puberty 1
  • • Novel Variants in the POU1F1 Beta Isoform are Associated with Isolated Growth Hormone Deficiency and Combined Pituitary Hormone Deficiency

      hrp0089fc9.1
    • Contribution of Functionally Assessed GHRHR Mutations to Idiopathic Isolated Growth Hormone Deficiency in a Cohort of 312 Unrelated Patients

      hrp0089fc9.2
    • Mutations in MAGEL2 and L1CAM are Associated with Congenital Hypopituitarism and Arthrogryposis

      hrp0089fc9.3
    • Neuroendocrine Morbidity after Paediatric Craniopharyngioma: a Longitudinal Single Centre Analysis of 93 Patients Over 30 Years

      hrp0089fc9.4
    • National Multidisciplinary Decision-Making Guideline for Children and Young People (Idiopathic Thickened Pituitary Stalk and/or Idiopathic Central Diabetes Insipidus

      hrp0089fc9.5
    • National UK Guidelines for Screening, Multi-Disciplinary Team Management and Long-Term Follow-Up of Children and Young People (CYP) with Multiple Endocrine Neoplasia Type 1 (MEN1)

      hrp0089fc9.6
  • Late Breaking
  • • Burosumab Improved Rickets, Phosphate Metabolism, and Clinical Outcomes Compared to Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH) - A Randomized Controlled Phase 3 Study

      hrp0089fc10.1
    • Efficacy and Safety of Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Results of a Randomised Open-Label, Controlled Phase 2 Trial

      hrp0089fc10.2
    • Identification of the MAPK/ERK Pathway as a Novel Therapeutic Target in Adamantinomatous Craniopharyngioma

      hrp0089fc10.3
    • Hypothalamus Sparing Surgery Improves the Outcome of Patients with Severe Initial Hypothalamic Involvement of Childhood Craniopharyngioma: Results of the Prospective Multinational Trial KRANIOPHARYNGEOM 2007

      hrp0089fc10.4
    • A 5-Year Single-Centre Experience on the Safety and Efficacy of Sirolimus Therapy used for the Treatment of Congenital Hyperinsulinaemic Hypoglycaemia

      hrp0089fc10.5
    • Primary Ovarian Insufficiency Incidence Rate and ETIOLOGY AMONG ISRAELI ADOLESCENTS between the Years 2000-2016 - A Multi-Center Study

      hrp0089fc10.6
  • Bone, Growth Plate & Mineral Metabolism 2
  • • Successful Immune Tolerance Induction in the First Case of Neutralizing Antibody Mediated Loss of Efficacy of Asfotase Alfa Treatment in Hypophosphatasia

      hrp0089fc11.1
    • Elevated Phosphate Levels Inhibit Skeletal Muscle Cell Differentiation In vitro

      hrp0089fc11.2
    • Evidence for Effects of FGF2 Aptamer in an Achondroplasia Mice Model and an In Vitro Chondrocyte Differentiation System Using Patient-Derived iPS Cells

      hrp0089fc11.3
    • Using Patient Derived Induced Pluripotent Stem Cells to Model Multiple Epiphyseal Dysplasia

      hrp0089fc11.4
    • A Recurrent 6-bp Intronic Deletion in NESP55 with Reduced Penetrance in Pseudohypoparathyroidism Type 1b

      hrp0089fc11.5
    • Management of Severe, Protracted Hypocalcaemia in Patients Undergoing Thymus Transplantation in a Tertiary Centre: A 10-Year Experience

      hrp0089fc11.6
  • Diabetes and Insulin 2
  • • Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Children and Adolescents: A Multicenter Prospective Study

      hrp0089fc12.1
    • Apoptosis and Oxidative Stress Markers During the Oral Glucose Tolerance Test (OGTT)

      hrp0089fc12.2
    • Impact of Insulin Sensitivity and [beta]-cell Function on the Development of Impaired Glucose Tolerance (IGT) in Obese European Children and Adolescents

      hrp0089fc12.3
    • How Does Thiol/Disulphide Homeostasis Change in Children with Type 1 Diabetes Mellitus?

      hrp0089fc12.4
    • Effect of Homocysteine-Lowering Therapy on Diabetic Nephropathy in children and adolescents with Type 1 Diabetes

      hrp0089fc12.5
    • Persistent Beneficial Effects of Metformin in Children and Adolescents with Type 1 Diabetes: Adelaide Metformin Randomized Controlled Trial Follow Up

      hrp0089fc12.6
  • Pituitary, Neuroendocrinology and Puberty 2
  • • Molecular Screening of Genes Associated with Central Precocious Puberty

      hrp0089fc13.1
    • Ablation of AgRP Neurons Decreases Survival in Activity-Based Anorexia Model

      hrp0089fc13.2
    • Role of GnRH Neuronal Migration and Development in Self-Limited Delayed Puberty

      hrp0089fc13.3
    • The Kallman Syndrome Gene Product is Specifically Expressed in ACTH-Expressing Cells and Dysplays Sexual Dimorphism Expression in Human Fetal Pituitary

      hrp0089fc13.4
    • Study of the Serum Kisspeptin Level in Healthy and Hypogonadotropic Boys

      hrp0089fc13.5
    • Teamwork Saves Lives: How Pediatric Multidisciplinary care can Prevent 'Unexplained Deaths' in Adults with Prader-Willi Syndrome

      hrp0089fc13.6
  • Multisystem Endocrine Disorders
  • • Awareness and Participation in Rare Disease Registries Within the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

      hrp0089fc14.1
    • National UK Guidelines for the Clinical Assessment, Diagnosis, Treatment and Follow-up of Children and Young People (CYP) Under 19 Years of Age with Phaeochromocytoma (PCC) and Paraganglioma (PGL) - On Behalf of the UK Paediatric Phaeochromocytoma and Paraganglioma Guideline Development Group (GDG)

      hrp0089fc14.2
    • Regulation of Salt, Sugar and Sex Steroids in Humans by Genetic Variations in NADPH Cytochrome P450 Oxidoreductase (POR) Identified in 1000 Genome Samples

      hrp0089fc14.3
    • Glucocorticoid Deficiency Causes Differentially Dysregulated Oxidative Stress Depending on the Steroidogenic Defects

      hrp0089fc14.4
    • Pubertal Females Produce an Enhanced Interferon-Alpha, Anti-viral Response Compared to Males, Which is Associated with X Chromosome Number, and Not Sex Hormones

      hrp0089fc14.5
    • Sex Differences in Autoimmune Disease: Testosterone is Associated with a Decrease in Expression of Key Anti-viral Genes During Puberty, Which may Decrease the Risk of Autoimmunity in Males

      hrp0089fc14.6
  • Growth and Syndromes
  • • The Diagnostic Yield of a Targeted Next Generation Sequencing Panel in Children with Short Stature of Undefined Aetiology

      hrp0089fc15.1
    • Effects of Caloric Restriction During Gestation on the Methylome of Offspring's Adipose Tissue and Reversibility of Such Effects by Metformin in a Swine Model

      hrp0089fc15.2
    • Methylation of the C19MC microRNA Locus in the Placenta: A Mechanism whereby Maternal Body Size Links to that of the Child

      hrp0089fc15.3
    • The Metabolic Profile Associated with RASopathies

      hrp0089fc15.4
    • Utility of BDNF and MMP-1 as Markers of Cardiometabolic Risk in Turner Syndrome Girls

      hrp0089fc15.5
    • Vosoritide for Children with Achondroplasia:a 30 Month Update from an Ongoing Phase 2 Clinical Trial

      hrp0089fc15.6
• Rapid Free Communications
• • Adrenals & HPA Axis
  • • The Relative Contributions of Genetic and Environmental Factors on Cortisol Metabolism at Pre-, Mid- and Post-Pubertal Ages

      hrp0089rfc1.1
    • Changes in CYP19A1 and CYP3A4 Activities due to Population Genetic Variations in Human P450 Oxidoreductase

      hrp0089rfc1.2
    • Sphingosine-1-Phosphate Lyase (SGPL1) Deficiency is Associated with Mitochondrial Dysfunction

      hrp0089rfc1.3
    • Mass Spectrometry-Based Assessment of Childhood Androgen Excess in 487 Consecutive Patients Over 5 Years

      hrp0089rfc1.4
    • Quantitative Urinary GC-MS Based Steroid Analysis for Treatment Monitoring of Adolescents and Young Adults with Autoimmune Primary Adrenal Insufficiency

      hrp0089rfc1.5
    • A Laboratory Harmonization Strategy for Steroid Hormone Profiling by MoM-Transformed, Normalized Reference Ranges Independent of Age, Sex and Units

      hrp0089rfc1.6
  • Bone, Growth Plate & Mineral Metabolism 1
  • • High-Resolution MRI Imaging of Bone-Muscle-Fat in Glucocorticoid Treated Boys with Duchenne Muscular Dystrophy: Results from the ScOT-DMD Study

      hrp0089rfc2.1
    • S-25OHD is Associated with Hand Grip Strength and Myopathy at Five Years in Girls: An Odense Child Cohort Study

      hrp0089rfc2.2
    • Measured Free 25-Hydroxyvitamin D in Healthy Children and Relationship to Total 25-Hydroxyvitamin D, Calculated Free 25-Hydroxyvitamin D and Vitamin D Binding Protein

      hrp0089rfc2.3
    • Novel Severe Skeletal Dysplasia with Under-Mineralisation Associated with Reduced In Utero Calcium Transport and TRPV6 Compound Heterozygous Variants

      hrp0089rfc2.4
    • Identification of Characteristic Neurological Complications in Infants with Achondroplasia by Routine MRI Screening

      hrp0089rfc2.5
    • The Novel R211Q POP1 Homozygous Mutation Causes Severe Short Stature But Uniquely Only Subtle Skeletal Dysplasia

      hrp0089rfc2.6
  • Diabetes and Insulin 1
  • • Diagnostics of Early Atherosclerosis Risk in Kids (DEAR-Kids): Retinal Vessel Analysis in Pediatric Type 1 Diabetes - Retinal Arteriolar Narrowing Caused By High HbA1c

      hrp0089rfc3.1
    • Personalized and Predictive Medicine for Pediatric Diabetes Through a Genetic Test Using Next Generation Sequencing

      hrp0089rfc3.2
    • Significant Prevalence of Severe Monogenic Immune Defects Among Children with Type 1 Diabetes and Low T1D-Genetic Risk Score

      hrp0089rfc3.3
    • Functional Characterization of a Novel KLF11 Mutation Identified in a Family with Autoantibody-Negative Type 1 Diabetes

      hrp0089rfc3.4
    • Recent Secular Change in Pre- and Postnatal Growth and Adiposity in Infants of Mothers with Gestational Diabetes

      hrp0089rfc3.5
    • Treatment Adherence and Weight Loss are Key Predictors of HbA1c One Year after Diagnosis of Childhood Type 2 Diabetes in UK

      hrp0089rfc3.6
  • GH & IGFs
  • • Abstract unavailable

      hrp0089rfc4.7
    • Data Mining and Computational Analysis of Human Growth Hormone Gene (GH1) Sequence in Normal Population to Identify Potential Variants with Disease-Causing Effects

      hrp0089rfc4.2
    • A Deletion Encompassing Exon 2 of the ALS Gene: Analysis of a Patient with ALS Deficiency and His Family

      hrp0089rfc4.3
    • A Longitudinal Study on miRNAs Circulating Levels in a Cohort of SGA and AGA Subjects, Evaluated During Childhood and Young Adulthood

      hrp0089rfc4.4
    • 12-Month Effects of Once-Weekly and Twice-Monthly Administration of Hybrid Fc-Fused Human Growth Hormone, GX-H9, Treatment in Pediatric with GHD Deficiency

      hrp0089rfc4.5
    • Effect of 2 Years of Growth Hormone Treatment on Glucose Tolerance in Adults with Prader-Willi Syndrome

      hrp0089rfc4.6
  • Thyroid
  • • Serum Levels of the Soluble Receptor for Advanced Glycation End Products are Reduced in Children with Hashimoto's Thyroiditis

      hrp0089rfc5.1
    • Analysis of Chosen Polymorphisms rs7138803 A/G - FAIM2, rs7093069 C/T - IL-2RA, rs5742909 C/T - CTLA-4 in Pathogenesis of Hashimoto's Thyroiditis in Children

      hrp0089rfc5.2
    • Incidence and Treatment Outcome of Childhood Thyrotoxicosis

      hrp0089rfc5.3
    • The Value of Cytological, Histological and US Examination to Determine of Management Children with Nodular Goiter

      hrp0089rfc5.4
    • Evidence for a Founder Effect in Multiple Endocrine Neoplasia 2

      hrp0089rfc5.5
    • DUOX2 Deficiency in Quebec: From Life-Threatening Compressive Goiter in Infancy to Lifelong Euthyroidism

      hrp0089rfc5.6
  • Fat, Metabolism and Obesity
  • • Abstract unavailable

      hrp0089rfc6.7
    • IGF-I at Four Months Associates to Visceral and Subcutaneous Adipose Tissue at 7 Years of Age

      hrp0089rfc6.2
    • Effect of the Melanocortin-4 Receptor Agonist, Setmelanotide, on Obesity and Hyperphagia in Individuals Affected by Bardet-Biedl Syndrome

      hrp0089rfc6.3
    • Functionality and Phenotypic Characteristics of Mutations in the Human Leptin Receptor

      hrp0089rfc6.4
    • High-Throughput Untargeted Plasma Metabolomics Unravels Gender Dimorphic Metabolic Trajectories in Naturally Conceived and ICSI Prepubertal Children

      hrp0089rfc6.5
    • Effects of Cherry's Extract on Increased Osteclastogenesis in Obese Children

      hrp0089rfc6.6
  • Fetal, Neonatal Endocrinology and Metabolism
  • • Next Generation Sequencing Results in 142 Patients with Congenital Hyperinsulinism

      hrp0089rfc7.1
    • Outcomes of a Quality Improvement Project Integrating Continuous Glucose Monitoring Systems into the Routine Management of Neonatal Hypoglycaemia

      hrp0089rfc7.2
    • Central Venous Cathether-Associated Thrombosis in Children with Congenital Hyperinsulinism

      hrp0089rfc7.3
    • Expression of MIR-576-5p in Umbilical Cord as a Novel Biomarker for the Identification of Catch-up Growth in Small-For-Gestational-Age Infants

      hrp0089rfc7.4
    • Alteration of Renal Corticosteroid Signaling Pathways in Preterm Infants: Neonatal Adaptation and Developmental Programming of Hypertension

      hrp0089rfc7.5
    • Assessment of Pituitary Stalk Anatomy by T2 DRIVE without Gadolinium in Pituitary Diseases

      hrp0089rfc7.6
  • Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology
  • • Male Fertility Genes Located in Y-Chromosomal Regions Display Differential mRNA Profiles in Response to GnRH Treatment of Cryptorchidism-Dependent Infertility

      hrp0089rfc8.1
    • High Mobility Group Box 1 (HMGB1) is Increased in Adolescents with Polycystic Ovarian Syndrome (PCOS) and Decreases after Treatment with Myo-Inositol in Combination with [alpha]-Lipoic Acid (MYO+ALA)

      hrp0089rfc8.2
    • Pharmacological Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS

      hrp0089rfc8.3
    • Establishing Age, Sex, and Method Related Reference Ranges for Anogenital Distance - a Marker of In Utero Androgen Action

      hrp0089rfc8.4
    • Latest Progress in Tissue Engineered Urethral Regeneration: From Rabbit to Dog, a Step from Human Clinical Trial for Surgical Treatment of VSD (Variation of Sex Development)

      hrp0089rfc8.5
    • Metabolic Profile of Young Adult Transgender Persons Who Started Gender Affirming Treatment in their Adolescence

      hrp0089rfc8.6
  • Pituitary, Neuroendocrinology and Puberty 1
  • • Clinical and Genetic Features of Central Precocious Puberty Associated with Complex Phenotypes

      hrp0089rfc9.1
    • Novel Variant in GNRHR Gene Regulatory Region in a Pedigree with Maternally Inherited Precocious Puberty

      hrp0089rfc9.2
    • What is the Best Parameter to Decide the Initial Dose of Depot Leuprolide Acetate in Girls with Idiopathic Central Precocious Puberty?

      hrp0089rfc9.3
    • REplacement of MAle mini-Puberty in Neonates and Children with Micropenis and Cryptorchidism due to Hypogonadotropic Hypogonadism: Results of the 'REMAP' Study ISRCTN13007297

      hrp0089rfc9.4
    • Non-Isolated Central Precocious Puberty: Prevalence of Brain Lesions and Other Associated Disorders

      hrp0089rfc9.5
    • Can Neuroimaging Predict Endocrine Morbidity in Congenital Hypothalamo-Pituitary (H-P) Disorders?

      hrp0089rfc9.6
  • Late Breaking
  • • Patients with GH Insensitivity and IGF-1 Resistance Harbour Copy Number Variants Causing a Silver-Russell-Like Phenotype

      hrp0089rfc10.1
    • Non-Inferiority Clinical Trial on Gonadotropinversus Pulsatile Gonadotropin-Releasing Hormone Infusion Therapy in Male Adolescent Patient Withcongenital Hypogonadotropic Hypogonadism

      hrp0089rfc10.2
    • Developmental Regulation of Obestatin and Adropin in Prader-Willi Syndrome and Non-Syndromic Obesity: Associations with Weight, BMI-z, HOMA-IR, and Lipid Profile

      hrp0089rfc10.3
    • Comparative Analysis between Immunoassay and Tandem Mass Spectrometry for Androgens before and after Human Recombinant Gonadotrophin in Children with Genital Ambiguity and 46,XY Karyotype

      hrp0089rfc10.4
    • Abstract unavailable

      hrp0089rfc10.5
    • Effect of the Current Treatment of X-Linked Hypophosphatemia During Growth on the Development of Osteoarticular Lesions in the Hyp Mouse Model

      hrp0089rfc10.6
  • Bone, Growth Plate & Mineral Metabolism 2
  • • Diagnosis and Management of Pseudohypoparathyroidism and Related Disorders: First International Consensus Statement

      hrp0089rfc11.1
    • Nationwide Hypophosphatemic Rickets Study

      hrp0089rfc11.2
    • Increased Levels of Bone Formation and Resorption Markers in Patients with Hypophosphatemic Rickets

      hrp0089rfc11.3
    • A New Form of Anhidrotic Ectodermal Dysplasia with Immunodeficiency Caused By Abolished Store-Operated Ca2+ Entry

      hrp0089rfc11.4
    • The Determinants of Skeletal Fragility in Children with Type 1 Diabetes Mellitus

      hrp0089rfc11.5
    • Reference Values of Automated Bone Age and Bone Health Index for Mexican Children and Adolescents

      hrp0089rfc11.6
  • Diabetes and Insulin 2
  • • Use of Acid-Suppressivemedications During Infancy and Early Childhood and Its Association with Type 1 Diabetes

      hrp0089rfc12.1
    • Bone Mineral Density is Increased in 276 Danish Children and Adolescents with Type-1-Diabetes

      hrp0089rfc12.2
    • Barriers and Sources of Support for the Performance of Physical Activity in Pediatric Type 1 Diabetes

      hrp0089rfc12.3
    • Use of Telemonitoring Via a Mobile Device App Reduces HbA1c in Type 1 Diabetic Children and Adolescents

      hrp0089rfc12.4
    • Insulin Gene Promoter Methylation Status in Greek Children and Adolescents with Type 1 Diabetes

      hrp0089rfc12.5
    • AMGLIDIA, a Suspension of Glibenclamide for Patients with Neonatal Diabetes, Long Term Data on Efficiency and Tolerance

      hrp0089rfc12.6
  • Pituitary, Neuroendocrinology and Puberty 2
  • • Risk of Long-Term Endocrine Sequelae in Survivors of Progressing Childhood Optic Pathway Glioma (OPG) Treated by Upfront Chemotherapy: Preliminary Analyses of 102 Subjects from the French Multicentric BB-SFOP Registry

      hrp0089rfc13.1
    • Growth Outcomes and Near Adult Height of Children with Congenital GH Deficiency (GHD) due to Abnormal Pituitary Development: Data from a Prospective, Multinational Observational Study

      hrp0089rfc13.2
    • Circulating MKRN3, Kisspeptin and IGF-1 Levels in Girls During the Clinical Onset of Puberty

      hrp0089rfc13.3
    • Gain in Predicted Adult Height Using the Combination of an LHRH Analogue and an Aromatase Inhibitor in Early Maturing Girls with Compromised Growth for 2 yrs or Until the Age of 11 is Maintained and Further Improved by Aromatase Inhibitor Monotherapy: Results on Final Height of the 'GAIL' Study ISRCTN11469487

      hrp0089rfc13.4
    • Pubertal Voice Break: Temporal Relation of Secondary Sexual Characteristics in Healthy Boys

      hrp0089rfc13.5
    • Close Correlation between Salivary and Blood Steroids in Normal Boys: Salivary Testosterone Best Characterizes Male Puberty

      hrp0089rfc13.6
  • Multisystem Endocrine Disorders
  • • Psychometric and Psycho-social Profile of Children and Adolescent Survivors of Pediatric Cancer

      hrp0089rfc14.1
    • British Society for Paediatric Endocrinology and Diabetes Peer Review of Specialised Paediatric Endocrinology Services in the UK - Evaluation of the Outcomes

      hrp0089rfc14.2
    • Dysregulated Glucose Homeostasis in Congenital Central Hypoventilation Syndrome

      hrp0089rfc14.3
    • A Novel Germline DICER1 Mutation in a Girl with Multinodular Goiter and Ovarian Sertoli-Leydig Cell Tumor

      hrp0089rfc14.4
    • Natural Course of MEN Type 2B Syndrome; a Dutch Single-Center Cohort

      hrp0089rfc14.5
    • Identification of Epithelial Sodium Channel (ENaC) in Endometrial Pipelle Biopsy Samples

      hrp0089rfc14.6
  • Growth and syndromes
  • • Diagnosis of Silver-Russell Syndrome in Patients with Chromosome 14q32.2 Imprinted Region Disruption: Phenotypic and Molecular Analysis

      hrp0089rfc15.1
    • Molecular and Clinical Analyses of Two UPD(16)mat Patients Detected by Screening of 94 Silver-Russell Syndrome Patients without Known Etiology

      hrp0089rfc15.2
    • Multiple Pituitary Hormone Deficiencies and Early Onset Obesity in Two Siblings with a Mutation in the MAGEL2-gene: Evidence for an Important Regulatory Function of the MAGEL2-gene in the Hypothalamic-Pituitary Hormone Pathways

      hrp0089rfc15.3
    • Characteristics, Effectiveness and Safety Data from Clinically Relevant Subgroups of Patients with Severeprimary IGF-I Deficiency (SPIGFD): Results from the European Increlex® Growth Forum Database (EU-IGFD) Registry

      hrp0089rfc15.4
    • Effect of Adjusting for Tanner Stage Age on Short and Tall Stature Prevalence in US Youths

      hrp0089rfc15.5
    • Latest Results from PATRO Children, a Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment

      hrp0089rfc15.6
• Poster Presentations
• • Adrenals and HPA Axis P1
  • • Evaluation of Long Term Metabolic Effects After Prenatal Dexamethasone Treatment in the Context of CAH - the Swedish Cohort

      hrp0089p1-p001
    • Obesity and Cardio-metabolic Risk Factors among Children and Adolescents with Non-Classic 21-Hydroxylase Deficiency

      hrp0089p1-p002
    • Cognition in Children with Congenital Adrenal Hyperplasia

      hrp0089p1-p003
    • Carriers of CYP21A2 Mutations have Decreased Mortality in Infectious Diseases, Anational Population Registry Study

      hrp0089p1-p004
    • Elevated Concentrations of Adrenal Steroid Precursors with Glucocorticoid Activity Might Prevent Addisonian Crisis in Untreated Patients with Classic Congenital Adrenal Hyperplasia

      hrp0089p1-p005
    • Altered DNA Methylation in Peripheral T-cells from Patients with Congenital Adrenal Hyperplasia

      hrp0089p1-p006
    • Birth Incidence, Age at Diagnosis, Mortality in Congenital Adrenal Hyperplasia in Korea: A Nationwide Population-based Study

      hrp0089p1-p007
    • Impact of Puberty on Final Height in Children and Adolescents with Congenital Adrenal Hyperplasia (CAH)

      hrp0089p1-p008
    • The Relationship of Baseline, Incremental and Peak Cortisol Following a Short Synacthen Test - Single-centre Analysis of Three Years' Data

      hrp0089p1-p009
    • The Circadian Rhythm of Cortisol Binding Globulin has Little Impact on Cortisol Exposure after Hydrocortisone Dosing

      hrp0089p1-p010
    • Characterizing the Steroidome in Ammniotic Fluid of Mid-gestation by LC-MS/MS

      hrp0089p1-p011
    • Pediatric Adrenocortical Tumors. A Single Tertiary Center Experience: Clinical, Biological and Pathologic Characteristics Analysis

      hrp0089p1-p012
    • Role of Mast Cells in the Establishment of the Mineralocorticoid Pathway in the Developing Mouse

      hrp0089p1-p013
    • Molecular Characterization of TNXA/TNXB Chimeras in CYP21A2 Gene Deletions: High Frequency of Undiagnosed Ehlers-Danlos Syndrome in Congenital Adrenal Hyperplasia Patients

      hrp0089p1-p014
    • New Insights into Low Dose Dexamethasone Suppression Test in Paediatric Cushing's Syndrome

      hrp0089p1-p015
    • Recurrent Hypoglycemia in a Preschooler Girl with Overgrowth: Isolated ACTH-Deficiency with a Novel TPIT Mutation

      hrp0089p1-p016
    • Biochemical, Genetic and Molecular Characterization of a Novel P399_E401Dup Mutation in P450 Oxidoreductase (POR) Altering Several Enzymatic Activities in a Patient with a 46,XX DSD Phenotype at Birth

      hrp0089p1-p017
    • Young Lean Women with Evidence of Both Premature Adrenarche and Pubarche Display a Metabolic, Hormonal and Psychologic Profile that is Similar to that of their Peers with Polycystic Ovary Syndrome

      hrp0089p1-p018
    • The Usefulness of Combined Analysis of Serum and Salivary Maximum Cortisol Response to Low-Dose ACTH Test to Define the Requirement of Hormone Replacement Treatment

      hrp0089p1-p019
    • High DHEAS (HD) in Girls Determines Earlier Pubertal Maturation and Mild Hyperandrogenism throughout Pubertal Development

      hrp0089p1-p020
    • Higher Dehydroepiandrosterone Levels in Prepubertal Children Born Very Preterm

      hrp0089p1-p021
    • A Large Consanguineous Family with a Mild and Transient form of Autosomal Recessive Pseudohypoaldosteronism type 1 (PHA1) Caused by a Novel Mutation in the SCNN1A Gene: Functional Studies

      hrp0089p1-p022
    • Associations Between Maternal and Offspring Hair Cortisol Concentrations and Child Behavioral Symptoms in Pairs of Children 18-48 Months Old and their Mothers With and Without Perinatal Mental Disorders

      hrp0089p1-p023
    • Gonadotropin-Dependent Pubertal Disorders are Common in Patients with Virilizing Adrenocortical Tumors in Childhood

      hrp0089p1-p024
  • Adrenals and HPA Axis P2
  • • Contribution of Direct Measurements of Steroids by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) in Non-classical Adrenal Hyperplasia (NCCAH)

      hrp0089p2-p001
    • GnRH-analogue Treatment in Children with Congenital Adrenal Hyperplasia (CAH): Data from a Multicenter CAH Registry

      hrp0089p2-p002
    • Glucocorticoid Replacement Regimens in the Treatment of 21-hydroxylase Deficiency Congenital Adrenal Hyperplasia: A Systematic Cochrane Review

      hrp0089p2-p003
    • Hydrocortisone (HC) Dose in Children with Congenital Adrenal Hyperplasia (CAH)

      hrp0089p2-p004
    • Perioperative Care of CAH - Incongruencies of Practices among Canadian Specialists

      hrp0089p2-p005
    • Analysis of Phenotypes and Genotypes in 84 Patients with 21-hydroxylase Deficiency

      hrp0089p2-p006
    • Miscarriages in Families with a Child with Classic Congenital Adrenal Hyperplasia and 21-Hydroxylase Deficiency (CAH)

      hrp0089p2-p007
    • Testing Antiandrogens and Aromatase Inhibitors to Achieve Normal Growth in Children with Classical Congenital Adrenal Hyperplasia: A Systematic Review and Meta-analysis

      hrp0089p2-p008
    • Phenotype-genotype Correlations of CYP21A2 Mutations in Patients with Congenital Adrenal Hyperplasia in Turkey

      hrp0089p2-p009
    • Hypoglycemic Crisis and Salt Loss in Children with Classic Congenital Adrenal Hyperplasia

      hrp0089p2-p010
    • Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38 935 Infants

      hrp0089p2-p011
    • Autoantibodies Against 21-Hydroxylase in Prediction of Adrenal Failure in APECED Patients

      hrp0089p2-p012
    • A First Combination Case of 21-Hydroxilase Deficiency and CHARGE Syndrome Confirmed by Genetic Analysis

      hrp0089p2-p013
    • Frequency of Enzyme Deficiencies in a Turkish Cohort of Congenital Adrenal Hyperplasia: A Single-Center Experience with 145 Patients

      hrp0089p2-p014
    • Study of Cardiovascular Risk Factors and Carotid Intima-Media Thickness in Children with Congenital Adrenal Hyperplasia

      hrp0089p2-p015
    • The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis

      hrp0089p2-p016
    • Childhood Growth Advancement in Girls with Premature Adrenarche Heralds Anabolic Effects by Adulthood

      hrp0089p2-p017
    • A Novel Mutation in the MC2R Gene in a Two-year-old Boy with Adrenal Insufficiency

      hrp0089p2-p018
    • Two Cases of Apparent Mineralocorticoid Excess due to Novel Mutations in HSD11B2 Gene

      hrp0089p2-p019
    • Long-term Follow-up of Safety and Disease Control for Hydrocortisone Granules Designed to give Age-appropriate Dosing with Taste Masking to Children with Adrenal Insufficiency

      hrp0089p2-p020
    • Borderline Peak Plasma Cortisol Following Synacthen Stimulation - Single-centre Analysis of Three Years Data

      hrp0089p2-p021
    • Unilateral Adrenalectomy for Primary Pigmented Nodular Adrenocortical Disease Causing Cushing Syndrome

      hrp0089p2-p022
    • Adrenal Crisis in Children with Adrenal Insufficiency: Prevalence and Risk Factors

      hrp0089p2-p023
    • The Effectiveness of a Stress-Management Intervention Program in Behavioral Parameters and Hair Cortisol Concentrations in Children with Attention Deficit Hyperactivity Disorder

      hrp0089p2-p024
    • Very High Dehydroepiandrosterone Sulfate (DHEAS) in Serum of an Overweight Female Adolescent without a Tumor

      hrp0089p2-p025
    • Early Recognition of Adrenal Insufficiency after Hematopoietic Stem Cell Transplantation During Childhood

      hrp0089p2-p026
    • Reference Values for Serum 17-alfa Hydroxyprogesterone and Adrenal Size in Healthy Newborns

      hrp0089p2-p027
    • A Rare Case of ACTH-Independent Cushing's Syndrome due to Bilateral Micronodular Adrenal Hyperplasia and Myoclonic Dystonia

      hrp0089p2-p028
    • Two Siblins and Three Cousins with Allgrove (4A) Syndrome in a Turkısh Family: A Novel Mutation in the 'Aladin' Gene

      hrp0089p2-p029
    • Ganglioneuroma Presenting as an Adrenal Incidentaloma in a 10-year-old boy-a Rare Entity

      hrp0089p2-p030
    • The Relationship Between Vitamin D Status and Metabolic Abnormalities in Females with Classical Congenital Adrenal Hyperplasia: A Pilot Study

      hrp0089p2-p031
    • Adrenal Hypoplasia Seemingly First as a Primary Hypoaldosteronism

      hrp0089p2-p032
    • Quantitative Ultrasound Evaluation in a Cohort of 43 Young Adults with Classical CAH due to 21-Hydroxylase Deficiency (21OHD): Is Bone Mineral Quality Impaired?

      hrp0089p2-p033
    • Etiology of Primary Adrenal Insufficiency in Children: a 29-year Single Center Experience

      hrp0089p2-p034
    • Pseudopubertas Praecox in a 4 Year Old Boy with Bilateral Atypical Adrenocortical Adenomas

      hrp0089p2-p035
  • Adrenals and HPA Axis P3
  • • Congenital Adrenal Hyperplasia: A Patient's Perspective, a Mother's Story

      hrp0089p3-p001
    • An Extremely Rare Cause of Cushing Syndrome in Chidhood

      hrp0089p3-p002
    • Nelson's Syndrome after Bilateral Adrenalectomy for Cushing's Disease in Pediatric Age - Report of a Case

      hrp0089p3-p003
    • Basal Levels of 17-hydroxyprogesterone can Distinguish Isolated Precocious Pubarche from Non-Classical Congenital Adrenal Hyperplasia in Children: A Prospective Observational study

      hrp0089p3-p004
    • Age at Diagnosis and Outcome in Maghreb patients with 21-hydroxylase Deficient Congenital Adrenal Hyperplasia; Urgent need for Newborn Screening

      hrp0089p3-p005
    • An Adrenal Tumor Ppresenting as a Premature Pubarche in a 7 Year-old Girl

      hrp0089p3-p006
    • Refractory Cyclical Cushing's Disease - a Case of Multiple Pituitary Micro-adenomas in a Three Year Old Girl after 8 Years Follow up

      hrp0089p3-p007
    • Topical Corticosteroid-Induced Adrenal Insufficiency

      hrp0089p3-p008
    • Early Diagnosis of Duchenne Muscular Dystrophy in 6-Months-Old Male with Primary Adrenal Insufficiency

      hrp0089p3-p009
    • Lipoid Adrenal Hyperplasia Diagnosed with Severe Cholestasis in Newborn

      hrp0089p3-p010
    • Severe Hyponatraemia with Absence of Hyperkalaemia in a Patient with Addison's Disease

      hrp0089p3-p011
    • Deep Bronze Skin without Sun Exposition in a 16-Year Old Girl

      hrp0089p3-p012
    • Case of Primary Pigmented Nodular Adrenocortical

      hrp0089p3-p013
    • Two Case Report of Adrenocortical Adenoma

      hrp0089p3-p014
    • A Homozygous Mutation c.518T>A (p.lle173Asn) of the CYP21A2 Gene Presenting as Non-Classical Congenital Adrenal Hyperplasia (NCAH)

      hrp0089p3-p015
    • Adrenals and HPA Axisa; Atypical Presentation of Adrenal Insufficiency

      hrp0089p3-p016
    • Non-classic Congenital Adrenal Hyperplasia Causing Alleles among Adolescent Girls with PCOS - Genetical Study

      hrp0089p3-p017
    • Adequate Interpretation of Cortisol Levels in Children

      hrp0089p3-p018
    • Erythrocytosis as First Manifestation of Adrenal Mass

      hrp0089p3-p019
    • A Neonatal Case with Familial Glucocorticoid Deficiency Type 1 Having Adrenal Crisis in Early Period

      hrp0089p3-p020
    • Presenting Features, Clinical Characteristics and Follow up of Familial Isolated Glucocorticoid Deficiency (FGD) due to Mutations in MC2R and MRAP Genes

      hrp0089p3-p021
    • Identification of X-linked Adrenoleukodystrophy in Boys Presenting with Adrenal Insufficiency in the Absence of Adrenal Antibodies

      hrp0089p3-p022
    • Secondary Hyperaldosteronism in the Course of Cystic Fibrosis

      hrp0089p3-p023
    • The P30L Mutation in the CYP21A2 Gene in a Girl with Congenital Adrenal Hyperplasia with Hidden Salt Loosing and Central Precocious Puberty

      hrp0089p3-p024
    • Congenital Adrenal Hyperplasia due to a Rare Homozygous Mutation R483P in the CYP21A2 Gene and Coexisting Growth Hormone Deficiency

      hrp0089p3-p025
    • Rare Case of Androgen Producing Tumor in 14 Month Old Girl

      hrp0089p3-p026
    • Adrenocortical Tumours in Children - A Case Series

      hrp0089p3-p027
    • Discrete Virilization in Girls with the Classic Form of Congenital Adrenal Hyperplasia: the Importance of a Detailed Genital Examination at Birth

      hrp0089p3-p028
    • A New Methodology for Early Identification of Steroid Resistant Acute Graft-Versus-Host Disease Patients

      hrp0089p3-p029
    • Delayed Diagnosis of a Patient with Antley-Bixler Syndrome

      hrp0089p3-p030
    • Clinical and Biochemical Phenotype of Aldosterone Synthase Deficiency

      hrp0089p3-p404
    • Is the Third Time Really a Charm? The Story about Three Brothers Suffering from Adrenoleukodystrophy and about HSCT being a Chance to Stop the Unstoppable Disease

      hrp0089p3-p414
  • Bone, Growth Plate & Mineral Metabolism P1
  • • Intrauterine Growth Restriction, Antenatal Steroids, Gestational Age and Breast Feeding Influence Bone Health in Prepubertal Children Born Preterm

      hrp0089p1-p025
    • Duration of Breastfeeding and Bone Mineral Density in Childhood - A Prospective Study Among Preschool Children

      hrp0089p1-p026
    • Bone Health in Adolescents Born Small for Gestational Age (SGA)

      hrp0089p1-p027
    • Longitudinal Study of Bone Mass in Swedish Children Treated with Modified Ketogenic Diet

      hrp0089p1-p028
    • Fracture Epidemiology for Children in Western Australia between 2005-2015: Do We Need to be Concerned about Bone Health?

      hrp0089p1-p029
    • Bone Biochemistry in Children with Fractures Presenting with Suspected Non-accidental Injury

      hrp0089p1-p030
    • Systematic Screening Using DXA Lateral Vertebral Morphometry is Associated with a High Prevalence of Vertebral Fractures in Duchenne Muscular Dystrophy: Results from ScOT-DMD Study

      hrp0089p1-p031
    • Bone Mineral Density and Glycemic Control in Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0089p1-p032
    • Comparison of Manual and Automated Bone Age Assessment in 1285 Children and Adolescents Aged 5 to 16 Years

      hrp0089p1-p033
    • Is Plasma C-Type Natriuretic Peptide Level Available for Typing and Diagnosis of Skeletal Dysplasia Cases?

      hrp0089p1-p034
    • Long-term Outcomes of Osteogenesis Imperfecta in the Bisphosphonate Era

      hrp0089p1-p035
    • Novel LRP5 Loss-of-function Mutation Causes Osteoporosis-pseudoglioma Syndrome

      hrp0089p1-p036
    • Hypercalcaemia after Treatment with Denosumab in Children: Bisphosphonates as an Option for Therapy and/or Prevention?

      hrp0089p1-p037
    • Disease Burden and Systemic Manifestations of HPP in Children Enrolled in the Global HPP Registry

      hrp0089p1-p038
    • 3-epi-25 Serum 25-hydroxyvitamin D3 Concentrations in Chilean Children between 5 and 8 Years

      hrp0089p1-p039
  • Bone, Growth Plate & Mineral Metabolism P2
  • • Length Estimation Based on Clinical and Anthropometric Measures in Newborns

      hrp0089p2-p036
    • Vitamin D Deficient (Nutritional) Rickets Presenting in Infancy

      hrp0089p2-p037
    • The Effect of Vitamin D Receptor Polymorphism on Bone Mineral Density in Egyptian Patients with Beta Thalassemia Major

      hrp0089p2-p038
    • Vitamin D in Adolescents: A Comprehensive Review of Guidelines and Recommendations

      hrp0089p2-p039
    • X-linked Hypophosphatemia Registry - An International Prospective Patient Registry

      hrp0089p2-p040
    • Clinical and Biological Parameters Associated to the Severity of X-linked Hypophosphatemia in Children

      hrp0089p2-p041
    • High Fibroblast Growth Factor (FGF) 23: An Unusual Cause of Severe Osteoporosis in a Patient with Chronic Liver Disease

      hrp0089p2-p042
    • Metabolic Syndrome in Children with X-linked Hypophosphatemic Rickets (XLHR)

      hrp0089p2-p043
    • High Incidence of Cranial Synostosis and Chiari Malformation in Children with X-linked Hypophosphatemic Rickets

      hrp0089p2-p044
    • An Unusual Case of Hypophosphatemia in a Child Affected by Di George Syndrome

      hrp0089p2-p045
    • Novel SLC34A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia

      hrp0089p2-p046
    • A Novel Variant of SLC34A1 Gene in an Infant with Idiopathic Infantile Hypercalcemia

      hrp0089p2-p047
    • Infantile Arterial Calcification and Subsequent Hypophosphatemia due to ENPP1 Mutation - A Case Followed through to Adulthood

      hrp0089p2-p048
    • Pediatric Quality of Life Inventory in Children with Osteogenesis Imperfect in Dr Soetomo Hospital Surabaya

      hrp0089p2-p049
    • Osteoporosis-pseudoglioma Syndrome (OPPG): Improvement of Osteoporosis on Biphosphonate Therapy

      hrp0089p2-p050
    • Bone Marrow Adiposity and IGF System in Obese Children and Adolescents

      hrp0089p2-p051
    • Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency

      hrp0089p2-p052
    • Follow-up on Bone Health in Children with Acute Lymphoblastic Leukemia (ALL)

      hrp0089p2-p053
    • Effect of Pubertal Inductionn Bone Mass Accrual, in Adolescent Boys with Duchenne Muscular Dystrophy

      hrp0089p2-p054
    • Oxandrolone Improves the Linear Growth and Osteoporosis in Teenage Bays with Osteogenesis Imperfecta

      hrp0089p2-p055
    • First Reported Cases of a Novel Variant of GNAS 1 Gene

      hrp0089p2-p056
    • An Unusual Cause of Short Stature

      hrp0089p2-p057
    • Validation of an Automated Method (BoneXpert) for the Determination of Bone Age in Paediatric Endocrinology - A Single Centre Experience

      hrp0089p2-p058
    • Arthrogryposis Multiplex Congenita Type II and Panhypopituitarism

      hrp0089p2-p059
  • Bone, Growth Plate & Mineral Metabolism P3
  • • Growth Hormone Treatment of 2 Patients with X-linked Hypophosphatemic Rickets Caused by PHEX Mutation: Effects on Linear Growth

      hrp0089p3-p031
    • A Novel Homozygous Mutation in the CASR Gene in a Neonate with Severe Primary Hyperparathyroidism; A Case Report

      hrp0089p3-p032
    • A 13 Year-Old Boy Diagnosed as Osteogenesis Omperfecta with Normal Bone Mineral Density

      hrp0089p3-p033
    • A Rare Cause of Hypercalcemia in Childhood: Hypercalcemia Associated with Parathormon-Related Peptid

      hrp0089p3-p034
    • Our Treatment Experience with Nocturnal Continuous Enteral Calcium Infusion in a Case with Vitamin D Resistance Rickets Type II

      hrp0089p3-p035
    • A Novel COL1A2 Gene Mutation in a Turkish Family with Osteogenesis Imperfecta

      hrp0089p3-p036
    • Hypophosphatemic Hypercalciuric Ricket: 3 Brothers with Dent's Disease

      hrp0089p3-p037
    • Infantile Hypophosphatasia

      hrp0089p3-p038
    • Carbonic Anhydrase Deficiency: Three Siblings

      hrp0089p3-p039
    • A Novel p.Gly775Glu Missense COL1A2 Mutation Causes Severe Osteogenesis Imperfecta in a Prepubertal Girl

      hrp0089p3-p040
    • SHOX Gene Deletion Screening by FISH in Children with Short Stature and Characteristics of Patients

      hrp0089p3-p041
    • Pseudoachondroplasia

      hrp0089p3-p042
    • Low Level of Vitamin D in Children Increases the Risk of Bone Fractures

      hrp0089p3-p043
    • Clinical Evaluation of Eight Patients with Parathyroid Adenoma

      hrp0089p3-p044
    • Idiopathic Hypoparathyroidism in a 10 Year-Old Girl with Concomitant Epilepsy, Long Q-T Syndrome (LQTS), Pericarditis and Pneumonia

      hrp0089p3-p045
    • The Level of the Vitamin D and Bone Mineral Density in Children with Obesity

      hrp0089p3-p046
    • Evaluation of Bone Mineral Density and Bone Metabolism Markers in Children Diagnosed as Celiac Disease

      hrp0089p3-p047
    • Comparison of Serum 25-Hydroxy Vitamin D Levels among Children & Adolescence with Attention Deficit Hyperactivity Disorder and Healthy Lranian People

      hrp0089p3-p048
    • Evaluating the Effect of Zoledronic Acid on Treatment of Primary and Secondary Pediatric Osteoporosis at Children's Hospital 1 in Vietnam

      hrp0089p3-p049
    • Hypocalcemia Secondary to Maternal Vitamin D Deficiency

      hrp0089p3-p050
    • Clinical and Genetic Evaluations of Three Patients with Vitamin D Dependent Rickets Type 1A

      hrp0089p3-p051
    • A Rare Case of Familial Hypocalcemia

      hrp0089p3-p052
    • HDR Syndrome: A Case Report of Hypoparathyroidism, Hearing Loss and Renal Agenesis

      hrp0089p3-p053
    • Growth in The Coeliac Disease of The Child

      hrp0089p3-p054
    • The British OsteoNEcrosis Study: A Multi-centre Prospective Study

      hrp0089p3-p055
    • Response to Pamidronate Therapy and Pharmacogenetics in Patients with Osteogenesis Imperfecta

      hrp0089p3-p056
    • Results of 22 Weeks of Burosumab Therapy in a Patient with Severe Bone Deformities due to XLH

      hrp0089p3-p057
    • Severe Neonatal Hypercalcemia: A Challenging Case

      hrp0089p3-p058
    • Assessment of Vitamin D Status in Healthy Pre-pubertal Egyptian Children

      hrp0089p3-p059
    • Are Caucasian Children at Risk of Sub-optimal Vitamin D Levels?

      hrp0089p3-p060
    • Incidence Rate of Vitamin D Deficiency in 12-year Old Children in Japan

      hrp0089p3-p061
    • Idiopathic Juvenile Osteoporosis: Common Symptoms in an Uncommon Condition

      hrp0089p3-p062
    • Abstract unavailable

      hrp0089p3-p063
    • Hypercalcemia Associated with Increased Parathyroid Hormone-related Protein (PTHrP) in a Patient with Medulloblastoma Successfully Treated with Pamidronate

      hrp0089p3-p064
    • A Novel Deletion Mutation in the GLUT 2 Gene in a Patient with Fanconi Bickel Syndrome

      hrp0089p3-p065
    • A Case of Turner Syndrome with Graves' Disease and Primary Hyperparathyroidism

      hrp0089p3-p066
    • Neonatal Hypocalcemia Revealing a Malignant Osteopetrosis

      hrp0089p3-p067
    • Frontal Behavior Dysfunctions Revealing a Dramatic Progression of Complex Cranial Base Abnormalities in a Severe Osteogenesis Imperfecta

      hrp0089p3-p068
    • Ionized Calcium and 25-Hydroxyvitamin D3 in Children with Steroid-sensitive Nephrotic Syndrome

      hrp0089p3-p069
    • Hypercalcemia due to Six Newly Identified Inactivating Mutations in the CaSR Gene

      hrp0089p3-p070
  • Diabetes & Insulin P1
  • • Poor Metabolic Control in Children and Adolescents with Type 1 Diabetes and Psychiatric Comorbidity

      hrp0089p1-p040
    • Concealment of Type 1 Diabetes in Adolescence Affects Adherence to Treatment, Metabolic Control, and Quality of Life

      hrp0089p1-p041
    • Risky Behaviors of Adolescents with Type 1 Diabetes in Comparison with their Healthy Peers

      hrp0089p1-p042
    • The Effect of Social Burden on Paediatric Diabetes Outcomes

      hrp0089p1-p043
    • Parental Anxiety about Hypoglycemia of Children and Adolescents with Type 1 Diabetes Mellitus (T1DM) and the Associated Factors

      hrp0089p1-p044
    • Management of Diabetes During Ramadan Fasting in Children and Adolescents: Survey of Physicians' Perceptions and Practices in the Arab Society of Paediatric Endocrinology and Diabetes (ASPED) Countries

      hrp0089p1-p045
    • Phenotypes of Diabetes and Determinants of Glycemic Control and Diabetes Complications in Haitian Youth Living in Haiti

      hrp0089p1-p046
    • Smoke Exposure and Cardio-metabolic Profile in Youth with Type 1 Diabetes

      hrp0089p1-p047
    • Menstrual Cycle Disorders in Young Women with Type 1 Diabetes Mellitus

      hrp0089p1-p048
    • Life Changing Decisions due to Etiological Genetic Diagnosis in Families of Children with Maturity Onset Diabetes of the Young (MODY)

      hrp0089p1-p049
    • NBAS Gene Mutation Causes Insulin-Dependent Diabetes Mellitus in a Patient with a Multisystem Disorder Consisting Immunodeficiency and Extremely Short Stature

      hrp0089p1-p050
    • Identification of Six Novel Mutations in Monogenic Diabetes and Congenital Hyperinsulinism and Detected by Targeted-Exome Sequencing in Korea

      hrp0089p1-p051
    • Genetic Susceptibility to Type 1 Diabetes in Children: Analysis of Polymorphisms rs1990760 - IFIH1, rs20541 - IL13, rs231775 - CTLA 4

      hrp0089p1-p052
    • Neonatal Diabetes as a First Symptom of IPEX Syndrom

      hrp0089p1-p053
    • CpG Methylation Status Changes within the Protein Tyrosine Phosphatase Non-Receptor Type 22 Gene Promoters in Children and Adolescents of Greek Origin with Type 1 Diabetes

      hrp0089p1-p054
    • Wolfram Syndrome Case with Hypergonadotropic Hypogonadism: A Novel Mutation

      hrp0089p1-p055
    • Different Clinical Findings in Maturity Onset Diabetes of the Young due to B-Lymphocyte Kinase Gene Mutations

      hrp0089p1-p056
    • Three New Gene Variants (PTPRD, SYT9, and WFS1) Related to Korean MODY Children Decrease Insulin Secretion in Human Pancreatic Beta Cells

      hrp0089p1-p057
    • Comprehensive Genetic Testing Shows One in Five Children with Diabetes and Non-Autoimmune Extra-Pancreatic Features Have Monogenic Aetiology

      hrp0089p1-p058
    • Impact of Diabetes During Pregnancy in Women Affected with GCK-MODY on Neonatal Health Outcome

      hrp0089p1-p059
    • IPEX as a Result of Mutations in FOXP3 Two Case Reports and Review of the Literature

      hrp0089p1-p060
    • The Prevalence of Autonomic and Peripheral Neuropathy in Children and Adolescents with Type 1 Diabetic Mellitus (T1D) and Its Association with the Homozygous Status of Z-2/Z-2 Polymorphism of the Aldose Reductase Gene (AKR1B1) in the Polyol Pathway

      hrp0089p1-p061
    • Establishment of Iron Overload Insulin Cell Model and the Effect Induced by Iron Overload on Oxidative Stress

      hrp0089p1-p062
    • Glucose Intolerance in Survivors of Childhood Hematologic Disorders

      hrp0089p1-p063
    • Efficacy of Mecasermin Treatment and Long-Term Survival in a Child with Leprechaunism

      hrp0089p1-p064
    • Evaluation of Diabetes Related Complications and Endothelial Dysfunction in Adolescents with Type 1 Diabetes

      hrp0089p1-p065
    • Complexities in the Management of New-Onset Diabetes after Transplantation (Nodat) in an Adolescent with Senior-Loken Syndrome

      hrp0089p1-p066
    • Insulin Resistance Parameters in Children Who Were Born Very Preterm and Adequate for Gestational Age

      hrp0089p1-p067
    • Impact on Final Height of Functional Insulin-Therapy in Type 1 Diabetes Mellitus Pediatric Patients - Experience from a Portuguese Pediatric Endocrinology Unit

      hrp0089p1-p068
    • Triglyceride Glucose Index as a Predictor of Impaired Glucose Tolerance in Overweight and Obese Adolescents

      hrp0089p1-p069
    • Birth Weight in Offsprings of Mothers with Gestational Diabetes Mellitus due to Mutations in GCK Gene

      hrp0089p1-p070
    • Review and Audit of Diabetes Control in Children and Young People with Diabetes Using the FreestyleLibre Flash Glucose Scanning System (FGS)

      hrp0089p1-p071
    • Increasing Use of Continuous Glucose Monitoring (CGM) Among Youth with Type 1 Diabetes (T1D): Icomparison of Youth from the T1D Exchange (T1DX) and the DPV Initiative

      hrp0089p1-p072
    • Efficacy of Real-time Continuous Glucose Monitoring in Type 1 Diabetic Pre-school and School Children Treated with Multiple Daily Injections

      hrp0089p1-p073
    • Catheter Site Selection and Anthropometric Measurements at Subjects with Type 1 Diabetes and Continuous Subcutaneous Insulin Infusion

      hrp0089p1-p074
    • Open Source Artificial Pancreas Systems Used from Bulgarian Children and Young People with Diabetes

      hrp0089p1-p075
    • National Survey of Usage of Continuous Glucose Monitoring in Children and Adolescents at Non Reimbursed Setting

      hrp0089p1-p076
    • Additional Insulin is Necessary to Prevent Rise in Blood Glucose after Fat-protein-rich Meals in Type 1 Diabetes

      hrp0089p1-p077
    • Efficacy of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Childhood Type 1 Diabetesefficacy of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Childhood Type 1 Diabetes

      hrp0089p1-p078
    • A Novel SLCA16A1 Mutation in an Infant with Hypoglycemia and Severe Metabolic Ketoacidosis

      hrp0089p1-p079
    • Successful Transition to Sulfonylurea Therapy in Infant with Neonatal Diabetes, Developmental Delay, Epilepsy (DEND Syndrome) due to F132L ABCC8 Mutation

      hrp0089p1-p080
    • ZFP57-associated Transient Neonatal Diabetes is Responsive to Oral Sulfonylurea Treatment

      hrp0089p1-p081
    • The Comparison of the Occurrence of Beta Cells Autoantibody and Regulatory T Cells (CD4+CD25+FoxP3+) in Patients with Type 1 Diabetes Mellitus, their Siblings and Healthy Children

      hrp0089p1-p082
    • HERV-W-Env Protein Expression in Pediatric Type 1 Diabetes Patients

      hrp0089p1-p083
    • The Comparison of the Occurrence of Beta Cells Autoantibody and Natural Killer Cells in Patients with Type 1 Diabetes Mellitus, Their Siblings and Healthy Children

      hrp0089p1-p084
    • T- and B-Lymphocytes Levels in Children with Type 1 Diabetes in Association with Candida Infection

      hrp0089p1-p085
    • Coincidence of Newly Diagnosed Type 1 Diabetes Mellitus with Enteroviruses and Respiratory Tract Viruses

      hrp0089p1-p086
    • Investigation into [beta]-cell Adaptation During Puberty

      hrp0089p1-p087
    • The Shape of the Glucose Curve and Time to Glucose Peak During an Oral Glucose Tolerance Test as Indicators of Beta Cell Function in Obese Adolescents

      hrp0089p1-p088
    • Features of T2DM in Adolescents with Low Titer of ICA and IAA

      hrp0089p1-p089
    • Increasing Trend of Fasting Plasma Glucose Levels and Impaired Fasting Glucose in Non-Diabetic Korean Youth and Young Adults: A Nationally Representative Population-Based Study

      hrp0089p1-p090
    • Screening for T2D in High Risk Egyptian Children and Adolescents Using Strip HbA1c and OGTT

      hrp0089p1-p091
    • Association of the Sizes and Composition of HDL with Hepatic Steatosis in Adolescents with Type 2 Diabetes (T2D)

      hrp0089p1-p092
  • Diabetes & Insulin P2
  • • Incidence of Childhood Type 1 and Type 2 Diabetes Mellitus in Qatar between 2012-2016

      hrp0089p2-p060
    • The Prevalence of Double Diabetes in Children and Adolescents in Qatar

      hrp0089p2-p061
    • Prevalence of Diabetes Type 1 and Type 2 in Children and Adults in Kazakhstan in 2016

      hrp0089p2-p062
    • Detection of the Pathogenic Genes in the Diagnosis and Treatment of Hyperglycemia Infants and Children

      hrp0089p2-p063
    • Early Diagnosis of Diabetes Type 2 in Children with Progeria Syndromes

      hrp0089p2-p064
    • Transient Neonatal Diabetes Mellitus due to not Described Mutation in ABCC8 Gene with Different Behaviour in Affected Family Members

      hrp0089p2-p065
    • Prothrombin Gene 20210A Mutation Heterozygosity and MTHFR Gene C677T Mutation Homozygosity Detected in a Male Toddler Experiencing Femoral Venous Thrombosis During Diabetic Ketoacidosis

      hrp0089p2-p066
    • Frequency of Occurrence of MODY in the Population of Diabetic Patients in St. Petersburg

      hrp0089p2-p067
    • Acute Painful Diabetic Neuropathy (Apdn) in a Boy with Type 1 Diabetes

      hrp0089p2-p068
    • Features of Japanese Patients with Early-Onset, Mody-Like Diabetes without Mutations in the Major Mody Genes

      hrp0089p2-p069
    • Frequency and Etiologic Spectrum of Monogenic Diabetes in Pediatric Diabetes in a Single Academic Center

      hrp0089p2-p070
    • Clinical Details, Molecular Genetic Analysisand Clinical Pheonotype Correlation of 14 Patients with Neonatal Diabetes from The South India - A Single Centre Experience

      hrp0089p2-p071
    • Syndromic Patients with Negative Islet Autoantibodies should be Tested for Mongenic Diabetes: Lessons from Patient with Trmt10a Mutation

      hrp0089p2-p072
    • A Novel Mutation in Phka2: Idiopathic Ketotic Hypoglycaemia May Represent Mild Gsdixa

      hrp0089p2-p073
    • The Application of Next Generation Sequencing Mody Gene Panel in Greek Patients

      hrp0089p2-p074
    • Type 5 Monogenic Diabetes: Reportof 7 Cases

      hrp0089p2-p075
    • Novel Gata6-Mutation in a Boy with Neonatal Diabetes and Diaphragmatic Hernia

      hrp0089p2-p076
    • Clinical and Genetic Characterizations of Maturity Onset Diabetes of the Young: Single Center Results

      hrp0089p2-p077
    • Protein and Fat Effects on Post - Prandial Glucose Responses among Egyptian Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0089p2-p078
    • Amino Acids Plasma Profile in Children with Type 1 Diabetes

      hrp0089p2-p079
    • Betatrophin as a New Biomarker of Type 1 Diabetes Mellitus in Paediatrics

      hrp0089p2-p080
    • Vitamin D Status among Children and Adolescent with T1DM

      hrp0089p2-p081
    • IGF-1 Relationship with Growth Velocity in Precocious Puberty with GnRHa Treatment

      hrp0089p2-p082
    • Relation between Hypomagnesemia and Increased Level of HbA1c in Patients with Diabetes Mellitus

      hrp0089p2-p083
    • PID1 Alters Antilipolytic Action of Insulin and Increases Lipolysis via Inhibited the Activation of AKT/PKA Pathway

      hrp0089p2-p084
    • The Efficacy of Tri-ponderal Mass Index and Body Mass Index in Estimating Insulin Resistance, Hyperlipidemia and Impaired Liver Enzymes During Childhood and Adolescents

      hrp0089p2-p085
    • Local Experience of Diabetes and Deafness

      hrp0089p2-p086
    • Translating the A1C Assay into Estimated Average Glucose Values in Children with Type 1 Diabetes Mellitus

      hrp0089p2-p087
    • Relationship Between Residual Endogenous Insulin Secretion and Glycemic Control in Japanese Children and Adolescents with Type 1 Diabetes

      hrp0089p2-p088
    • A Curious Case of Persistent Lactic Acidosis in a Child with Diabetic Ketoacidosis

      hrp0089p2-p089
    • An Unusual Case of an Exclusively Vegan Child with Diabetic Acidosis

      hrp0089p2-p090
    • HLA-DQ Genotyping in Patients with Type 1 Diabetes Mellitus and Celiac Disease

      hrp0089p2-p091
    • Hypertriglyceridemia in Type 1 Diabetes Children During Diabetic Ketoacidosis; Relation to DKA Severity and Glycemic Control

      hrp0089p2-p092
    • Acute Mononeuropathy in an 8-Year-Old-Girl with Newly Diagnosed Type 1 Diabetes

      hrp0089p2-p093
    • HLA-G Gene Promoter Methylation Status in Children and Adolescents with Type 1 Diabetes

      hrp0089p2-p094
    • Impaired Adrenal Function in Pediatric Patients with Diabetes Mellitus Type 1 Evaluated with Low-Dose Synacthen Test

      hrp0089p2-p095
    • The Incorporation of Available Technologies for Diabetes Care Among Different Worldwide Centers: The ESPE/ISPAD Working Group on Diabetes Technology Survey

      hrp0089p2-p096
    • Higher Percentage of Insulin Pump Users at Isle of Man (IOM) - Two Years Observational Data

      hrp0089p2-p097
    • Use of Continuous Glucose Monitoring Systems in the Early Detection And Management of Cystic Fibrosis Related Diabetes in Children

      hrp0089p2-p098
    • Metabolic Improvement Offered by Medtronic Minimed 640 G Associated to Transient Insulin Perfusion Suspension before Hypoglycemia in Young Patients with Type 1 Diabetes

      hrp0089p2-p099
    • The Glycemic Variability in Children with Diabetes Mellitus

      hrp0089p2-p100
    • The Levels of Blood Glucose and Counting of Carbohydrate-Fat-Protein in Diabetic Children Using Pump with Aspart and Glulisine

      hrp0089p2-p101
    • A Novel Missense Variant, p.(Thr405Arg), in the SLC19A2 Gene in an Infant with Thiamine Responsive Megaloblastic Anemia Syndrome Presenting with Anemia and Diabetes but with Normal Hearing

      hrp0089p2-p102
    • Donohue Syndrome with Hypertrophic Cardiomyopathy

      hrp0089p2-p103
    • Age and Exocrine Pancreatic Enzyme Requirements are Major Determinants for Carbohydrate Metabolism Impairment in Children Affected with Cystic Fibrosis

      hrp0089p2-p104
    • Post-Prandial Hyperinsulinaemic Hypoglycaemia after Oesophageal Surgery in Children

      hrp0089p2-p105
    • Congenital Hyperinsulinism: Clinical and Molecular Characteristics - Fluorine-18-L-Dihydroxyphenylalanine Positron Emission Tomography (F-DOPA PET) Scan Results - Treatment Responses and Short Term Outcomes of 5 Patients

      hrp0089p2-p106
    • Congenital Hyperinsulinism in a Child with Alagille Syndrome

      hrp0089p2-p107
    • Severe Stress-Induced Subcutaneous and Intravenous Insulin Resistance in an Eight Year Old Boy with T1DM, Necessitating Seven Months of IV Insulin, Reversed after Psychiatric Treatment

      hrp0089p2-p108
    • A Case of Neonatal Diabetes Due to Pancreatic Hypoplasia

      hrp0089p2-p109
    • Neonatal Diabetes Mellitus Caused by a Novel GLIS3 Mutation in Twins

      hrp0089p2-p110
    • Permanent Neonatal Diabetes, Hepatic Failure and Progressive Left Hemispheric Cerebral Atrophy in a Patient with Wolcott-Rallison Syndrome: A Clinical and Genetic Study from the State of Qatar

      hrp0089p2-p111
    • A Rare Case of Diabetes Mellitus Type 1 in a Child with Neurofibromatosis Type 1

      hrp0089p2-p112
    • Detection and Analysis of Glycometabolism Related Genes in Children Diabetes

      hrp0089p2-p113
    • Gender Characteristics of Responsibility for Their Own Health of Adolescents with Type I Diabetes Mellitus

      hrp0089p2-p114
    • Favorable Outcome Despite Prolonged Hypoglycemic Episodes Following a Massive Insulin Overdose: A Case Series

      hrp0089p2-p115
    • Effect of a Reduced Fluid Replacement Regimen on the Resolution of Diabetic Ketoacidosis (DKA) in Children

      hrp0089p2-p116
    • Prevalence of and Risk Factors for Nonadherence to Insulin Among Paediatric Type 1 Diabetes Patients in Singapore

      hrp0089p2-p117
    • [ldquo]What do You Know About Your Diabetes?': A Qualitative and Quantitative Study of Teenagers and Young Adults' Understanding of their Disease

      hrp0089p2-p118
    • Parental Knowledge and Attitudes Toward Diabetes Mellitus Type 1: A Cross Sectional Study

      hrp0089p2-p119
    • Identifying the Association of Depression and Diabetic Distress in Pakistani Patients Diagnosed with Type 1 Diabetes

      hrp0089p2-p120
    • Role of Breastfeeding in Prevention of Type 1 Diabetes in Pakistan

      hrp0089p2-p121
    • A Young Type 1 Diabetic with Acute Hemichorea: Rare Central Nervous System Complications

      hrp0089p2-p122
  • Diabetes & Insulin P3
  • • Multiple Autoimmune Association and Varied Spectrum of Presentation in Indian Diabetic Children

      hrp0089p3-p071
    • Severe Hypertriglyceridemia and Multiple Autoimmune Phenomenon at new onset Type 1 DM

      hrp0089p3-p072
    • Effects of Diabetes Mellitus Type-1 on Vitamin D Status Among Children

      hrp0089p3-p073
    • Association between Prior Toxic Stressors and Development of T2DM in Adolescents

      hrp0089p3-p074
    • First Four Cases of Neonatal Diabetes from Kazakhstan, Almaty with Proven Mutations in KCNJ11 and INS Genes

      hrp0089p3-p075
    • First 2 Cases of Monogenic Diabetes (MODY) from Kazakhstan, Almaty with Proven Heterozygous Mutation in Hepatocyte Nuclear Factor 1-Alpha (HNF1A) Gene

      hrp0089p3-p076
    • Achievement of Therapy Targets in Children and Adolescents with Type 1 Diabetes Mellitus at the 'Diabetes School'

      hrp0089p3-p077
    • Characteristics of MODY-GCK Diabetes in Children and Adolescents in Siberia

      hrp0089p3-p078
    • Clinical Case of MODY-GCK Diabetes: Heterogeneity of Course among Relatives from One Family

      hrp0089p3-p079
    • Clinical and Biochemical Characteristics of Familial Type 1 Diabetes Mellitus (FT1DM) Compared to Non-Familial Type 1 DM (T1DM)

      hrp0089p3-p080
    • Prevalence of Beta-cell Antibodies and Associated Autoimmune Diseases in Children and Adolescents with Type 1 (T1DM) vs Type 2 Diabetes Mellitus (T2DM) in Qatar

      hrp0089p3-p081
    • Clinical Presentation and Autoimmune Markers in Children and Adolescents with Familial Type 1 Diabetes Mellitus (FT1DM) and Familial Type 2 Diabetes Mellitus (FT2DM)

      hrp0089p3-p082
    • Real-world Clinical Evolution of Type 1 Diabetes Patients on Twenty Years

      hrp0089p3-p083
    • Diabetic Capilaropathy: A Case Report

      hrp0089p3-p084
    • A Sibling Case of Wolfram Syndrome with Diabetes Mellitus Diagnosed within 10 Months in Early Childhood

      hrp0089p3-p085
    • Continuous Subcutaneous Insulin Infusion in Children and Adolescents: Analysis of Initial and Follow Up Basal Rates

      hrp0089p3-p086
    • Prevalance of Fatty Liver in Patients with Type 1 Diabetes Mellitus Attending Diabetes Clinic at Alexandria University Children's Hospital

      hrp0089p3-p087
    • The Triad of Obesity, Acanthosis Nigricans and Diabetes Mellitus in a Newly Diagnosed Adolescent; Is This Type 1 Or Type 2 Diabetes Mellitus?

      hrp0089p3-p088
    • A Female Patient with Atypical Diabetes Features, Showing Heterozygous Mutations on G6PC2 (Glucose 6 Phosphatase, Catalytic Subunit 2): Does Explain All Clinical Manifestations or Is It Only Polymorphism?

      hrp0089p3-p089
    • Clinical and Laboratory Features at the Onset of Childhood Type 1 Diabetes Mellitus in the Nortwest Region (Trakya) of Turkey

      hrp0089p3-p090
    • Clinical and Epidemiological Features of Children with Type 1 Diabetes

      hrp0089p3-p091
    • Predictors of Optimal Glycemic Control in Children with Diabetes Mellitus Type 1 Receiving Pump Insulin Therapy

      hrp0089p3-p092
    • Symptomatic Cerebral Infarction: A Rare Complication of Diabetic Ketoacidosis

      hrp0089p3-p093
    • Our Clinical Experiences in Type 2 Diabetes

      hrp0089p3-p094
    • The Relationship between Serum Levels of C-Peptide and the Age, BMI, and Insulin Doses in Reply to: Newly Diagnosed Type 1 Diabetic Children

      hrp0089p3-p095
    • Serum Trace Element Levels in Children Presenting with Diabetic Ketozis and Diabetic Ketoacidosis: A Longitudinal Controlled Study

      hrp0089p3-p096
    • Evaluation of Relation between Diabetic Education Levels of Type 1 DM Child/Adolescent and Parents and Metabolic Control

      hrp0089p3-p097
    • A Case of Childhood Type 1 Diabetes Mellitus Who Developed Granuloma Annulare

      hrp0089p3-p098
    • Case Report: De Novo Mutation of Foxp3 Causing Mild Phenotype of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-Link Syndrome

      hrp0089p3-p099
    • Is There a Relationship between Immune-Mediated Type 1 Diabetes Mellitus and Congenital Rubella Infection?

      hrp0089p3-p100
    • Changes in Glycemic Control after Switching from NPH & RI to Insulin Glargine and Lispro in Children with Type 1 Diabetes Mellitus (T1DM)

      hrp0089p3-p101
    • When Type Mody Ii Diabetes Simulates Type I Diabetes

      hrp0089p3-p102
    • Epidemiological Study and Analysis of Type 1 Diabetes Comparing Patients with and Without Ketoacidosis in the Last 5 Years

      hrp0089p3-p103
    • The Frequency of Diabetic Ketoacidosis Hospitalization in Siberian Children and Adolescent

      hrp0089p3-p104
    • Monogenic Diabetes Cause by Mutation of the Gene HNF-1A

      hrp0089p3-p105
    • Reversibility of Early Acute Diabetic Neuropathy (DN) in Adolescents with Type 1 Diabetes Mellitus (T1D)

      hrp0089p3-p106
    • The Value of Continuous Hemodiafiltration in Rescuing Children with Severe Diabetic Ketoacidosis

      hrp0089p3-p107
    • Psychosocial Risks, Comorbidities and Health Events During the Follow-up of Children and Adolescents with Type 1 Diabetes

      hrp0089p3-p108
    • Clinical Profile and Outcome of Diabetic Ketoacidosis in a Tertiary Care Teaching Hospital of a Developing Country

      hrp0089p3-p109
    • Diabetes Mellitus, Autoimmune Hemolytic Anemia, Hepatosplenomegaly and Lymphadenopathy: A Rare Association in Chinese Children

      hrp0089p3-p110
    • Type 1 Diabetes and Central Precocious Puberty a Rare Association

      hrp0089p3-p111
    • Diabetic Ketoacidosis among Egyptian Children with Type 1 Diabetes: 3-Years Study

      hrp0089p3-p112
    • Fructosamine Level in Type 1 Diabetes Mellitus Children Performing Ramadhan Fasting

      hrp0089p3-p113
    • Metformin Therapy Ina Lean Adolescent Girl with Prediabetes Dysglycemia Treated: Good Response

      hrp0089p3-p114
    • Association between Thyroid Stimulating Hormone and Hemoglobine A1c in Type 1 Diabetes Mellitus Children

      hrp0089p3-p115
    • Monogenic Diabetes in 2 Years and 4 Months Old Girl: Is it DEND?

      hrp0089p3-p116
    • Compliance for Monitoring of Glycemic Control in Children with Type 1 Diabetes

      hrp0089p3-p117
    • Ketogenic Diet in a Child with Diabetes and Global Developmental Delay

      hrp0089p3-p118
    • A Rare Cause of Severe Anemia in a Patient with Type 1 Diabetes

      hrp0089p3-p119
    • Oral Gliclazide (A Sulfonylurea) Monotherapy is Effective and Safe in the Management of T2DM in Children: A Case Report

      hrp0089p3-p120
    • Pediatric Stroke as the Presenting Symptom of New Onset Diabetes without DKA

      hrp0089p3-p121
    • Challenges in Educating New Onset Type 1 Diabetes Mellitus Patients: Can the Use of a Tablet be the Answer?

      hrp0089p3-p122
    • AID-GM System (Advanced Intelligent Distant - Glucose Monitoring) to Monitor Health Status and Metabolic Control of Young People with Type 1 Diabetes

      hrp0089p3-p123
    • Continuous Glucose Monitoring Results of Our Cases with MODY Type 2 Diabetes

      hrp0089p3-p124
    • Family Investigation and Clinical Phenotype Analysis of Type A Insulin Resistance Syndrome

      hrp0089p3-p399
    • Epidemiology, Demographic Criteria and Risk Factors in Type 1 DM Egyptian Children; A Single Center Study

      hrp0089p3-p403
    • Degludec Versus Glargine in Pediatric and Adolescent Patients with Type 1 Diabetes

      hrp0089p3-p407
    • A Rare and Unexpected Cause of Diabetes in Childhood

      hrp0089p3-p416
    • Study of Children with Type 1 Diabetes Mellitus of Long Duration Attending Alexandria University Children'S Hospital

      hrp0089p3-p417
    • Abstract unavailable

      hrp0089p3-p419
  • Fat, Metabolism and Obesity P1
  • • Functional Characterization of Novel and Known Genetic Variants in the Leptin Receptor (LEPR) Gene of Two Patients with Morbid Obesity

      hrp0089p1-p093
    • Association of Single Nucleotide Polymorphisms in TNFA, PNPLA3, ADIPOQ and APOC3 Genes with Obesity and Non-Alcoholic Fatty Liver Disease in North Indian Adolescents

      hrp0089p1-p094
    • Variation of Circulating Brain-Derived Neurotrophic Factor According to Gender, Body Mass Index and Metabolic Syndrome Parameters in Adolescents

      hrp0089p1-p095
    • Kisspeptin and the Genetic Obesidome

      hrp0089p1-p096
    • Circulating Exosomal miRNAs Involved in the Pathogenesis of Children Nonalcoholic Steatohepatitis

      hrp0089p1-p097
    • Placental Fatty Acid Profile, DNA Methylation and Adverse Metabolic Outcomes in the Offspring at School Age

      hrp0089p1-p098
    • Association of Serum Fibroblast Growth Factor 21 and Irisin with Insulin Sensitivity Markers and Serum Lipids in 12-year-old Children

      hrp0089p1-p099
    • Serum Catestatin Levels in Obese Children and Adolescents

      hrp0089p1-p100
    • Circulating Mots-C Levels are Decreased in Obese Male Children and Adolescents and Associated with Insulin Resistance

      hrp0089p1-p101
    • Plasma Adropin Levels are Associated with Lipid Characteristics Amongst Children with Obesity

      hrp0089p1-p102
    • Associations of Non-High-Density Lipoprotein Cholesterol with Metabolic Syndrome and Its Components in Korean Children and Adolescents: the Korea National Health and Nutrition Examination Surveys 2008-2014

      hrp0089p1-p103
    • Chromosomal Deletions at Chromosome 16p11.2 Associated with Severe Early-Onset Obesity- 3 Additional Patients

      hrp0089p1-p104
    • Effect of a Melanocortin-4 Receptor (MC4R) Agonist, Setmelanotide, on Obesity and Hyperphagia in Individuals Affected by Alstrom Syndrome

      hrp0089p1-p105
    • Towards a Greater Understanding of the Pathophysiology of Obesity: Hypothalamic Obesity as a Model of Dysregulation of Appetite and Metabolic Homeostasis

      hrp0089p1-p106
    • Serum Uric Acid Level and Its Association with Metabolic Syndrome in Korean Adolescents

      hrp0089p1-p107
    • More than A Gut Feeling: Preliminary Evidence Supporting a Role for Lifestyle Habits in Shaping the Intestinal Microbiota in Childhood and Adolescence

      hrp0089p1-p108
    • Efficiency of Alpha-lipoic Acid in Metabolic Syndrometreatment in Children

      hrp0089p1-p109
    • Lipid Accumulation Product is a Predictor of Non-alcoholic Fatty Liver Disease in Childhood Obesity

      hrp0089p1-p110
    • Selected Serum Adipokines in Children with Irritable Bowel Syndrome

      hrp0089p1-p111
    • Role of Urinary NGAL and KIM-1 as Early Kidney Injury Biomarkers in Obese Prepubertal Children

      hrp0089p1-p112
    • Maternal Resveratrol Intake During Pregnancy and Lactation Modulates the Long-term Metabolic Effects of Maternal Nutrition on Offspring Depending on the Sex and Diet

      hrp0089p1-p113
    • Intrauterine Metformin Exposure and Offspring Metabolic Health at 8-Years Follow-up

      hrp0089p1-p114
    • Greater Maternal BMI Early in Pregnancy and Excessive Gestational Weight Gain are Independently Associated with Adverse Health Outcomes in the Offspring at Age 7 Years

      hrp0089p1-p115
    • Rapid BMI Gain During Later Infant Accelerates Skeletal Maturation at Prepubertal Obese Children

      hrp0089p1-p116
    • The More Obese - The Less Pubertal Height Gain

      hrp0089p1-p117
    • Longitudinal Changes in Abdominal Fat Distribution in the First Two Years of Life

      hrp0089p1-p118
    • Telemedicine Therapy for Overweight Adolescents: First Results of a Novel Smartphone App Intervention Using a Behavioural Health Platform

      hrp0089p1-p119
    • Cardiorespiratory Fitness Effectiveness is Related to Abdominal Adiposity and Insulin Sensitivity in Overweight Adolescents

      hrp0089p1-p120
    • Promoting Healthy Lifestyles in Youth: Preliminary from the CIRCUIT Program

      hrp0089p1-p121
    • Determinants of Attrition from a Healthy Lifestyle Intervention: Experience from the CIRCUIT Program

      hrp0089p1-p122
    • Interleukin-6 Levels are Associated with High Blood Pressure and Low HDL Cholesterol in Healthy 4-year-old Children

      hrp0089p1-p123
    • Metabolic Phenotype of Human Adipocytes Overexpressing UCP1

      hrp0089p1-p124
    • M2 Macrophage Markers are Enriched in Human Deep Neck Adipose Tissue and Do Not Correlate with UCP1 Expression

      hrp0089p1-p125
    • Effect of Hormonal Changes on Exocrine Pancreatic Function in Girls with Anorexia Nervosa

      hrp0089p1-p126
    • PCSK9 and Lp(a) Levels of Children Born after Assisted Reproduction Technologies

      hrp0089p1-p127
    • Rate of Accumulation of Abdominal Fat is Associated with Fasting Glucose Levels in Early Childhood

      hrp0089p1-p128
    • Early Menarche is Associated with Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Obese Adolescents

      hrp0089p1-p129
    • The Frequency of Obstructive Sleep Apnea in Children with Hypothalamic and Exogenous Obesity

      hrp0089p1-p130
    • The Importance of Universal Lipid Profile Screening in Two to Ten Years Old Lebanese Children

      hrp0089p1-p131
    • Non-Invasive Measurements of Central Blood Pressure with Arterial Stiffness Indicators as a New Research Tool for Predicting Cardiovascular Risk in Children with Type 1 Diabetes Mellitus and Obesity

      hrp0089p1-p132
    • Severe Obesity and Cardiometabolic Comorbidities in Adolescents: Chronology of an Epidemic

      hrp0089p1-p133
    • Evaluation of Intraocular Pressure and Retinal Nerve Fiber Layer, Retinal Ganglion Cell, Central Macular Thickness and Choroidal Thickness Using Optical Coherence Tomography in Obese Children and Healthy Controls

      hrp0089p1-p134
  • Fat, Metabolism and Obesity P2
  • • Allopurinol Ameliorates Non-Alcoholic Fatty Liver Disease in Rats

      hrp0089p2-p123
    • Relationships of Dietary Intake and Sugar Rich Products Consumption with Hepatic Fat Content and Insulin Resistance among Children with Overweight/Obesity: The PREDIKID Study

      hrp0089p2-p124
    • Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Obese Children and Adolescents: Relation to Hypertension Risk

      hrp0089p2-p125
    • Serum Calprotectin Level in Children: Marker of Obesity and Its Metabolic Complications

      hrp0089p2-p126
    • Pediatric Continuous Metabolic Syndrome Score (PsiMS score): Use in Everyday Clinical Practice

      hrp0089p2-p127
    • Leptin and Cytokines are Not the Best Markers for Metabolic S

      hrp0089p2-p128
    • Early-Life Risk Factors and Their Association with Hypertension in Spanish Children and Adolescents

      hrp0089p2-p129
    • A Rare Case of Diabetes Mellitus in an Adolescent: Partial Lipodystrophy

      hrp0089p2-p130
    • Visfatin, RBP4 and STRA6 polymorphisms' in relation with Childhood Obesity

      hrp0089p2-p131
    • Characteristics of Blood Lipids in Boys with Hypoandrogenia

      hrp0089p2-p132
    • Tri-Ponderal Mass Index: A Good Anthropometric Index to Evaluate Adiposity in Children and Adolescents

      hrp0089p2-p133
    • Serum Spexin Concentrations in Adolescent Females with Metabolic Syndrome, Polycystic Ovary Syndrome and Anorexia Nervosa

      hrp0089p2-p134
    • A Simple Relaxation Exercise Reduces Stress in Obese Youth - A Path to a Healthy Lifestyle?

      hrp0089p2-p135
    • Dyslipidemia and Its Related Factors in Chinese Children and Adolescents with Turner Syndrome

      hrp0089p2-p136
    • Severity, Duration and Phenotype of Obesity Promote Precocious Cardiovascular Sonographic Alterations in Childhood Obesity

      hrp0089p2-p137
    • Physical Activity Determined by Accelerometry Before and After an Integral Treatment Program in Children with Abdominal Obesity

      hrp0089p2-p138
    • The Associations Between Neck - and Upper Arm Circumference with Cardiometabolic Risk Over Traditional Risk Factors in Adolescents - Data from Five EUROPEAN Countries (PreSTART-Study)

      hrp0089p2-p139
    • Sex-related Differences and Effect of Puberty on Metabolic Syndrome in Obese Children and Adolescents

      hrp0089p2-p140
    • Associations between Total Leptin, Bio-inactive Leptin, Soluble Leptin Receptor and Anthropometrics in Children with Severe Early-onset Obesity (SEOO) - the German-Polish Study (EOL-GPS)

      hrp0089p2-p141
    • Children with Obesity are Taller in Early Childhood with Subsequent Catch-down Growth Until Adolescence

      hrp0089p2-p142
    • The Relationship between Anthropometric Measurements and Breast Milk Ghrelin and Nesfatin-1 Levels in Infants with Small for Gestational Age

      hrp0089p2-p143
    • Efficacy, Safety and Tolerability of Liraglutide, GLP-1 Analogue, in Indian Adolescent Population with Obesity

      hrp0089p2-p144
    • The Effect of Exclusive Breastfeeding and Formula Feeding on Body Composition During the First Two Years of Life

      hrp0089p2-p145
    • Body Composition and Cardiovascular Function in Pre-adolescent Children of South Asian and White European Origin: Relationship to Maternal Status in Pregnancy

      hrp0089p2-p146
    • Relation Between Cardiac Function and Anthropometric Parameters in Overweight and Obese School Boys

      hrp0089p2-p147
    • Evaluation of Hydration Status of Obese Children - A Pilot Study

      hrp0089p2-p148
    • Galanin is Positively Correlated with Insulin Resistance and Triglyceride Levels in Obese Children

      hrp0089p2-p149
    • Brown Adipose Tissue in Prepubertal Children: Associations with Sex and With the Sequence of Prenatal Growth Restraint and Postnatal Catch-up

      hrp0089p2-p150
    • The Age of Pubertal Onset Correlates with Pubertal Growth Pattern and Body Weight Change in Girls

      hrp0089p2-p151
    • Does Late Sleeping Time Results Increased Bedtime Snack? What is the Risk of this in Childhood Obesity?

      hrp0089p2-p152
    • Early BMI Trajectory Classes are Linked to Distinct Body Fat Partitioning Later in Childhood

      hrp0089p2-p153
    • Hair Cortisol Concentrations in Overweight and Obese Children and Adolescents

      hrp0089p2-p154
    • Associations between Body Fat Mass and Internalizing and Externalizing Behaviors and Anxiety in Children and Adolescents

      hrp0089p2-p155
    • Pharmacotherapy and the Effects on LDL Levels and Growth in 2 Children with Severe Familial Hypercholesterolemia

      hrp0089p2-p156
    • Brown Tumors in Children on Hemodialysis

      hrp0089p2-p157
    • The Role of Fibroblast Growth Factor 21 and Irisin in the Pathogenesis of Obesity in Childhood and Adolescence

      hrp0089p2-p158
    • Serum NAMPT Levels are not Associated with Parameters of Liver Function in Children and Adolescents

      hrp0089p2-p159
    • Obesogenic Environment and Their Influence on Adiposity on Mexican Children and Adolescents

      hrp0089p2-p160
    • Metabolic Alterations and Weight Status in Children at 8 Years: A Prospective Cohort Study

      hrp0089p2-p161
    • Correlation of Dietary Habits with Systolic Blood Pressure in Healthy Children

      hrp0089p2-p162
    • Evaluation of Voiding Dysfunction in Obese Children

      hrp0089p2-p163
    • Comparison of Antropometric and Biochemical Parameters in Obese Children with or without Primary Headache

      hrp0089p2-p164
    • The Protective Effect of Exclusive Breastfeeding for overweight/Obesity in Children with High Birth Weight

      hrp0089p2-p165
    • Determinants and Consequences of Exaggerated Adrenarche in Simple Obesity

      hrp0089p2-p166
    • Metabolic Alteration in Patients Affected by PseudoHypoParathyroidismo 1a (PHP1a): A Preliminary Data

      hrp0089p2-p167
    • Weight Loss Outcomes in Two-Year Multidisciplinary Lifestyle Intervention Program Involving Obese Children and their Parents

      hrp0089p2-p168
    • Relationship between Glucose and Lipid Metabolism, Inflammatory Factors and Adipokines in Children with Obesity

      hrp0089p2-p169
    • Development of Resistance to Sorafenib, a Multikinase Inhibitor, in Hepatocellular Carcinoma is Mediated by SIRT

      hrp0089p2-p170
    • Gender and Pubertal Tendencies of Plasma leptin and Dopamine Levels Depending on TaqIA DRD2 Gene Polymorphism in the Different Pediatric Obesity Classes

      hrp0089p2-p171
    • Iron Metabolism Disorders in Prepubertal Obese Children with and Without NAFLD

      hrp0089p2-p172
    • Familial Hypercholesterolemia Due to Homozygous LDLRAP1 Mutation: Variability of Phenotype and Response to Medical Therapy

      hrp0089p2-p173
    • CAN Triponderal Mass Index be a New Indicator in the Predicting Cardiometabolic Risk in Obese Adolescents?

      hrp0089p2-p174
    • Social Networks, Social Support and Weight-Related Outcomes among Adolescents

      hrp0089p2-p175
    • Identification of A Novel Homozygous Mutation in BBS10 in Five Children With Bardet-Biedl Syndrome

      hrp0089p2-p176
    • The Effects of the Birth Weight on the Fat Distribution and Fatness Parameters of the Body

      hrp0089p2-p177
    • Oxidative Homeostasis Dysregulation May Promote Pathogenesis of Cardio-metabolic Complications in Childhood Obesity

      hrp0089p2-p178
    • Body Composition Parameters, Systemic Inflammation and Metabolic Syndrome Manifestations in Children and Adolescents

      hrp0089p2-p179
    • Relationships between Obesity Parameters and Urinary Concentrations of Phthalates and Phenols in Korean Girls

      hrp0089p2-p180
  • Fat, Metabolism and Obesity P3
  • • NKX2-2 Human Mutation Causes Neonatal Diabetes followed by Severe Infantile Obesity Associated with Paradoxical Upregulated Ghrelin Levels - Do Beta-cells Secrete Ghrelin?

      hrp0089p3-p125
    • Tracing the Effect of the Melanocortin-4 Receptor Pathway in Obesity: Study Design and Methodology of the TEMPO Registry

      hrp0089p3-p126
    • BigO: Big Data Against Childhood Obesity

      hrp0089p3-p127
    • Exposure to Bisphenol-A and Phtalates in Obese Girls

      hrp0089p3-p128
    • Obesity of Childhood and Ambulatory Glucose Monitorization

      hrp0089p3-p129
    • Familial Partial Lipodystrophy, Importance of Family History - A Case Report

      hrp0089p3-p130
    • Development of Severe Obesity in a Children with a Brainstem Tumor

      hrp0089p3-p131
    • Correlation Between Obesity, BMI and Insulin Resistance in Bulgarian Children

      hrp0089p3-p132
    • Nonclassical Manifestation of PWS

      hrp0089p3-p133
    • Metabolic Parameters in Children with Syndromic Obesity

      hrp0089p3-p134
    • Cut-off for the Follow-up of Obese Children: Cynicism or Realism?

      hrp0089p3-p135
    • Proximal Microdelection 16p11.2 Syndrome

      hrp0089p3-p136
    • The Level of the Vitamin D and Metabolic Status in Children with Obesity

      hrp0089p3-p137
    • A Compound Heterozygote Mutation in a Chinese Patient Affected with Methylmalonic Acidemia

      hrp0089p3-p138
    • Lymposomal Acid Lipase Deficit in Patients with Hypercholesterolemia

      hrp0089p3-p139
    • Hepatic Steatosis and its Relationship with the Metabolic Syndrome

      hrp0089p3-p140
    • Serum Hepcidin and Ferritin in Prepubertal Obese Children

      hrp0089p3-p141
    • Osse Registry for Patients with Lipodystrophy Run by the European Consortium of Lipodystrophy (ECLip)

      hrp0089p3-p142
    • Acanthosis Nigricans in Obese Children and Adolescents in relation to Severity of Obesity and Insulin Resistance

      hrp0089p3-p143
    • Serum Uric Acid and Its Correlation with Metabolic Syndrome Factors in Simple Obesity Children

      hrp0089p3-p144
    • Thyroid Function, Lipid Profile and Carbohydrate Metabolism Parameters in Patients with Alstrom Syndrome

      hrp0089p3-p145
    • Does the Level of Studies of Parents Influence the Follow-up of the Recommendations of the Nutritional Pyramid?

      hrp0089p3-p146
    • Bariatric Surgery as Treatment of Primary Pseudotumor cerebriin a Male Adolescent: Case Report

      hrp0089p3-p147
    • Investigation of Pubertal Effect on Thyroid Volume and IGF-1 Changes in Morbid Obese Children

      hrp0089p3-p148
    • The Effect of Vitamin D Supplementation on Metabolic Syndrome Parameters in Overweight and Obese Children and Adolescents in Greece

      hrp0089p3-p149
    • Mother's Obesity and High Child's Waist Circumference are Predictive Factors of Severe Child's Obesity: An Observational Study in French Guiana

      hrp0089p3-p150
    • Lipidogram, Leptin-and Adiponectinaemia in Teenagers and Adolescents with Metabolic Syndrome

      hrp0089p3-p151
    • Metabolic Endotoxemia in Egyptian Obese Children and Adolescents

      hrp0089p3-p152
    • Resting Metabolic Rate and the Development of Metabolic Disorders in Obese Children

      hrp0089p3-p153
    • Relation of Screen-Time (Phone-Computer-TV-Online Games) and Physical Activity with Childhood Obesity

      hrp0089p3-p154
    • Effect of Three-Month Diet and Physical Activity on Adipokines and Inflammatory Status in Children with Metabolic syndrome

      hrp0089p3-p155
    • Neck Circumference and Lipid Profile in Adolescents with Overweight/Obesity

      hrp0089p3-p156
    • A Not So 'Simple Obesity'

      hrp0089p3-p157
    • Effect of Obesity on Bone Age and Hormonal Parameters in Indian Children

      hrp0089p3-p158
    • Compliance of Obese Children and Their Family to the Directions of a Pediatric Endocrinology Medical Office

      hrp0089p3-p159
    • Risk Factors and Comorbidities of Childhood Obesity

      hrp0089p3-p160
    • Autonomic Nervous System - Inflammation Link: A New Independent Mechanism for Homeostasis

      hrp0089p3-p161
    • Effects of a Brief Physician Delivered Counseling on Childhood Obesity

      hrp0089p3-p162
    • The Prevalence of Obesity in Boys in the Region of the Russian Federation

      hrp0089p3-p163
    • Obesity in Adolescents, is Accompanied by a High Levels of Leptin and a Low Serum Ghr Level in the Blood Plasma. A High Degree of Obesity is Accompanied by a Greater Higher Leptin Level and Decrease in the Ghr Level. These Changes are More Significant Registered in Abdominal Ob

      hrp0089p3-p164
    • Hidden Hunger in Overweight/obese Indian Adolescents

      hrp0089p3-p165
    • Assessment of Obesity in Children with Achondroplasia and Hypochondroplasia

      hrp0089p3-p166
    • Correlation of Lipoprotein(a) Levels and Family History of Cardiovascular Disease in a Sample of Overweight/obese Children and Adolescents

      hrp0089p3-p167
    • Beneficial Effect of Metformin Treatment in Obese Children and Adolescents

      hrp0089p3-p168
    • Comparison of the Effectiveness of a Battery Powered and Manual Toothbrush in Removal of a Dental Plaque for Good Oral Hygiene in Adolesents with Over-Weight

      hrp0089p3-p169
  • Fetal, Neonatal Endocrinology and Metabolism P1
  • • Cardiac and Vascular Assessments in Small- vs Appropriate-for-Gestational-Age Infants at Ages 1 and 2 Years

      hrp0089p1-p135
    • Bone Maturation as a Predictive Factor of Catch-up Growth During the First Year of Life in Born Small for Gestational Age Infants: A Prospective Study

      hrp0089p1-p136
    • Neonatal Screening Tests in Premature Newborns in Southern Brasil

      hrp0089p1-p137
    • Measurement of Estradiol and Testosterone in Umbilical Cord Blood by Gas Chromatography-Tandem Mass Spectrometry (GC-MS/MS); Comparisons with Radioimmunoassay (RIA)

      hrp0089p1-p138
    • Transient Neonatal Iatrogenic Hypothyroidism due to Iodinated Contrast

      hrp0089p1-p139
    • Sexual Dimorphism of IGF1 and IGF2 Expression in the Neonatal Rat Brain

      hrp0089p1-p140
  • Fetal, Neonatal Endocrinology and Metabolism P2
  • • Clinical characteristics of Congenital Hyperinsulinism Caused by Dominant KCNJ11/ABCC8 Mutations

      hrp0089p2-p181
    • Clinical Characterstics, Genotype-Phenotype Correlations and Follow Up of Patients with Congenital Hyperinsulinaemic Hypoglycaemia; Single Center Experience from a Southeastern City of Turkey

      hrp0089p2-p182
    • Congenital Hyperinsulinism: Management and Outcome in West of Scotland

      hrp0089p2-p183
    • 20 Cases of Congenital Hyperinsulinism in Ukraine

      hrp0089p2-p184
    • Nifedipine Therapy in Hyperinsulinaemic Hypoglycaemia Due to Mutations in the PMM2 Gene Improves Fast Tolerance, Stabilises Blood Glucose Profile, and Enables Rationalisation of Treatments for Glycaemic Control and Hypertension: The First Reported Trial in 3 Patients in a Tertiary Centre

      hrp0089p2-p185
    • Potentially Modifiable Predictors of Adverse Neonatal Outcomes in Women with Gestational Diabetes Mellitus (GDM)

      hrp0089p2-p186
    • A Boy with Diazoxide Unresponsive Congenital Hyperinsulinism due to a Homozygous ABCC8 Missense Mutation Previously Reported to be Dominant

      hrp0089p2-p187
    • Diazoxide Unresponsive Congenital Hyperinsulinism due to a Novel ABCC8 Missense Mutation

      hrp0089p2-p188
    • Neonatal Hypoglycaemia: Unchanged Risk of Neurodevelopmental Impairment, But Sex-Specific Decreased Fine Motor Function and Increased Internalizing Behaviour at School Age

      hrp0089p2-p189
    • Atypical Hepatoblastoma and Wilm's Tumour in an Infant with Beckwith-Wiedemann Syndrome and Diazoxide Resistant Congenital Hyperinsulinism

      hrp0089p2-p190
    • Association between Rubenstein-Taybi Syndrome and Hyperinsulinaemic Hypoglycaemia

      hrp0089p2-p191
    • Hyperinsulinemic Hypoglycemia in Congenital Disorder of Glycosylation Type-1a (CDG-1a)

      hrp0089p2-p192
    • A Rare Cause of Hyperinsulinemic Hypoglycemia: Costello Syndrome

      hrp0089p2-p193
    • Molecular Defects Identified by Whole Exome Sequencing in a Chinese Boy with Fructose-1,6-Bisphosphatase Deficiency

      hrp0089p2-p194
    • The Benefit of Universal Neonatal Screening for Hypoglycemia

      hrp0089p2-p195
    • Prematurity of 23 or Less Weeks' Gestation is a Risk for Transient Late-Onset Hyperglycemia in Neonates

      hrp0089p2-p196
    • An unusual cause of neonatal hyperglycemia - case report

      hrp0089p2-p197
    • Neonatal Hypocalcemia Due to Maternal Hypovitaminosis D: A Cohort of Children in a Region of Northern Spain

      hrp0089p2-p198
    • Evaluation of Vitamin D Status and Its Correlation with Gonadal Function in Children at Mini-puberty

      hrp0089p2-p199
    • Systemic Pseudohypoaldosteronism Type 1 Due to 3 Novel Mutations in SCNN1A and SCNN1B Genes; Report of 3 Cases

      hrp0089p2-p200
    • Postnatal Growth of Infants with Neonatal Diabetes: Insulin Pump (CSII) Versus Multiple Daily Injection (MDI) Therapy

      hrp0089p2-p201
    • Serum Vaspin Concentration in Full-term, Appropriate-for-Gestational-Age Newborns: Effect of Early-Onset Infections

      hrp0089p2-p202
    • First Three Years of The Congenital Adrenal Hyperplasia Neonatal Screening Program of the State of Parana, Southern Brazil

      hrp0089p2-p203
    • Assessment of the Stretched Penile Length in Sri Lankan Newborns

      hrp0089p2-p204
    • Auxological Catch Up Growth and Evaluation of Spontaneous Motility in the Term Newborn Small for Gestational Age Employing the Prechtl Assessment of General Movements

      hrp0089p2-p205
  • Fetal, Neonatal Endocrinology and Metabolism P3
  • • A Rare Case of Congenital Hyperinsulinemina with ABCC8 Missense Mutation Presenting with Focal Pancreatic Lesion

      hrp0089p3-p170
    • Comparison of Metabolic Parameters of Children's Blood Depending on the Level of Mother's Glycemia During Pregnancy

      hrp0089p3-p171
    • Forty patients with persistent, non-focal congenital hyperinsulinism: Urgent need for new treatment modalities

      hrp0089p3-p172
    • Outcome of Eight Patients with Congenital Hyperinsulinism (CHI) Studied with 18[F]Dihydroxyphenyl-Alanine Positron Emission Tomography Imaging (18F-DOPA-PET-CT) in Argentina

      hrp0089p3-p173
    • Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination

      hrp0089p3-p174
    • Neonatal Diabetes Mellitus in Vietnam National Children Hospital

      hrp0089p3-p175
    • Axillary Temperature Relation to Blood Serum Insulin-like Growth Factor-I in the Not-life-Threatened Newborn: Relevance of Preterm Birth

      hrp0089p3-p176
    • Birth Estimated Brain Weight Relation to Ratios between Insulin-like Growth Factor-II and Insulin-like Growth Factor Binding Protein-3 in the Not-life-threatened Newborn: Relevance

      hrp0089p3-p177
    • Congenital Hyperinsulinism in Children with Beckwith-Wiedemann Syndrome

      hrp0089p3-p178
    • Comparison of the Phenylketonuria Phenotypes in Qazvin Province Before and After Neonatal Screening Until 2017

      hrp0089p3-p179
    • From Hypoglycemia to Hyperglycemia

      hrp0089p3-p180
    • Population Screening of Hypophosphatasia. A Metabolopathy to Consider. National Multicentric Study

      hrp0089p3-p181
    • Dumping Syndrome in a Neonate with Esophagical Atresia Surgery

      hrp0089p3-p182
    • Diagnosis and Treatment of Persistent Hyperkalemia in Newborn Twins - Rare Case Report of Gordon Syndrome

      hrp0089p3-p183
    • Mutation in UCP2 Gene: A Rare Cause of Hyperinsulinemic Hypoglycaemia Syndrome in a Small-for-Gestational Age Newborn

      hrp0089p3-p184
    • Hyperinsulinemic Hypoglycaemia Syndrome in Small-for-Gestational Age Newborns: Clinical Characteristics and Genetic Study

      hrp0089p3-p185
    • Pediatric Insulinoma: A Case Report

      hrp0089p3-p186
    • Mutations in Indian children with Neonatal Diabetes

      hrp0089p3-p187
    • Weight Outcome in Infants with Prolonged Hyperinsulinemic Hypoglycemia Treated with Diazoxide vs Those with Spontaneous Resolution

      hrp0089p3-p188
    • Neonatal Hyper- and Hypoglycaemia; Widening the Clinical Phenotype of Transient Neonatal Diabetes Mellitus due to 6q24 Methylation Defects

      hrp0089p3-p189
    • Clinical and Molecular Genetic Characterization of Two Patients due to Mutations

      hrp0089p3-p190
    • Transient Central Hypothyroidism due to Maternal Graves' Disease

      hrp0089p3-p191
  • GH & IGFs P1
  • • Autosomal Dominant Growth Hormone Deficiency due to a Novel c.178G>A Mutation in the GH1 Gene Causing Instability of the Mutant GH Protein (p.Ala34Thr)

      hrp0089p1-p141
    • Growth Hormone Deficiency due to Whole-Gene Deletion of GHRHR

      hrp0089p1-p142
    • Severe Pre- and Postnatal Growth Retardation in a Child Harboring a Novel Homozygous IGF1 Gene Mutation

      hrp0089p1-p143
    • A New p.(Ile66Serfs*93) IGF2 Variant Is Associated with SRS-like Phenotype

      hrp0089p1-p144
    • Response to Growth Hormone in Patients with Isolated Familial Growth Hormone Deficiency due to RNPC3 Mutations

      hrp0089p1-p145
    • Laron Syndrome Patients have an Abnormal Plasma Amino Acid Pattern

      hrp0089p1-p146
    • Serum IGFBP-2 Concentration in Neonates with Potential Diagnosis of Growth Hormone Deficiency (GHD)

      hrp0089p1-p147
    • GH Treatment Causes an Increase in Klotho Concentration in Children with Growth Hormone Deficiency

      hrp0089p1-p148
    • Assesment of SDF-1 and Ang-1 and Ang-2 in Children with Growth Hormone Deficiency before and after 1- year Therapy with Recombinant Growth Hormone

      hrp0089p1-p149
    • Total Sum of Growth Hormone Values Obtained from Growth Hormone Stimulation Test May be Useful in the Diagnosis of Prepubertal Children with Idiopathic Growth Hormone Deficiency

      hrp0089p1-p150
    • Growth of Premature Infants Born Small by Gestational Age

      hrp0089p1-p151
    • Microalbuminuria and Glomerular Filtration Rate in SGA Born Young Adults

      hrp0089p1-p152
    • Testing the Performance of a Preexisting Growth Prediction Model in a Cohort of Prepubertal Patients Born Small for Gestational Age (SGA) Receiving GH Treatment in PATRO Children

      hrp0089p1-p153
    • Early Onset GH Replacement in GH Deficiency: Is Neonatal Hypoglycemia Important for Long Term Follow-Up?

      hrp0089p1-p154
    • Prevalence of Diabetes among Children Treated with Growth Hormone in Israel

      hrp0089p1-p155
    • The Effect of Growth Hormone Treatment in Children after Hematopoietic Stem Cell Transplantation

      hrp0089p1-p156
    • EasypodTM Connect Observational Study: The Italian Experience

      hrp0089p1-p157
    • Patients and Caregivers Perspectives on a Mobile App that Tracks Adherence and Outcomes in Children with Growth Disorders Treated with Recombinant Human Growth Hormone (r-hGH)

      hrp0089p1-p158
  • GH & IGFs P2
  • • Identification of Three Novel GLI2 Gene Variants Associated with Hypopituitarism

      hrp0089p2-p206
    • Clinical and Preliminary Molecular Description of a Cohort of Patients with Growth Retardation due to Severe Primary IGF1 Deficiency (GROWPATI Study)

      hrp0089p2-p207
    • A Novel, Synonymous, Heterozygous, Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor: Causality for Mild Growth Impairment and IGF-I Deficiency in an Affected Patient?

      hrp0089p2-p208
    • A Novel Mutation of Type I Insulin-like Growth Factor Receptor (IGF1R) Gene in a Severe Short Stature Pedigree Identified by Targeted Next-generation Sequencing (NGS)

      hrp0089p2-p209
    • Severe Short Stature, Growth Hormone (GH) Deficiency, Hypospadias, and Microcephaly: New Insights into the Role of Chromosome 4 Long Arm Duplication

      hrp0089p2-p210
    • Growth Hormone Treatment for Short Stature Associated with TRNT1 Deficiency: A Case Series

      hrp0089p2-p211
    • Case Report: Novel Case of Short Stature and Co-occurrence of SHOX Gene Mutation and Fanconi Anemia

      hrp0089p2-p212
    • Different Genetic Causes of Short Stature in a Family

      hrp0089p2-p213
    • Incidence of Cranial MRI Abnormalities in Patients with Isolated Growth Hormone Deficiency: 20 Years of Results

      hrp0089p2-p214
    • Systematic Prospective Study of Eye Funduscopy Before and After Starting Treatment with Growth Hormone in 290 Patients

      hrp0089p2-p215
    • Incidence and Prevalence of GH Deficiency in the Russian Federation - An Analysis of Two Registries

      hrp0089p2-p216
    • The BSPED National GH Audit: Trends in Prescribing from 2013-2016

      hrp0089p2-p217
    • The Rationale and Design of TransCon GH

      hrp0089p2-p218
    • Baseline Demographics of the TransCon GH Phase 3 heiGHt Trial

      hrp0089p2-p219
    • The ZOMATRIP Study: Four Year Combination Therapy of GH and GnRHa in Girls with a Short Predicted Adult Height During Early Puberty: Adult Height Outcome

      hrp0089p2-p220
    • Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

      hrp0089p2-p221
    • Height Perception of Children with GH Deficiency: Influencing Factors and Links to Psychosocial Functioning

      hrp0089p2-p222
    • Health Lifestyle and Obesity of Adult Patients with Congenital Isolated Growth Hormone Deficiency Treated in Childhood

      hrp0089p2-p223
    • Factors Influencing Health Related Quality of Life in Children/Adolescents with GH Deficiency

      hrp0089p2-p224
    • Health-Related Quality of Life and Psychosocial Functioning in Young Adults Born SGA after GH/GnRHa Treatment

      hrp0089p2-p225
    • Adherence to Treatment in Growth Hormone Deficient and Small for Gestational Age Patients Naive to EasypodTM in Mexico: Final Results of the EasypodTM Connect Observational Study (ECOS)

      hrp0089p2-p226
    • Growth Pattern and Final Height Outcome in Children with Septo-optic Dysplasia and Isolated Hypopituitarism Treated with rhGH in a Single Centre

      hrp0089p2-p227
    • Reliability of Clonidine Testing for the Diagnosis of Growth Hormone Deficiency in Children and Adolescents

      hrp0089p2-p228
    • Area under the Curve of Growth Hormone, An Additional Tool in Assessing Stimulation Test Results

      hrp0089p2-p229
    • Evaluation of Spontaneous Nocturnal GH Secretion: Noe Versus Two Consecutive Nights

      hrp0089p2-p230
    • Relationship between Growth Velocity and Change of Serum Insulin-Like Growth Factor-1 (IGF-1), Serum IGF Binding Protein-3 (IGFBP-3) Concentrations, and IGFBP-3 Promoter Polymorphism during Gonadotropin-Releasing Hormone Agonist (GnRHa) Treatment

      hrp0089p2-p231
    • The Predictive Role of IGF-1 on Irradiation-Dependent Growth Hormone Deficiency (GHD) in Childhood Cancer Survivors (CCS)

      hrp0089p2-p232
    • Effects of Zinc, Magnesium and Vitamin B6 (ZMA) Supplementation on Serum IGF-I, IGFBP-3 and Testosterone Concentrations in Young Athletes

      hrp0089p2-p233
    • High Protein Nutritional Supplementation Increases Serum IGF-I Concentrations in Short Children with Low IGF-I

      hrp0089p2-p234
    • Hormonal Predictors of Growth Hormone Therapy Effectiveness in Children with Short Stature - Evidence from Neural Prediction Model for Final Height

      hrp0089p2-p235
    • Artificial Neural Networks for Prediction Final Height in Children with growth Hormone Deficiency

      hrp0089p2-p236
    • Predictors of Poor Response to Growth Hormone Therapy in Children with Short Stature - Evidence from Neural Prediction Model for Final Height

      hrp0089p2-p237
    • Growth Hormone Therapy and Its Challenges in GH Deficient Cases in a Multinational Population-a Sneak-Peek

      hrp0089p2-p238
  • GH & IGFs P3
  • • Good Growth Response to Growth Hormone Therapy in Short Children with Normal Growth Hormone Secretion

      hrp0089p3-p192
    • Growth Hormone Deficiency Intwo Children with Williams-Beuren Syndrome: The Long-Term Response to Growth Hormone (GH) Therapy

      hrp0089p3-p193
    • Growth Hormone Treatment: Does Timing Matter?

      hrp0089p3-p194
    • Support for Patients Treated with Growth Hormone to Reach their Growth Potential: Addressing Adherence Barriers through Personalised Behavioural Patient-support Programmes

      hrp0089p3-p195
    • Main Discrepancies between Predicted and Observed Growth Responses with iGRO in Children Treated with GHr in Spain

      hrp0089p3-p196
    • Adherence and Long-term Outcomes of Therapy in Pediatric Subjects in Greece Using Easypod™ Electromechanical Device for Growth Hormone Treatment: The Phase IV Multicentre Easypod™ Connect Observational Study (ECOS)

      hrp0089p3-p197
    • Growth Hormone Deficiency in Neurofibromatosis: Report of Four Cases

      hrp0089p3-p198
    • Extremely Low Body Mass Index Negatively Impact the Response to Growth Hormone Treatment in Children with Growth Hormone Deficiency

      hrp0089p3-p199
    • Small for Gestational Age (SGA) Patients with Premature Treatment Discontinuation: Their Journey in French Real-life Settings

      hrp0089p3-p200
    • Effects on Near-adult Height and Safety of Recombinant Human Growth Hormone in Growth Hormone Deficiency and Turner Syndrome Patients: Results from the LG Growth Study

      hrp0089p3-p201
    • Final Adult Height After Growth Hormone Treatment in Patients with Turner Syndrome

      hrp0089p3-p202
    • Results of Mecasermin Treatment in Pediatric Patients Evaluated for Severe and Partial Primary Deficiency of IGF-1

      hrp0089p3-p203
    • Children Born Small for Gestational Age Treated with Growth Hormone: Evolutionary Aspects

      hrp0089p3-p204
    • Small for Gestational Age (SGA) Patients in Real Life French Clinical Practice: What is the Difference Between Good and Poor Responders to GH Treatment

      hrp0089p3-p205
    • Body Mass Index (BMI) in Patients with Growth Hormone Deficiency (GHD) at Diagnosis, One Year and Two Years After Treatment with Growth Hormone (GH)

      hrp0089p3-p206
    • Erythropoietin and Granulocyte Macrophage Colony Stimulating Factor Levels in Growth Hormone Deficient Children after 1 Year of Growth Hormone Therapy

      hrp0089p3-p207
    • Cost-effectiveness of Growth Hormone Therapy in Children in Russia

      hrp0089p3-p208
    • Vitamin D Status in Children with Isolated Idiopathic GH Deficiency (GHD) in North and Central Greece

      hrp0089p3-p209
    • A Pilot Study for Comparing Efficacy and Safety of the CinnaTropin® to the Reference Recombinant Human GH in Children with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiency

      hrp0089p3-p210
    • Study of the Effectiveness of GH in Children Born Small for Gestational Age in an Area of Northwestern Spain and its Associated Factors

      hrp0089p3-p211
    • Height Velocity and Height Gain in the First Year of GH Treatment: Predictive Factors of Good Statural Response in Small for Gestational Age (SGA) Patients

      hrp0089p3-p212
    • Role of Insulin like Growth Factors on the Growth Parameters in Children with Acquired Hypothyroidism: An Analysis

      hrp0089p3-p213
    • Two Siblings with Short Stature

      hrp0089p3-p214
    • RHGH Replacement Therapy and Side-Effects: A Retrospective Study of 10 Years

      hrp0089p3-p215
    • Efficacy and Safety of Recombinant Human GH in Treating Chinese Children with Idiopathic Short Stature

      hrp0089p3-p216
    • Comparison the Recombinant Human GH (rhGH) Treatment in Children with Idiopathic Short Stature (ISS) and GH Deficiency (GHD)

      hrp0089p3-p217
    • Bone Age Maturation During the Three Years of GH Treatment in Patients with Idiopathic GH Deficiency and Idiopathic Short Stature: Analysis of Data from LG Growth Study

      hrp0089p3-p218
    • Recombinant Growth Hormone Therapy in Prepubertal Children with Idiopathic Short Stature in Korea: A Phase III Randomized Trial

      hrp0089p3-p398
  • Growth & Syndromes P1
  • • Does X-Chromosome Gene Dosage Determine Growth and Phenotypic Features in Turner Syndrome with 45,X/46,XX Mosaicism on Standard Karyotyping? A Cross-Sectional Analysis of the French National Rare Disease Network Database

      hrp0089p1-p159
    • Abstract unavailable

      hrp0089p1-p160
    • Analysis of Osteoblats Precursors in Girls with Turner Syndrome

      hrp0089p1-p161
    • Comparing the Cumulative Dose of Growth Hormone Therapy Using Body Weight-Based Dosing Versus Body Surface Area-Based Dosing in Children with Turner Syndrome - Data from the ANSWER Study

      hrp0089p1-p162
    • The Association between Growth Hormone Dose and Short-Term Height Outcomes in a Large Cohort of Paediatric Patients with Turner Syndrome: Real-World Data from the NordiNet® International Outcome Study (IOS) and ANSWER Program

      hrp0089p1-p163
    • Changing Patterns of Growth in Prader-Willi Syndrome

      hrp0089p1-p164
    • Sleep-Disordered Breathing in Children with Prader-Willi Syndrome in relation to Growth Hormone Therapy Onset

      hrp0089p1-p165
    • Safety and Effectiveness of Growth Hormone Treatment in Patients with Prader-Willi Syndrome under 2 Years of Age in a Reference Hospital

      hrp0089p1-p166
    • Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children with Prader-Willi Syndrome

      hrp0089p1-p167
    • GH Response to GHRH and Arginine in Previously GH-Treated Young Adults with Prader-Willi Syndrome

      hrp0089p1-p168
    • A Novel Type of Pubertal Height, Weight, and BMI Reference, Aligned for Onset of Puberty

      hrp0089p1-p169
    • Evaluating Cut-offs for Automatic Growth Screening in Swedish Children - Using the Finnish Growth Monitoring Algorithm

      hrp0089p1-p170
    • Prospective Study of Growth in Swedish Children Treated with Modified Ketogenic Diet

      hrp0089p1-p171
    • Early Gut Microbiota and childhood Growth

      hrp0089p1-p172
    • Clinical and Radiological Manifestations in a Large Swedish Family with a Pathogenic Heterozygous ACAN Variant

      hrp0089p1-p173
    • Identification of ADAMTS6 as a Novel Candidate Gene for Idiopathic Short Stature with Advanced Bone Maturation

      hrp0089p1-p174
    • Dual Function of the Retinoic Acid Catabolizing Enzyme CYP26C1 - Underlying Idiopathic Short Stature and Modifying Disease Severity in SHOX Deficiency

      hrp0089p1-p175
    • Growth Plate Disorders are the Main Cause of Severe Familiar Short Stature in Children Classified and Treated with Growth Hormone as SGA or GHD

      hrp0089p1-p176
    • Genetic Investigation of Children with Syndromic Prenatal Onset Short Stature

      hrp0089p1-p177
    • Identification of Three Novel Mutations in 10 Pediatric Patients with Unexplained Syndromic Short Stature Identified by Targeted Exome Sequencing in Korea

      hrp0089p1-p178
    • Beckwith Wiedemann Syndrome: First International Consensus Regarding Diagnosis and Clinical Management

      hrp0089p1-p179
    • Silver Russell and Beckwith-Wiedemann Syndromes: Mosaic Distribution of Epigenetic Anomalies

      hrp0089p1-p180
    • Long Term Effects of Childhood Growth Hormone Treatment on Height and Body Mass Index in Adolescents and Adults with Silver-Russell Syndrome

      hrp0089p1-p181
    • Year-one Effectiveness and Overall Safety of NutropinAq® for Growth Hormone Deficiency (GHD) and Other Paediatric Growth Disorders: Completion of the International Cooperative Growth Study (iNCGS) European Registry

      hrp0089p1-p182
    • Carriers of IGF1-receptor Mutations As A Subgroup of SGA Patients: A Comprehensive Retrospective Comparison of Response to rhGH Treatment and Health Profile

      hrp0089p1-p183
    • Characteristics, Effectiveness and Safety Data for Patients with Growth Failure Treated with Recombinant IGF-I (rhIGF-I) and Achieving Adult or Near-adult Height (AH): Results from the European Increlex® Growth Forum Database (EU-IGFD) Registry

      hrp0089p1-p184
    • Growth Outcome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-releasing Hormone Agonist

      hrp0089p1-p185
    • Maternal Uniparental Disomy for Chromosome 20: Physical and Endocrinological Characteristics of Six Patients

      hrp0089p1-p186
    • A Novel Deadly Variant in the TP53 Gene Causing Li-Fraumeni Syndrome. The Importance of Clinical Awareness and the Contribution of Molecular Diagnosis in Active Prevention Within Families with Multiple Tumor Incidents at a Young Age

      hrp0089p1-p187
    • Mutations in SHOX, GHR and IGFALS Genes Among Indian Children with 'Idiopathic Short Stature'

      hrp0089p1-p188
  • Growth & Syndromes P2
  • • Heart and Aorta Anomalies in Turner Syndrome and Relation with Karyotype

      hrp0089p2-p239
    • The Validation of an Automated Bone Age Assessment in Girls with Turner Syndrome - A Pilot Study

      hrp0089p2-p240
    • Turner Syndrome and Autoimmune Thyroid Disease: Pecularities of Evolution in 93 Turner Syndrome Patients

      hrp0089p2-p241
    • Unusual Clinical Manifestations in Turner Syndrome

      hrp0089p2-p242
    • Effect of Combined GH and Estrogen Treatment on the Lipid Profile and Systolic Function of the Left Ventricle in Girls with Turner Syndrome (TS)

      hrp0089p2-p243
    • Familial Turner Syndrome: Case Report

      hrp0089p2-p244
    • Clinical Review of Seven Patients Affected with 49,XXXXY Syndrome

      hrp0089p2-p245
    • Poor Weight Gain in Prader-Willi Syndrome - Not Always Over-restriction Consider Coeliac Disease

      hrp0089p2-p246
    • GH Unmasked Laryngomalacia and worsened Obstructive Sleep Apnea in Infants with Prader-Willi Syndrome

      hrp0089p2-p247
    • How Frequent Are Growth Charts Used in Paediatric Clinics? An Audit of Growth Chart Use in a District General Hospital in Scotland

      hrp0089p2-p248
    • GrowInform - A Campaign for Early Diagnosis and Treatment of Growth Disorders

      hrp0089p2-p249
    • Growth and Body Composition of Term Healthy Indian Infants from Birth to 2 Years of Age

      hrp0089p2-p250
    • Growth, Body Composition and Metabolic Parameters during Childhood in a Cohort of Children Born with a Small for Gestational Age

      hrp0089p2-p251
    • Final Results of NordiNet® International Outcome Study: Key Outcomes in Paediatric Patients

      hrp0089p2-p252
    • Influence of Puberty on Adult Height of SGA Children Treated with GH

      hrp0089p2-p253
    • Burden and Impacts of Daily Recombinant Human Growth Hormone (r-hGH) Injections in Growth Hormone Deficient (GHD) Paediatric Patients

      hrp0089p2-p254
    • Clinical and Cost-Effectiveness of GH Treatment for Children in Wales

      hrp0089p2-p255
    • Bone Mineral Density and Body Composition of Young Adults Who Were Born Small for Gestational Age and Treated with Growth Hormone, after Treatment Completion

      hrp0089p2-p256
    • Clinical Effectiveness and Cost-Effectiveness of Somatropin Treatment for Short Children in Egypt: Analysis of 1-Year Data

      hrp0089p2-p257
    • Clinical and Molecular Analyses of 24 Patients with Beckwith-Wiedemann SYNDROME

      hrp0089p2-p258
    • Unusual Case of Combination of Beckwith-Wiedemann Syndrome and SHOX Gene Deficiency

      hrp0089p2-p259
    • An Irish Regional Study of Paediatric Growth Hormone Deficiency (CO-GHD): Classification of Causes and Factors Associated with Persistent GHD at Transition

      hrp0089p2-p260
    • Two Different Variants of Short Stature Homeobox-Containing Gene (SHOX) Mutation in the Same Family

      hrp0089p2-p261
    • Identification of a Novel Heterozygous ACAN Mutation in a Patient with Non-Syndromic Short Stature

      hrp0089p2-p262
    • Genetic Investigation of SHORT Stature: A Case Report of Complex Constitutive Rearrangement Involving Chromosome 15

      hrp0089p2-p263
    • Targeted/Exome Sequencing Identified Mutations in 55 Chinese Children Diagnosed with Noonan Syndrome and a Autosomal Recessive form Associated with LZTR1 Variants

      hrp0089p2-p264
    • A Novel Heterozygous Missense Variant in the LZTR1 Gene as a Cause of Noonan Syndrome

      hrp0089p2-p265
    • A Novel FGFR1 Mutation in Kallmann Syndrome with Growth Hormone Deficiency

      hrp0089p2-p266
    • Clinical and Molecular Characterization of Eight Chinese Children with Cornelia de Lange Syndrome Using Targeted Next Generation Sequencing

      hrp0089p2-p267
    • A New Mutation in IHH Gene Causing Severe Short Stature

      hrp0089p2-p268
    • Case Report: Ellis Van Creveld Syndrome With a Novel Mutation

      hrp0089p2-p269
    • A Homozygous Pathogenic Variant in the TRHR Gene in a Boy Who Presented With Severe Familial Short Stature and Central Hypothyroidism

      hrp0089p2-p270
    • Unexpected Growth Patterns in Branchio-Oto-Renal Syndrome

      hrp0089p2-p271
    • Mild Autistic Spectrum Disorder in a 33 Year-old Male Japanese Patient with Temple Syndrome

      hrp0089p2-p272
    • Seventeen-year Observation in a Japanese Female Case of Tatton-Brown-Rahman Syndrome: An Overgrowth Syndrome with Intellectual Disability

      hrp0089p2-p273
    • KBG Syndrome: Our Experience and Unreported Clinical Features

      hrp0089p2-p274
    • Growth of Infants Born by Intracytoplasmic Sperm Injection (ICSI) Technique

      hrp0089p2-p275
    • Earlier Mother's Age at Menarche is a Risk Factor of Daughter's Early Menarche and Short Stature in Young Korean Female: Epidemiologic Study

      hrp0089p2-p276
    • Pulling the Brakes - 'Catch Down Growth': A Phenomenon for Achieving Mid-parental Height Centile After Acquired, All-cause, Brain Injury

      hrp0089p2-p277
    • Effects of Inhaled Corticosteroids and Montelukast on Growth and BMI in Children with Asthma

      hrp0089p2-p278
    • Abstract unavailable

      hrp0089p2-p279
    • Skeletal Disproportion and Growth Impairment in Glucocorticoid Treated Boys with Duchenne Muscular Dystrophy

      hrp0089p2-p280
    • A Novel Mutation in the SLC2A2 Gene in a 19-Year-Old Female with Diabetes Mellitus and Renal Tubular Acidosis: A Therapeutic Conundrum

      hrp0089p2-p281
    • Vesico-Ureteral Reflux and Effect on Growth Indices

      hrp0089p2-p282
    • A Novel in Frame Deletion Mutation in Exon11 in BTK Gene to X-linked Agammaglobulinemia: Case Report and Function Analysis

      hrp0089p2-p283
  • Growth & Syndromes P3
  • • Is Growth Hormone Deficiency a Contributor to Short Stature in Cutis Laxa Syndrome?

      hrp0089p3-p219
    • Effect of Sickle Cell Disease on Growth and Puberty

      hrp0089p3-p220
    • Two Siblings with Alstrom Syndrome

      hrp0089p3-p221
    • Development of an Online Learn-pro Module to Support Health Care Professionals Knowledge about Growth and Puberty

      hrp0089p3-p222
    • Coeliac Disease in Turner Syndrome More Frequent Than Expected

      hrp0089p3-p223
    • A 14-Year-Old Boy with Simpson-Golabi-Behmel Syndrome - Case Report

      hrp0089p3-p224
    • Central Precocious Puberty in a Girl with Silver Russell Syndrome

      hrp0089p3-p225
    • Etiologies of Short Stature in Pedaitric Endocrine Clinic in Northwest Region (Trakya) of Turkey

      hrp0089p3-p226
    • Auditing Presentation, Investigations and Management of Turner's Syndrome

      hrp0089p3-p227
    • Children Born Small for Gestational Age: Catch-up Growth During the First Four Years of Life

      hrp0089p3-p228
    • A Novel Heterozygous Pathogenic Variant in PORCN Gene Causing Focal Dermal Hypoplasia with Short Stature: Case Report and Literature Review

      hrp0089p3-p229
    • Endocrinological Evaluation of Girls with Turner Syndrome Attending Alexandria University Children's Hospital

      hrp0089p3-p230
    • A Long Follow-up in a Young Patient with Atypical Progeroid Syndrome

      hrp0089p3-p231
    • GH Treatment in Kabuki Syndrome: A Case Report

      hrp0089p3-p232
    • GH Treatment in Oto-Spondylo-Megaepiphyseal Dysplasia: A Case Report

      hrp0089p3-p233
    • Hepatic Glycogen Synthasedeficiency Associated with Growth Hormone Deficiency: A Case Report

      hrp0089p3-p234
    • Analysis of Genetic Mutations in a Chinese Patient Affected with Noonan Syndrome

      hrp0089p3-p235
    • A Novel Homozygous Mutation in ERCC8 Cause Cockayne Syndrome a in a Chinese Family

      hrp0089p3-p236
    • Growth Hormon Deficiency in Identical Twins with Gitelman Syndrome due to Compound Heterozygous Mutation (p.R80fs*35/p.K957X) of the SLC12A3 Gene and the Evaluation of the Response to Growth Hormone Replacement Therapy

      hrp0089p3-p237
    • Hypothyroidism and Growth Hormone (GH) Deficiency, a Spotlight on De Novo Chromosomal 20p11.2 Deletion

      hrp0089p3-p238
    • Pharmacoeconomic and Adherence Analysis in Growth Hormone According to Galenic Presentation: In Vivo Study vs In Vitro

      hrp0089p3-p239
    • The Expression of Cytokines in SGA Children Throughout Lactation Allows to Characterize Early the Type of Cath-up

      hrp0089p3-p240
    • Small Stature: A Singular Difference for Accessing to Job

      hrp0089p3-p241
    • A Case of Hutchinson-Gilford Progeria Syndrome (HGPS) due to a Pathogenic LMNA Variant c.433G>A (p.Glu145Lys): Growth Hormone Administration Failed to Improve Growth and Long-term Outcome

      hrp0089p3-p242
    • Increased Serum Activity of Liver Aminotransferases in Young Patients with Turner Syndrome

      hrp0089p3-p243
    • Terner Syndrome: Epidemiological Study in Uzbekistan

      hrp0089p3-p244
    • Shox Haploinsufficiency in Short and Not Short Children: A Sigle Italian Cetre Data

      hrp0089p3-p245
    • Microduplication of 3p25.3 and 4p23 Regions in a Patient with Multiple Congenital Anomalies, Congenital Hypothyroidism and Adrenogenital Syndrome

      hrp0089p3-p246
    • A Rare Chromosomal Disorder, Trisomy 4p

      hrp0089p3-p247
    • Prediction of Response to Growth Hormone Treatment in Korean Girls with Turner Syndrome

      hrp0089p3-p248
    • A Rare Case of Turner Syndrome with the Presence of the Y Chromosome Genetic Material

      hrp0089p3-p249
    • Prader-Willi Patient with Rectal Bleeding - Experience in Center for Rare Endocrine Disordesrs in Varna, Bulagria

      hrp0089p3-p250
    • Mosaicism 47XXX/45X0, a Case Report

      hrp0089p3-p251
    • Factors Influencing the Selection of Injection Areas During Self-therapy for Growth Hormone Therapy Among Patients 10-15 Years Old

      hrp0089p3-p252
    • Tall Stature: A Diagnosis is Sometimes Difficult

      hrp0089p3-p253
    • Woodhouse-Sakati Syndrome: Clinical and Molecular Study on a Qatari Family with C2orf37 Gene Mutation

      hrp0089p3-p254
    • Factors Affecting Height Velocity in Normal Prepubertal Children

      hrp0089p3-p255
    • Low Dose Growth Hormone using IGF1 Dose Titration is Associated with Sustained Optimal Growth in a Child with Both Turner and Down Syndrome

      hrp0089p3-p256
    • Growth Response in Noonan Syndrome in Indian Children

      hrp0089p3-p257
    • Late Referral of Siblings with Combined Pituitary Hormone Deficiency (PROP1)

      hrp0089p3-p258
    • 17p13.1 Microduplication Syndrome in a Child with Familial Short Stature and GH Deficiency: A Short Case Report

      hrp0089p3-p259
    • Prader Willi Syndrome: Clinical Profile

      hrp0089p3-p260
    • Leri-Weill Syndrome Phenotype with Atypical Cytogenetic Finding

      hrp0089p3-p261
    • Deletion of 12q12 Increases the Risk of Growth Retardation and Intellectual Disability

      hrp0089p3-p262
    • A Patient with Turner Syndrome (45X/46XX) and Congenital Adrenal Hyperplasia

      hrp0089p3-p263
    • Congenital Tufting Enteropathy Caused by Mutation of EPCAM Gene: A Case Report and Review of Literature

      hrp0089p3-p264
    • Is Using a Specific Growth Charts a Chance to be More Precise in Evaluation the Growth of the Children and Adolescence with Down Syndrome? Comparison of the Down's Syndrome Growth Charts with the Growth Charts for Polish Population

      hrp0089p3-p401
    • Two Siblings with Prader-Willi Syndrome Caused by Microdeletion Derived from the Paternal Grandmother

      hrp0089p3-p406
    • Novel Mutation of CHD7 in a Chinese Boy with Kallmann Syndrome

      hrp0089p3-p412
    • Conversion of Hypothyroidism to Hyperthyroidism in Children

      hrp0089p3-p413
    • Case Report: Novel ACAN Mutation in a SGA Short Stature without Accelerated Skeletal Maturation

      hrp0089p3-p415
  • Multisystem Endocrine Disorders P1
  • • Clinical Features and Assessment of the Pathway-Care Proposed by ISPED-Gsa Study Group in an Pediatric Italian Cohort with Pseudohypoparathyroidism

      hrp0089p1-p189
    • Overview of Leading Causes of Death among French Patients with Prader-Willi Syndrome, 2004-2014

      hrp0089p1-p190
    • SGPL1 Missense Mutation in an Infant with Primary Adrenal Insufficiency (PAI), Congenital Nephrotic Syndrome, Primary Hypothyroidism and Gonadal Failure

      hrp0089p1-p191
    • Final Adult Height, Insulin-like Growth Factor 1 (IGF-I) Concentration in Adolescents and Young Adults with [beta]-Thalassemia Major (BTM) with and Without Growth Hormone Deficiency

      hrp0089p1-p192
    • McCune-Albright-Syndrome: Clinical and Genetic Study in a Large Cohort of Pediatric Patients

      hrp0089p1-p193
  • Multisystem Endocrine Disorders P2
  • • Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study

      hrp0089p2-p284
    • Bone Marrow Failure in McCune Albright Syndrome

      hrp0089p2-p285
    • Final Adult Height, Insulin-Like Growth Factor 1 (IGF-I) Concentration and Endocrine Complications in Adolescents and Young Adults with [beta]-Thalassemia Major (BTM) Who Received Oral Iron Chelation (OIC) in Comparison with Those Who Did Not Use OIC

      hrp0089p2-p286
    • Endocrine Challenges in Patients with Thalassemia

      hrp0089p2-p287
    • Can Oral Iron Chelation Therapies Reduce Endocrine Complications in [beta]-Thalassemia Major Patients?

      hrp0089p2-p288
    • Statural Growth and Endocrinopathies in Relation to Liver Iron Content (LIC) and Insulin-Like Growth Factor 1 (IGF-I) Concentration in Adolescents with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD)

      hrp0089p2-p289
    • Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year Old Girl

      hrp0089p2-p290
    • Hypoglycemia in Adolescence as the Presenting Sign of Familial MEN1

      hrp0089p2-p291
    • Aldosterone, Renin, Sodium and Potassium Excretion in Normotensive Prepubertal Children

      hrp0089p2-p292
    • What is the Impact of a Structured Healthcare Pathway Dedicated to Patients in Transition on Their Long-term Follow-up?

      hrp0089p2-p293
    • British Society for Paediatric Endocrinology and Diabetes Peer Review of Specialised Paediatric Endocrinology Services in the UK - Evaluation of the Process

      hrp0089p2-p294
    • Paediatric Endocrinology Mapping and Services in Nigeria: A Decade After

      hrp0089p2-p295
    • The Impact of Military Conflict in the East of Ukraine on the Physical Development of Children and Adolescents

      hrp0089p2-p296
    • Polycystic Ovary Syndrome Metabolic Syndrome Predisposition in Puberty

      hrp0089p2-p297
    • Fanconi-Bickel Syndrome in Sudanese Children, Case Series

      hrp0089p2-p298
    • The N309K Pro-Protein Convertase Type 1 (PCSK1) Gene Mutation Causes Lack of Spontaneous Puberty and Primary Amenorrhea

      hrp0089p2-p299
    • Somatostatin Experiment in Prohormone Convertase Deficiency

      hrp0089p2-p300
  • Multisystem Endocrine Disorders P3
  • • Insulinoma as Initial Presentation of Multiple Endocrine Neoplasia Type 1

      hrp0089p3-p265
    • Assessment of Ovarian Reserve in Young Women with Hashimoto Disease - The Pilot Study

      hrp0089p3-p266
    • Unusual Clinical Presentation of Autoimmune Polyendocrinopathy Type 1

      hrp0089p3-p267
    • Glycemic Abnormalities and Normal Thyroid Function in Adolescent Survivors of Childhood Acute Lymphocytic Leukemia Who Required Repeated Packed Red Cell Transfusion During Treatment

      hrp0089p3-p268
    • Graves' Disease in Children with T1DM: A Report of Three Cases

      hrp0089p3-p269
    • Case Report: Neonatal McCune-Albright Syndrome with Juvenile Ovarian Granulosa Cell Tumor in a 4 Months Old Girl

      hrp0089p3-p270
    • Polyostotic Fibrous Dysplasia of McCune Albright Syndrome Responding to Intravenous Zoledronate Therapy

      hrp0089p3-p271
    • Two Cases of Costello Syndrome and Literatures Review

      hrp0089p3-p272
    • Endocrine Complications in Beta-Thalassaemia Major Children

      hrp0089p3-p273
    • The Case of Combination of Multinodular Goiter and Sertoli-Leydig Cell Ovarian Tumor due to Mutation in DICER1 Gene

      hrp0089p3-p274
    • Unusual Case of Autoimmune Polyglandular Syndrome

      hrp0089p3-p275
    • Autoimmunepolyendocrinopathy-Candidiasis-Ectodermal Dystrophy: A Case Report

      hrp0089p3-p276
    • Wolman Disease: Long-Term Endocrine and Metabolic Comorbidities

      hrp0089p3-p277
    • Pallister Hall Syndrome: with a Varied Spectrum of Endocrine Disorders

      hrp0089p3-p278
    • Near Electromagnetic Fields - Induced Syndrome: Unsuspected and Newly Recognised

      hrp0089p3-p279
    • Polycystic Ovary Syndrome Gene/Gene Products Interaction Network

      hrp0089p3-p280
    • Basal Metabolic Rate as Moderator of Inflammation in PCOS

      hrp0089p3-p281
    • Insight of Differential Diagnosis of DAX-1 from Two Patients with Elevated Testosterone in Early Infancy

      hrp0089p3-p282
    • Rapid Onset and Progression of Chronic Kidney Disease in a Child with Autoimmune Polyglandular Syndrome Type 1

      hrp0089p3-p283
    • Clinical Characteristics and Outcome of Patients with Beta-Ketothiolase Deficiency in China

      hrp0089p3-p402
    • Lessons from Wolfram Syndrome: Initiation of DDAVP Therapy Causes Renal Salt Wasting due to Elevated ANP Levels, Rescued by Fludrocortisone Treatment

      hrp0089p3-p405
    • A Novel Detrimental Homozygous Mutation of WFS1 Gene in Two Sisters from Non-consanguineous Parents with Untreated Diabetes Insipidus

      hrp0089p3-p410
    • General Public' Attitudes Towards the Use and Storage of NBS Blood Samples for Research in China

      hrp0089p3-p411
  • Pituitary, Neuroendocrinology and Puberty P1
  • • A 7-Year Update Report of a National, Interdisciplinary Endeavour to Improve Outcomes for Children and Young People Under 19 Years of Age with Hypothalamic Pituitary Axis Tumours (HPAT) Using Multi-site Video Conferencing

      hrp0089p1-p194
    • Long Term Reversibility of Presumed ACTH Deficiency (ACTHd) in Children and Young People (CYP) with Intracranial Germ Cell Tumours (IGCT)

      hrp0089p1-p195
    • Endocrine Follow-up of Children with a History of Brain Tumour: Data from Our Large Cohort at Necker University Hospital, Paris, 2010-2015

      hrp0089p1-p196
    • A Single Centre Experience of Managing a Series of Childhood Macro/Giant-Prolactinoma

      hrp0089p1-p197
    • A National UK Guideline for Managing Pituitary Adenomas in Children and Young People Under 19 Years Developed According to the AGREE II Framework

      hrp0089p1-p198
    • Growth Hormone Deficiency and Cryptorchidism in a Family with Xq26.3 Duplication and Position Effect on SOX3

      hrp0089p1-p199
    • PROKR2 Mutations in Patients with Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency

      hrp0089p1-p200
    • Anastrozole is Safe as Monotherapy in Early Maturing Girls with Compromised Growth, Further Improving Gain in Predicted Adult Height by the Initial Combination Therapy of an LHRH Analogue and an Aromatase Inhibitor: Results from the 'Gail' Study ISRCTN11469487

      hrp0089p1-p201
    • Long-acting Octeotride Treatment in Children with Neurofibromatosis Type 1 - Optic Pathway Tumors and Growth Hormone Excess

      hrp0089p1-p202
    • Serum Concentrations of the Endocrine Disruptors-organochlorine Pesticides (OCPs) in Greek Children with Neurodevelopmental Disorders

      hrp0089p1-p203
    • Whole-exome Sequencing Identifies Novel Pathogenic Variants in Korean Families with Central Precocious Puberty

      hrp0089p1-p204
    • A Paternally Inherited Familial Precocious Puberty Caused by a Novel MKRN3 Frameshift Variant

      hrp0089p1-p205
    • MKRN3 Levels in Girls with Central Precocious Puberty During GnRHa Treatment: A Longitudinal Study

      hrp0089p1-p206
    • Urinary Gonadotropins as a Useful Non-invasive Marker of Central Precocious Puberty

      hrp0089p1-p207
    • Testicular Development and Puberty in Boys with Duchenne Muscular Dystrophy: Results From the ScOT-DMD Study

      hrp0089p1-p208
    • Exposure to BPA and Phthalates and Timing of Puberty in Girls

      hrp0089p1-p209
    • Hypothalamic-pituitary-testicular Axis Response to Sub-maximal Aerobic Exercise, in Pre- and Early- Pubertal Normal Weight and Obese Boys

      hrp0089p1-p210
    • Effect of Pubertal Blockade and Cross-sex Hormone Treatment on the Growth Spurt in Young Transgender Adolescents: A First Report

      hrp0089p1-p211
    • Real-World Safety Data in a Cohort of Children with Noonan Syndrome Treated with GH: Final Results from NordiNet International Outcome Study (IOS) and ANSWER Program

      hrp0089p1-p212
  • Pituitary, Neuroendocrinology and Puberty P2
  • • Efficacy and Safety of Triptorelin 3-Month Formulationin Patients with Central Precocious Puberty and BMI Evaluation.

      hrp0089p2-p301
    • Triptorelin Test in Idagnosing Central Precocious Puberty

      hrp0089p2-p302
    • Foot Length Growth is a Novel Marker of Early Puberty

      hrp0089p2-p303
    • Ultrasound-Based Measurements of Testicular Volume in 6-16 Year Old Boys: Intra- and Inter-Observer Agreement and Comparison with Prader Orchidometry

      hrp0089p2-p304
    • Abstract unavailable

      hrp0089p2-p305
    • Longitudinal Follow-up to Near Final Height of Auxological Changes in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analog and Grouped by Pretreatment BMI level

      hrp0089p2-p306
    • The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and Their Families

      hrp0089p2-p307
    • A Novel Inactivating Compound Heterozygous Mutation in KISS1R/GPR54: Cases of Three Siblings

      hrp0089p2-p308
    • MKRN3 Gene Mutations in a Cohort of Patients with Central Precocious Puberty

      hrp0089p2-p309
    • Can Basal Levels of Luteinizing Hormone (LH) Replace the GnRH Test in the Diagnosis of Precocious Puberty in Girls?

      hrp0089p2-p310
    • Incidence of Delayed Puberty in Adolescents. A Population-Based Study in a County in Central Sweden

      hrp0089p2-p311
    • Ultrasound Assessment of Pubertal Breast Development: Intra- and Inter-Observer Agreement

      hrp0089p2-p312
    • Neuroendocrine Consequences of Hypothalamic Hamartoma and their Imaging (MRI) and Surgery Correlates

      hrp0089p2-p313
    • The Start Predictors of Puberty in Boys with Constitutional Delay of Puberty

      hrp0089p2-p314
    • Research on the Relationship between Secular Trends of Pubertal Development and Obesity in Child and Adolescent

      hrp0089p2-p315
    • Gonadotropin Levels and Frequency of Testosterone Supplementation in Adolescents with Klinefelter Syndrome

      hrp0089p2-p316
    • The Effect of Letrozole on the Reproductive Function and Linear Growth in the Early and Mid Puberty Boys

      hrp0089p2-p317
    • SOX3 Gene Duplication Associated with Midline CNS Malformations, Hypopituitarism and Neurodevelopmental Abnormalities: 5 Unrelated Cases

      hrp0089p2-p318
    • An 18 Month Old Boy with Hypoglycemic Convulsion and Obesity Due to POMC Deficiency

      hrp0089p2-p319
    • Pituitary Stalk Interruption Syndrome (PSIS) is Not a Rare Cause of the Congenital Hypopituitarism

      hrp0089p2-p320
    • Pallister Hall Syndrome: An Unusual Case of Central Precocious Puberty, Prolonged Vaginal Bleeding, Gelastic Seizures and Polysyndactyly in a 3 Month Old Infant

      hrp0089p2-p321
    • Primary Empty Sella Syndrome and Clnical Endocrine Polymorphisms in Children: a Report of 15 Cases

      hrp0089p2-p322
    • Growth Hormone Deficiency (GHD) in a Patient with Persistence of the Craniopharyngeal Canal with Cephalocele

      hrp0089p2-p323
    • Endocrine-Metabolic Characterization of Pediatric Patients with Craniopharyngioma: A Single-centre Cohort study

      hrp0089p2-p324
    • Growth Hormone (GH) Secreting Pituitary Adenomas in Paediatric Practice: 5 Cases Over 20 Years in a Single Tertiary NeuroEndocrine Centre

      hrp0089p2-p325
    • Pituitary Adenomas in Children and Adolescents: A Retrospective Single-Centre Analysis

      hrp0089p2-p326
    • Changes of Body Composition of Male Adolescents with GH Deficiency are Diagnostic During Transition

      hrp0089p2-p327
    • AMH and Inhibin B Level in Girls with Central Precocious Puberty

      hrp0089p2-p328
    • Gender-Related Differences in Etiological Distribution of Organic Causes of Central Precocious Puberty

      hrp0089p2-p329
    • Final Adult Height in Girls with Idiopathic Central Precocious Puberty Treated with Monthly Leuprorelin Acetate VS Triptorelin Acetate

      hrp0089p2-p330
    • The Impact of Central Precious Puberty on Health-relatedqualityoflifeand Social, Emotive and Behavioral Competences Among Children Treated with GnRHa

      hrp0089p2-p331
    • Basal and GnRH Analog-stimulated Peak LH Levels for Diagnosing Girls with Early Phase of Central Precocious Puberty

      hrp0089p2-p332
    • Determination of Urinary Metabolic Profiles of Children with Central and Peripheral Precocious Puberty

      hrp0089p2-p333
    • Hypertension During GNRH Analogues Therapy in a 10-year-old Girl

      hrp0089p2-p334
    • The Effect of Polychlorinobiphenyls on Premature Puberty in Girls

      hrp0089p2-p335
    • A Novel Mutation in 5'; Untranslation Region of Makorin Ring Finger 3 Gene Associated with the Familial Precocious Puberty

      hrp0089p2-p336
    • A Case of Testotoxicosis Due to a Constitutive Mutation of the LH Receptor Initially Presented as a Central Precocious Puberty at 3 Years Old

      hrp0089p2-p337
  • Pituitary, Neuroendocrinology and Puberty P3
  • • Infant with Osteogenesis Imperfecta and Panhypopituitarism: A Case Report

      hrp0089p3-p284
    • Panhypopituitarism with Tall Stature Diagnosed in a 20 Years Old Boy

      hrp0089p3-p285
    • Post-Traumatic Hypopituitarism Caused by Pituitary Stalk Transection

      hrp0089p3-p286
    • Invasive Macroprolactinoma with Cabergoline Induced Cerebrospinal Fluid Rhinorrhoea in Childhood

      hrp0089p3-p287
    • Bilateral Optic Nerve Hypoplasia Revealing Septo Optic Dysplasia or De Morsier Syndrome: A Case Report

      hrp0089p3-p288
    • Investigating Malnutrition Among Children Diagnosed with Neuroendocrine Tumors Receiving Chemotherapy in a Tertiary Care Hospital of Pakistan

      hrp0089p3-p289
    • An Interesting Etiology in Childhood Central Diabetes Insipidus HIBERNOMA

      hrp0089p3-p290
    • Neonatal Panhypopituitarism with Hypoglycemia, Edema, Inspiratory Stridor and Cholestasis

      hrp0089p3-p291
    • MRI Changes in Time after Cranial Irradiation, and their Relation with Pituitary Function in Survivors of Childhood Medulloblastoma

      hrp0089p3-p292
    • Two Identical Twins … But not in Everything. A Difficult Diagnosis

      hrp0089p3-p293
    • Growth Hormone Deficit Associated to Complex Arteriovenous Malformation - Case Report

      hrp0089p3-p294
    • Does Acquired Hypothyroidism Lead to Precocious Puberty?

      hrp0089p3-p295
    • Analysis of Influencing Factors on Bone Maturation in Girls with Central Precocious Puberty (CPP)

      hrp0089p3-p296
    • Is Premature Adrenarch Associated with Precocıous Puberty via Kisspeptin?

      hrp0089p3-p297
    • Distinct Presentations of McCune Albright Syndrome, Report of Two Cases

      hrp0089p3-p298
    • A Case of Atypical McCune-Albright Syndrome with Vaginal Bleeding

      hrp0089p3-p299
    • Evaluation of Cases with Pubertal Gynecomastia

      hrp0089p3-p300
    • A Case of Central Diabetes Insipidus Developed 4 Years after the Non-CNS-Risk Unifocal Bone Lesion of Langerhans Cell Histiocytosis

      hrp0089p3-p301
    • Effect of Triptoreline in Patients with Central Precocious Puberty at Children's Hospital 1, Ho Chi Minh City, Vietnam

      hrp0089p3-p302
    • Morning Basal Luteinizing Hormone, A Good Screening Tool for Diagnosing Central Precocious Puberty

      hrp0089p3-p303
    • A 2-Year-Old Boy with Epiphysis Tumor and Precocious Puberty

      hrp0089p3-p304
    • Central Precocious Puberty as a Result of Hypotalamus Hamartoma

      hrp0089p3-p305
    • Precocious Puberty as a Result of Ectopic Hormone-Producing Tumor

      hrp0089p3-p306
    • Premature Adrenarche and Pseudohypoparathyroidism - Mechanistically Linked or Coincidence?

      hrp0089p3-p307
    • Efficacy of Ziyin Xiehuo Granules and Zishen Qinggan Granules in girls with Partial Precocious Puberty: A Multicenter, Randomized, Single-Blinded, Controlled Trial

      hrp0089p3-p308
    • GLP-1 Receptor Agonist in a Patient with Craniopharyngioma-Related Obesity

      hrp0089p3-p309
    • Poland's Syndrome and Hypogonadotropic Hypogonadism

      hrp0089p3-p310
    • Congenital Hypopituitarism Associated with Complex Cranio-Vertebral Junction Anomalies

      hrp0089p3-p311
    • Premature Thelarche Followed by Acute Lymphoblastic Leukemia in a 1.5 Year Old Girl

      hrp0089p3-p312
    • Two Cases of Non-syndromic Congenital Unilateral Hypoplasia in One Family

      hrp0089p3-p313
    • Klinefelter Syndrome with Ambiguous Genitalia in a Child

      hrp0089p3-p314
    • The Change in Growth's Velocity in Patients with Premature Puberty Receiving Treatment with Analogues of Lyuliberin

      hrp0089p3-p315
    • The Efficacy of Treatment in Vietnamese Children with Central Precocious Puberty

      hrp0089p3-p316
    • The Characteristics of Central Precocious Puberty at Children's Hospital 2 in Vietnam

      hrp0089p3-p317
    • SIG (Special Interest Group)-ENDOPED/RUTE (Brazil): Seven Years Integrating Pediatric Endocrinology Centers throughout the Country

      hrp0089p3-p318
    • The Relationship Between Prolactin and Development of Puberty in Girls with Early Breast Development

      hrp0089p3-p319
    • Central Precocious Puberty Appeared in Infancy Period in a Patient of Sotos Syndrome

      hrp0089p3-p320
    • Clinical and Endocrinological Manifestations of Partial Ectopic Posterior Pituitary: A New Imaging Entity

      hrp0089p3-p418
  • Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P1
  • • Insights in Promoter Transactivation of CBX2 Expression

      hrp0089p1-p213
    • In Silico and In vitro Studies of Human SRD5A2 Variants in Search for Activating Variants Explaining Androgen Excess Reveal Additional Loss of Function Variants

      hrp0089p1-p214
    • Mutations Involving Nuclear Receptors and Their Cofactors as a Major Cause of 46,XX DSD

      hrp0089p1-p215
    • SDgeneMatch, A New Tool to Aid the Identification of the Genetic Causes of DSD

      hrp0089p1-p216
    • Reduced Androgen Receptor Expression in Patients with 45,X/46,XY Mosaicism

      hrp0089p1-p217
    • Primary Gonadal Dysgenesis in Male 46,XY Patients with NR5A1 Variants Predominantly Affects Sertoli Cell Function

      hrp0089p1-p218
    • Evaluation of Genetic Etiology in Patients with 46,XY Disorders of Sex Development: One Center Experience

      hrp0089p1-p219
    • Pitfalls in the Diagnosis of An Infant with 46,XX DSD with Congenital Adrenal Hyperplasia due to Cytochrome P450 Oxidoreductase Deficiency - the Value of Simultaneous Genetic Analysis to the Diagnosis in DSD

      hrp0089p1-p220
    • High Mobility Group Box 1 (HMGB1) and Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) are Increased, Insulin Decreased and IL-6 Unchanged in Follicular Fluid (FF) from Polycystic Ovarian Syndrome (PCOS)

      hrp0089p1-p221
    • A De Novo Missense Mutation in the 4th Zinc Finger of the WT1 Gene Causes 46,XY and 46,XX DSD in Two Sibs

      hrp0089p1-p222
    • Sex-Differences in Reproductive Hormones During Mini-Puberty in Infants with Normal and Disordered Sex Development

      hrp0089p1-p223
    • The 'ExternalGenitaliaScore' to Describe External Genitalia in Male and Female Infants: A Europeanmulticenter Validation Study

      hrp0089p1-p224
    • Living with Clitoromegaly: Aqualitative Interview Study of Parent's Responses to Clitoromegaly in Congenital Adrenal Hyperplasia (CAH) with or Without Appearance Altering Surgery

      hrp0089p1-p225
    • 'You Can Put Ideas into Their Heads': Parental Concerns about Children's Participation in DSD Research

      hrp0089p1-p226
    • Testosterone Levels in Newborn Boys and Girls Related to Penile Length, Anogenital Distance (AGD) and External Genitalia Score (EGS)

      hrp0089p1-p227
    • Clinical Factors that Determine Surgical Outcome Following Hypospadias Repair

      hrp0089p1-p228
    • Prevalence of Hypogonadism in Prepubertal Boys with Cryptrochdism

      hrp0089p1-p229
    • Testicular Ultrasound Measurements to Stratify Pituitary-Gonadal Hormone References in a Cross-Sectional Norwegian Study of Male Puberty

      hrp0089p1-p230
    • Altered Vascular Function in Boys with Hypospadias - Role of Reactive Oxygen Species

      hrp0089p1-p231
    • Gonadectomy for Adults with DSD Conditions in the International Disorders of Sex Development Registry

      hrp0089p1-p232
    • Phenotypic and Genetic Assessment of Boys with a Suspected XY Disorder of Sex Development

      hrp0089p1-p233
    • Pediatricians' Attitudes and Beliefs towards Transgender Persons

      hrp0089p1-p234
    • Diagnosis of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS

      hrp0089p1-p235
    • Identification and Analysis of the Genetic Causes of Premature Ovarian Failure (POF) in a Cohort of Adolescent Girls

      hrp0089p1-p236
    • Premature Ovarian Insufficiency in Girls Caused by Autosomal Microdeletions: 3 Case Reports

      hrp0089p1-p237
    • Effect of Intrauterine Growth Restriction on Ovarian Follicle Pool

      hrp0089p1-p238
    • Sustainability of Estradiol Drug Concentrations in Cut Matrix Patches; A Study of Different Brands with Potential Use for Pubertal Induction

      hrp0089p1-p239
    • Serum Anti-Mullerian Hormone (AMH) concentrations and Reduced Appendix Testis Estrogen Receptor Expression in Cryptorchidism

      hrp0089p1-p240
    • The Comparisons of the Adult Height Gain and the Menarchal Age of the Girls with Central Precocious Puberty after Gonadotropin Releasing Hormone Agonist Alone and Those Treated with Combined Growth Hormone Therapy

      hrp0089p1-p241
    • AMH Level of Infants with Premature Thelarche and Possible Relationship between AMH and Mini-puberty

      hrp0089p1-p242
    • Circulating Makorin Ring Finger Protein 3 Levels Predict Central Precocious Puberty in Girls

      hrp0089p1-p243
    • Polycystic Ovarian Syndrome in Adolescents: Characterising the Clinical Phenotype and the Role of Precision Medicine

      hrp0089p1-p244
    • Thyroid Function in Central Precocious Puberty Girls

      hrp0089p1-p245
    • Clinical Phenotypes and Mutation Spectrum of Patients with Isolated Gonadotropin-Releasing Hormone Deficiency in a Single Academic Center

      hrp0089p1-p246
    • Evaluation of Hormonal Profiles and Autoantibodies Against Sperm and Leydig Cells in Patients after Testicular Torsion Treatment

      hrp0089p1-p247
  • Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P2
  • • Physical Assessment in Chinese Children with 5a-reductase Type 2 Deficiency

      hrp0089p2-p338
    • Results of Exome Sequencing in Disorders of Sex Development

      hrp0089p2-p339
    • Awareness is The Key: Heavy Delay in Diagnosis of 17-[beta]-Hydroxysteroid-Dehydrogenase III Deficiency (17bHSD3D) and Other Insights and Conclusions from a Cohort of Ten 17bHSD3D Patients in Germany

      hrp0089p2-p340
    • Evaluation of Three Patients with 46,XY Gonadal Dysgenesis due to Desert Hedgehog Gene Mutations

      hrp0089p2-p341
    • In-silico Gene-protein Analysis and Clinical Phenotype Characterisation of Three Novel NR5A1/SF1 Gene Mutations Presenting with 46,XY DSD

      hrp0089p2-p342
    • Clinical, Biochemical, Structural and Functional Characterization of a Novel P450 Oxidoreductase Mutation Causing Virilization in a 46,XX Patient

      hrp0089p2-p343
    • Copy-Number Variations of the Human Olfactory Receptor Gene Family in Patients with Macromastia and Prepubertal Gynecomastia

      hrp0089p2-p344
    • Histopathologic Characterization of Patients with 46,XX Testicular and Ovotesticular Disorders of Sex Development

      hrp0089p2-p345
    • Current Medical Care of Children and Adolescents with Disorders/differences of Sex Development in Switzerland

      hrp0089p2-p346
    • Clinical, Laboratory and Molecular Genetic Findings of Patients with 17[beta]-Hydroxysteroid Dehydrogenase 3 Deficiency

      hrp0089p2-p347
    • Revisiting the Diagnosis: Next Generation Sequencing (NGS) Identifies Concurrence of PAIS in a Previously Reported Case of Klinefelter Syndrome (47,XXY) with Hypospadias

      hrp0089p2-p348
    • A 46,XX Female with WT1 Mutation, Congenital Nephrotic Syndrome and a Complex Disorder of Sex Development

      hrp0089p2-p349
    • Psychological Gender Features and Social Abilities and in Adolescent Girls - Influence of Obesity and Hyperandrogenism

      hrp0089p2-p350
    • Two Unrelated Cases of Severe Insulin Resistance Due to Insulin Receptor Mutation Discovered During Adolescence

      hrp0089p2-p351
    • A Systematic Review of Reported Outcomes for Hypospadias

      hrp0089p2-p352
    • Young Transgender People's Attitudes to Fertility Preservation and Practice

      hrp0089p2-p353
    • Etiology of Disorders of Sex Development in Kenyan Children and Adolescents

      hrp0089p2-p354
    • Adiponectin as a Marker of Peripheral Insulin Resistance in Adolescents with Polycystic Ovarian Syndrome (PCOS) and as a Tool to Suspect Insulin Receptor Defects

      hrp0089p2-p355
    • Diagnostic Experiences and Concerns in Adolescents with Polycystic Ovary Syndrome

      hrp0089p2-p356
    • Impact of Hydrocortisone Treatment on Clitoral Size During First Year of Life in Girls with Congenital Adrenal Hyperplasia (CAH)

      hrp0089p2-p357
    • Persistent Mullerian Duct Syndrome: Rare But Important Aetiology of an Inguinal Hernia and Cryptorchidism in Boys

      hrp0089p2-p358
    • Clinical, Hormonal and Metabolic Profile in Adolescent Girls Treated with Gonadotropin Releasing Hormone Agonist for Idiopathic Central Precocious Puberty

      hrp0089p2-p359
    • Spontaneous Pregnancies in Female Survivors of Childhood Hematological Malignancies Post Allogeneic Haemopoietic Stem Cell Transplantation

      hrp0089p2-p360
    • Towards an Integrated Approach to Diagnosis of 46,XY Disorder of Sex Development

      hrp0089p2-p361
    • Mini-Puberty in Boys with Inguinal Cryptorchidism

      hrp0089p2-p362
    • The Human Genital Tubercle is Steroidogenic Organ at Earlypregnancy

      hrp0089p2-p363
    • Transgender Medicine is a Significant Part of Paediatric Endocrinology

      hrp0089p2-p364
    • Prospective Investigation of the Influence of Triptorelin Treatment on Body Weight and Body Mass Index of Girls Who Were Diagnosed with Idiopathic Precocious Puberty or Early Puberty

      hrp0089p2-p365
    • Genetic Etiologies and Gender Outcomes of Patients with Disorders of Sex Development Presenting with Asymmetric Gonads

      hrp0089p2-p366
    • A Rare Form of Ovotesticular DSD: Diagnostic and Management Challenges

      hrp0089p2-p367
    • A Case of Gonadal Dysgenesis Due to a Novel Homozygous Mutation in NR5A2 Gene

      hrp0089p2-p368
    • Assessment of Initial Investigation Requested in Adolescents with Menstrual Disorders

      hrp0089p2-p369
    • Persistent Mullerian Duct Syndrome in Twin Brothers Caused by a Novel Mutation in the AMHR2 Gene

      hrp0089p2-p370
    • No Difference in Cognitive Performance or Gender Role Behaviour in Men with and without Hypospadias

      hrp0089p2-p371
    • Assessment of the Gonadotrophin-Gonadal Axis and Sertoli Cell Function in Partial Androgen Insensitivity Syndrome

      hrp0089p2-p372
    • Prevalence and Ethiologic Factors of Hirsutism in Adolescents

      hrp0089p2-p373
    • Evaluation of Serum Anti-Mullerian Hormone and Androstenedione Levels in Adolescents Girls with Menstrual Irregularities

      hrp0089p2-p374
    • Could Basal AMH Replace hCG Stimulation Test in XY Disorder of Sex Development Cases

      hrp0089p2-p375
  • Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P3
  • • Gonadal Tumor Incidence in Patients with Disorders of Sex Development Containing Y Chromosome or Y-derived Sequences - Experience from One Clinical Center

      hrp0089p3-p321
    • New Method of Surgical Correction of Female Hypospadias in Girls with Disorders of Sex Development and Stenosis of Artificial Introitus

      hrp0089p3-p322
    • Novel Mutation in Two Related 46, XY Phenotypic Females with 17[beta]-Hydroxysteroid Dehydrogenase 3 Deficiency

      hrp0089p3-p323
    • Challenges in Managing 46, XY Partial Gonadal Dysgenesis in Saudi Arabia

      hrp0089p3-p324
    • A Paternally Inherited NR5A1 Mutation in a Case of 46,XY Partial Gonadal Dysgenesis

      hrp0089p3-p325
    • Clinical Presentation and Characteristics of DSD in Kenyan Children and Adolescents

      hrp0089p3-p326
    • Evolutive Profile of Pauci-symptomatic Forms of Mc Cune Albright Syndrome

      hrp0089p3-p327
    • A 45X0/46XY Girl Diagnosed with Prepubertal FSH Elevation

      hrp0089p3-p328
    • About a Case of Leydig Cell Tumor Associated with Central Precocious Puberty

      hrp0089p3-p329
    • Gender Dysphoria

      hrp0089p3-p330
    • GnRH Analogues and Cross-Sex Hormonal therapy: Side Effects in Transgender Youth

      hrp0089p3-p331
    • Klinefelter Syndrome with Low Gonadotropin Levels

      hrp0089p3-p332
    • Young Male Adolescent with Gender Dysphoria (GD)/Gender Incongruence - A Case Presentation

      hrp0089p3-p333
    • Effect of Gonadotropin-Releasing Hormone Agonist Treatment in Boys with Central Precocious Puberty and Early Puberty

      hrp0089p3-p334
    • DSD in Ukraine: Our Experience

      hrp0089p3-p335
    • A Turkish Family with 46,XY Disorder of Sex Development Due to 17b-Hydroxysteroid Dehydrogenase Type 3 Deficiency

      hrp0089p3-p336
    • Normal External Genitalia in a Female with Classic, Salt-Wasting 21-Hydroxylase Deficiency

      hrp0089p3-p337
    • Ovarian Leydig Cell Tumor in an 8 Years Old Girl Misdiagnosed as Congenital Adrenal Hyperplasia Due to Elevated 17-Hydroxi-Progesterone

      hrp0089p3-p338
    • Analysis of Genetic Mutations in a Chinese Pedigree Affected with Idiopathic Hypogonadotropic Hypogonadism Syndrome

      hrp0089p3-p339
    • Cytogenetic Spectrum of Ovotesticular Disorder of Sex Development in Egyptian DSD Patients

      hrp0089p3-p340
    • Cytogenetic Spectrum of Ovotesticular Disorder of Sex Development in Egyptian DSD Patients

      hrp0089p3-p341
    • Characterization of Genotype-Phenotype in Inter-Familial and Intra-Familial Patients with Same Mutation of SRD5A2 Gene

      hrp0089p3-p342
    • Genital Abnormalities and Management Outcomes as Seen in the University of Port Harcourt Teaching Hospital

      hrp0089p3-p343
    • A Case Report: A Girl with 46,XY Karyotype and Disorder of Androgen Synthesis

      hrp0089p3-p344
    • The Positive Effect of the Low-Dose Contraceptive on the Course of Cystic Fibrosis in the Adolescent Female

      hrp0089p3-p345
    • Ovotesticular Disorder of Sexual Development: 31 Cases Followed-up in a Single-Center in Brazil

      hrp0089p3-p346
    • Genital Swelling and Ovarian Stimulation Syndrome in an Extremely Preterm Infant

      hrp0089p3-p347
    • Significant Penile Growth with Local DHT-Gel in an Infant with 17-Beta HSD-Deficiency

      hrp0089p3-p348
    • Mother and Baby Diagnosed Noonan Syndrome with Dysmorphic Findings

      hrp0089p3-p349
    • 5-Alpha Reductase Type 2 Deficiency among Iranian Patients with Ambiguous Genitalia

      hrp0089p3-p350
    • A Case Report of Spironolactone Treatment for Becker's Nevus Associated Ipsilateral Breast Hypoplasia

      hrp0089p3-p351
    • New Mutation in 5-Alpha-Redoctase: A Five-Month-Old Infant with a Karyotype of 46 XY

      hrp0089p3-p352
    • A Novel Compound Heterozygous Mutation in CYP19A1 Resulting in Aromatase Deficiency with Normal Gonadotropin Levels and Ovarian Tissue

      hrp0089p3-p353
    • Emblematic Case CAH

      hrp0089p3-p354
    • The Republic of Colombia Has a Constitutional Jurisprudential Precedent Identified as T622 of 2014,1 This Sentence Reaffirms the Importance of the Accurate Diagnosis of Intersexual Patients and Updates How the State Looks at Them2

      hrp0089p3-p355
    • Paediatric Doctors' Experience and Knowledge of the Initial Management of Neonatal Ambiguous Genitalia

      hrp0089p3-p356
    • A Case of Transverse Testicular Ectopia with Persistant Mullerian Duct Syndrome: A Novel AMH Gene Mutation

      hrp0089p3-p357
    • Argentinean First Experience with Transgender Children and Youths

      hrp0089p3-p358
    • Long-Term Follow-up in a Chinese Child with Lipoid Congenital Adrenal Hyperplasiadue to STARmutation

      hrp0089p3-p359
    • 46,XY Gonadal Dysgenesis Accompanied by Neuropathy Caused by a DHH Mutation

      hrp0089p3-p360
    • Clinical and Molecular Characterization of One Nr5a1 Gene Mutation Found in a Patient WITH 46, XY DSD

      hrp0089p3-p400
    • Genetic Testing by SNP Array Analysis in A Group of Romanian Patients with Disorders of Sexual Development

      hrp0089p3-p408
    • A Novel Gene Mutation and Atypical Clinical Phenotype of Kallmann Syndrome

      hrp0089p3-p409
  • Thyroid P1
  • • Early Determinants of Thyroid Function Outcome in Children with Congenital Hypothyroidism and a Normally Located Thyroid Gland: A Regional Cohort Study

      hrp0089p1-p248
    • Neonatal Screening for Congenital Hypothyroidism: Age-dependent Reference Intervals for Dried Blood Spot TSH in the Neonatal Period

      hrp0089p1-p249
    • Thyroid Scintigraphy in the Diagnosis of Congenital Hypothyroidism

      hrp0089p1-p250
    • Congenital Hypothyroidism (CH) with Delayed TSH Elevation: The Importance of The Second-Screening Strategy and the Evolution of CH in Preterm Infants

      hrp0089p1-p251
    • Morning Versus Bedtime Levothyroxine Administration: What is the Choice of Children?

      hrp0089p1-p252
    • Long Term Comparison between Liquid and Tablet Formulations of L-Thyroxine (L-T4) in the Treatment of Congenital Hypothyroidism (CH)

      hrp0089p1-p253
    • Isolated Congenital Central Hypothyroidism due to a Novel Mutation in TSH Beta Subunit Gene

      hrp0089p1-p254
    • Patterns of Thyroglobulin Levels in Infants Referred With High TSH on Newborn Screening, Compared with Iodine-sufficient Healthy Controls

      hrp0089p1-p255
    • Mutation Screening in 60 Chinese Patients with Congenital Hypothyroidism

      hrp0089p1-p256
    • Results of the hTPO Mutational Screening in Bulgarian Patients with Congenital Hypothyroidism (CH)

      hrp0089p1-p257
    • Thyroid Hormone Resistance Beta: Eighteen Pediatric Patient Experience

      hrp0089p1-p258
    • A Novel Mutation of IGSF1 Gene

      hrp0089p1-p259
    • Multinodular Goiter in Childhood: A Diagnostic Gateway for Screening DICER1 Syndrome

      hrp0089p1-p260
    • A Novel DICER1 Mutation Identified in a Family with the Multinodular Goiter of Children

      hrp0089p1-p261
    • Subclinical Hypothyroidism, Thyroid Nodule or Cyst in Prepubertal Children: How Many Children were Diagnosed at Age 6?

      hrp0089p1-p262
    • Expression of ZnT8 Transporter in Thyroid Tissues from Patients with Immune and Non-Immune Thyroid Diseases

      hrp0089p1-p263
    • Thyroid Nodules in a Childhood Cancers Survivors Population: A Monocentric Experience

      hrp0089p1-p264
    • HLA Alleles and Amino Acid Variants of HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 Molecules in Early-Onset Autoimmune Thyroid Disease

      hrp0089p1-p265
    • Childhood Thyroid Autoimmunity and Relation to Islet Autoantibodies in Children at Risk for Type 1 Diabetes

      hrp0089p1-p266
    • Evaluation of Serum Concentrations of Selected Cytokines OPG and sRANKL in the Diagnosis of Autoimmune Thyroid Disease in Children

      hrp0089p1-p267
    • Analysis of Zinc-Transporter ZnT8 Autoantibodies in Children and Adolescents with Autoimmune Thyroid Diseases

      hrp0089p1-p268
    • The Association between TSHR, IFIH1 and ETV5 Polymorphisms with Graves' Disease and Diabetes Mellitus Type 1 in Children

      hrp0089p1-p269
  • Thyroid P2
  • • Long Term Monitoring of Graves Disease in Children and Adolescents: Single Center Experience

      hrp0089p2-p376
    • Effects of Thyroid Autoimmunity on Non-Alcoholic Fatty Liver Disease in Euthyroid Girls with Hashimoto's Thyroiditis

      hrp0089p2-p377
    • The Prevalence of Clinically Significant Anti-TPO Positivity in Children with HLA-Conferred Susceptibility to Type 1 Diabetes

      hrp0089p2-p378
    • Encephalopathy Associated with Autoimmune Thyroid Disease: A Case Report

      hrp0089p2-p379
    • Celiac Disease Screening Should be Routinely Offered in Pediatric Population with Autoimmune Thyroid Disease

      hrp0089p2-p380
    • Autoimmune Thyroiditis in Klippel-Feil Syndrome with Arnold Chiari and Syringomyelia

      hrp0089p2-p381
    • Neonatal Monitoring of Newborns Born from Mothers with Graves' Disease: Results of a Retrospective Monocentric Study

      hrp0089p2-p382
    • A Successful Switch Experience from High-dose PTU to MMI on Day 4 of Graves' Thyroid Storm in a 14-Year-Old Girl

      hrp0089p2-p383
    • Graves's Disease During Pregnancy: The Impact on the Fetus and the Newborn

      hrp0089p2-p384
    • Thyroid Hormone Receptor [beta] (THRB) Mutation: Two New Cases of Heterozygous Mutation with Significant Family History

      hrp0089p2-p385
    • Triac Treatment Response to Thyroid Hormone Resistantance

      hrp0089p2-p386
    • Phenotype and Genotype of Four Patients with Thyroid Hormone Resistance Syndrome due to Mutations in the THRB Gene

      hrp0089p2-p387
    • Clinical Course in a Girl with Two hTPO Mutations - Homozygous c.1268G>A (p.Gly393Arg) and Heterozygous c.208C>G (p.Ala70Pro): 27 Years of Follow Up

      hrp0089p2-p388
    • A Neurological Disease Mimicking Central Hypothyroidism: MCT8 Deficiency

      hrp0089p2-p389
    • Multinodular Goiter in Childhood: Look for DICER1 Mutation

      hrp0089p2-p390
    • Application of Elastography in Assesment of Different Benign Thyroid Lesions in Children and Adolescents

      hrp0089p2-p391
    • Clinical Characteristics and Predictive Factors for the Detection of Thyroid Cancer in Children with Thyroid Nodules

      hrp0089p2-p392
    • Thyroid Nodules in Prader-Willi Syndrome

      hrp0089p2-p393
    • Early Medullary Thyroid Carcinoma (MTC) in an Infant with Multiple Endocrine Neoplasia Type 2B (MEN2B, RETS Mutation codon 891)

      hrp0089p2-p394
    • Serum Level of Biotin Rather than the Daily Dose is the Main Determinant of the Interference on Thyroid Function Assays in Patients with Biotinidase Deficiency

      hrp0089p2-p395
    • Thyroid Function Tests and Affecting Factors in Twins and Triplets

      hrp0089p2-p396
    • Hypothyroidism in a Child During Treatment with Nivolumab for a Glioblastoma

      hrp0089p2-p397
    • Diagnosis and Clinical Course of Amiodarone Induced Hyperthyroidism in Three Adolescent Patients

      hrp0089p2-p398
    • Allogenic Bone Marrow Transplantation in Children: Effect on Thyroid Function

      hrp0089p2-p399
    • Follow-up in Children with Non-obese and Non-autoimmune Subclinical Hypothyroidism

      hrp0089p2-p400
    • Clinical Management of Childhood Hyperthyroidism: A Longitudinal Study at a Single Center

      hrp0089p2-p401
    • Association of Thyroid Stimulating Hormone and Free Thyroxine with Cardiometabolic Risk Factors in Euthyroid Korean children and Adolescents Aged 10-18 Years: The Korean National Health and Nutrition Examination Survey 2015

      hrp0089p2-p402
    • Asymptomatic Hyperthyrotropinaemia in Children, Does it Correlate to true Thyroid Gland Dysfunction?

      hrp0089p2-p403
    • Hearing Loss Among Patients with Congenital Hypothyroidism

      hrp0089p2-p404
    • Predictors of Permanent Congenital Hypothyroidism in Children

      hrp0089p2-p405
    • Absence of Uptake on Scintigraphy Does Not Always Correlate with Athyreosis: Re-evaluation of Patients Diagnosed with Athyreosis Over a 10 Year Period in the Republic of Ireland

      hrp0089p2-p406
    • Bannayan-Riley-Ruvalcaba Syndrome with PTEN Mutation in a Patient Affected by Congenital Hypothyroidism due to TPO Gene Alteration

      hrp0089p2-p407
    • The Congenital Hypothyroidism Screening Programme in a Sigle Italian Centre: a 5-Years Retrospective Study

      hrp0089p2-p408
    • Do Insulin Like Growth Factors also Influence Growth in Children with Congenital Hypothyroidism: A Cohort Analysis

      hrp0089p2-p409
    • Study of Hearing Function in Children with Congenital Hypothyroidism Attending Alexandria University Children's Hospital

      hrp0089p2-p410
    • Awareness of the Risks of Acquired Iodine Deficiency in Strict Vegan Diets

      hrp0089p2-p411
    • Thyroid Function in the Korean Obese Children and Adolescents: Korea National Health and Nutrition Examination Survey 2013 to 2015

      hrp0089p2-p412
  • Thyroid P3
  • • Prevalence and Demographic Profile of Thyroid Disorders in Indian Children

      hrp0089p3-p361
    • Graves' Disease in a Pediatric Population: Results from the Last 17 Years at a Pediatric Endocrinology Unit

      hrp0089p3-p362
    • Acquired Severe Hypothyroidism in Children - Forgotten or Unbelievable Diagnosis in a Time of Large and Easy Availability of Thyroid Tests?

      hrp0089p3-p363
    • Thyroid Disorders and Autoimmunity in Children and Adolescents with Type 1 (T1DM) and Type 2 Diabetes Mellitus (T2DM)

      hrp0089p3-p364
    • The Reference and Follow-up Signs and Symptoms of the Cases Who Are Diagnosed As Hyperthyroidism

      hrp0089p3-p365
    • Clinical Features in Childhood Graves' Disease

      hrp0089p3-p366
    • General Characteristics of Autoimmune Thyroid Diseases and Evaluation of Accompanied Morbiditis

      hrp0089p3-p367
    • Amiodarone Induced Hyperthyroidism in a Pediatric Patient

      hrp0089p3-p368
    • Abstract unavailable

      hrp0089p3-p369
    • Thyroid Carcinoma in Children: 7 Years' Experience of a Single Center

      hrp0089p3-p370
    • Autoimmune Thyroiditis (Hashimoto Thyroiditis) in a Known Case of Autoimmune Hemolytic Anemia

      hrp0089p3-p371
    • Dento - Maxillary and Periodontal Changes in Puberty/Adolescence in Subclinical Hypothyroidism of Autoimmune Cause

      hrp0089p3-p372
    • Hypovitaminosis D and Chronic Autoimmune Thyroiditis Mammary Echostructural Involvements in Puberty

      hrp0089p3-p373
    • Two Contrasting Cases of Solitary Thyroid Nodules in Adolescent Girls

      hrp0089p3-p374
    • Congenital Hypothyroidism - Diagnose Early and Keep Going

      hrp0089p3-p375
    • An Impressive Recovery of Arrested Growth and Puberty in a 13 Year Old Boy after Being Treated for Simultaneously Diagnosed Severe Hypothyroidism and Coeliac Disease

      hrp0089p3-p376
    • A Very Rare Thyroid Hormone Resistance Case Having Heterozygous Mutation in THRB Genes

      hrp0089p3-p377
    • Clinical Case (Children's Endocrinology)

      hrp0089p3-p378
    • Thyroid Imaging Study for the Diagnosis of Congenital Hypothyroidism with Thyroid Dysgenesis

      hrp0089p3-p379
    • A Case of Permanent Congenital Hypothyroidism with Compound Heterozygous Mutations in the DUOX2 Gene

      hrp0089p3-p380
    • Growth Catch-up on Acquired Hypothyroidism Presenting with Growth Delay

      hrp0089p3-p381
    • Thyroid Disease in Children and Adolescences with Down Syndrome- 16 Years of Follow Up in a Single Service

      hrp0089p3-p382
    • Corticosteroid Resistant Immune Thrombocytopenic Purpura, is it a Marker of Future Graves Disease?

      hrp0089p3-p383
    • Neonatal Hypothyroidism following Transplacental Amiodarone Treatment for Supraventricular Tachyarrhythmia

      hrp0089p3-p384
    • Rare Case Report of Thyroiditis De Quervain in a Six Years Old Girl

      hrp0089p3-p385
    • Papillary Thyroid Carcinoma in a 7 Year Old Boy Presenting with a Goiter Without Microcalcifications and Enlarged Cervical Lymph Nodes

      hrp0089p3-p386
    • Graves' Disease, Methimazole and SLE-like Reaction:A Case Report

      hrp0089p3-p387
    • A Rare Case of Pediatric Hyperthyroidism

      hrp0089p3-p388
    • Allan-Herndon-Dudley Syndrome in a Patient with Global Delay Development - a Case Report

      hrp0089p3-p389
    • Multi Autoimmune Phenomenon in Indian Children with Thyroid Disorder

      hrp0089p3-p390
    • Levothyroxine Treatment of Subclinical (SH) and Overt (OH) Hypothyroidism in Children with Autoimmune Hashimoto Thyroiditis (AHT): A Retrospective Study in Regard with TSH and Free T4 (FT4) at Diagnosis

      hrp0089p3-p391
    • Hashitoxicosis:a Rare Diagnosis in Childhood

      hrp0089p3-p392
    • An Assay Led Astray: A Curious Case of Biotin-Induced Hyperthyroidism

      hrp0089p3-p393
    • A Case of Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) in a Girl with Newly Diagnosed Hashimoto Thyroiditis

      hrp0089p3-p394
    • Intellectual Outcome at Childhood in Congenital Hypothyroidism According to Etiology and Treatment Related Factors

      hrp0089p3-p395
    • Myastenia Gravis in a Girl with Hashimoto Thyroiditis

      hrp0089p3-p396
    • Head Circumference, Birth Length, and Weight of Neonates of Mothers with Hypothyroidism

      hrp0089p3-p397
  • Late Breaking P1
  • • A Second Growth Hormone Receptor Pseudoexon Mutation Causing Frameshift and Severe Postnatal Growth Failure

      hrp0089lb-p1
    • Abstract unavailable

      hrp0089lb-p2
    • Glycemic Impact of Long Term Use of Diazoxide Choline Controlled-Release Tablets in Patients with Prader-Willi Syndrome or with Very High Triglycerides

      hrp0089lb-p3
    • An Updated Evolutionary Study in Glucocorticoid Receptors; Insights from a Comprehensive Phylogenetic, SNP's and Mutation's Analysis of the Nuclear Receptors Family: An Updated Evolutionary Study in Glucocorticoid Receptors; Insights from a Comprehensive Phylogenetic, SNP's and Mutation's Analysis of the Nuclear Receptors Family

      hrp0089lb-p4
    • Association between the Use of Antenatal Steroids for Lung Maturation and Hypoglycemia in Newborns Between 26 and 34 6/7 Weeks of Gestation

      hrp0089lb-p5
    • Sex Hormone Levels in Young Children: a Pilot Study of the Japan Environment and Children's Study

      hrp0089lb-p6
    • Mutational Analysis of SRD5A2 and AR Genes in Indian Children with 46 XY Disorders of Sex Development

      hrp0089lb-p7
    • Pharmacokinetics of Diazoxide Choline Controlled-Release Tablets, a Once Daily Treatment Being Evaluation in Patients with Prader Willi Syndrome

      hrp0089lb-p8
    • Two Siblings with Autosomal Recessive Syndromic Hypopituitarism Caused By Mutations in TBC1D32

      hrp0089lb-p9
    • The Influence of Oil-Soluble Iodinated Contrast Medium (Lipiodol) on Child's Thyroid Function in Mice

      hrp0089lb-p10
    • Metabolic Profile in Survivors of Pediatric Hematopoietic Stem Cells Transplantation after Chemotherapy-Only Conditioning

      hrp0089lb-p11
    • Disrupting the Norm: The Experience of Young People with DSD

      hrp0089lb-p12
    • Clinical and Endocrine Characteristics and Genetic Analysis of Korean Children with McCune-Albright Syndrome

      hrp0089lb-p13
    • Beta-cell Function in Chinese Youngsters with Type 1 Diabetes and Assessment of Surrogate Markers of Severe Insulin Deficiency

      hrp0089lb-p14
    • A Novel Compound Heterozygous Mutation of the CYP17A1 Gene is Associated with Rhabdomyolysis: Demonstration of Combining 17[alpha]-hydroxylase/17,20-Lyase Deficiency

      hrp0089lb-p15
    • Successful Treatment of Alopecia Totalis with Calcitriol and Paricalcitol in Two Girls Aged 3 and 7-Years

      hrp0089lb-p16
    • Protein-Induced Hypoglycemia Secondary to Hyperinsulinism-Hyperammonemia (HI/HA) Syndrome: A GLUD1 Gene Mutation

      hrp0089lb-p17
    • The Efficacy of GnRHa alone or in Combination with rhGH for the Treatment of Idiopathic Central Precocious Puberty or Early and Fast Puberty in Chinese Girls

      hrp0089lb-p18
    • Characterization and Clinical Course of Prolactinoma in Korean Adolescents

      hrp0089lb-p19
    • The Efficacy and Safety of Octreotide Treatment for Diazoxide-Unresponsive Congenital Hyperinsulinism in China

      hrp0089lb-p20